Molcan Corporation (Page 1) @ ChemBuyersGuide.com, Inc.

Group :

(2S)-1-[(2S,4R)-4-Benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-(1,1-dimethylethyl)piperazine-2-carboxamide ;
CAS:150323-38-9
IDN02 :
Indinavir EP Impurity B ; Desnictoinyl Indinavir (USP) ; Des-3-pyridylmethyl Indinavir ;

(2S)-1-[2-[(3,5-Dihydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile ;
VDG55 :
Vildagliptin Diol ; Hydroxy Vildagliptin ;

(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)-N-hydroxyamino]acetyl]-2-pyrrolidinecarbonitrile ;
VDG56 :
Vildagliptin N-Hydroxy ;

(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidine carbonitrile ;
CAS:274901-16-5
VDG00 :
Vildagliptin ;

(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidine carboxamide ;
CAS:565453-39-6
VDG41 :
Vildagliptin Amide Impurity ; Vildagliptin IP Impurity A ;

(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidine carboxylic acid ;
CAS:565453-40-9
VDG42A :
Vildagliptin Carboxylic Acid ; Vildagliptin IP Impurity C ;

(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidine carboxylic acid lithium salt ;
VDG42L :
Vildagliptin Carboxylic Acid (Lithium Salt) ;

(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidine carboxylic acid methyl ester ;
CAS:948574-56-9
VDG52 :
Vildagliptin Carboxylic Acid Methyl Ester ;

(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile O-+¦-D-glucopyranosiduronic acid ;
CAS:1147403-03-9
VDG50 :
Vildagliptin +¦-D-Glucuronide ;

(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)imino]acetyl]-2-pyrrolidinecarbonitrile ;
CAS:2246354-69-6 1846606-31-2
VDG76 :
Vildagliptin Impurity 6 ;

(2S)-1-Amino-3-[[3-fluoro-4-(4-morpholinyl)phenyl]amino]-2-propanol 2-acetate ;
CAS:333753-71-2
LNZ52B :
Linezolid O-Acetyl Impurity (Base) ;

(2S)-1-Amino-3-[[3-fluoro-4-(4-morpholinyl)phenyl]amino]-2-propanol 2-acetate dihydrochloride ;
LNZ52H :
Linezolid O-Acetyl Impurity (2HCl) ;

(2S)-2,2GÇÖ-[[(5R)-2,2GÇÖ-Diamino-4,4GÇÖ,6-trioxo-1,4,4GÇÖ,6,7,7GÇÖ-hexahydro-1GÇÖH,5H-5,6GÇÖ-bipyrrolo[2,3-d]pyrimidine-5,5GÇÖ-diyl]bis(ethane-2,1-diylbenzene-4,1-diylcarbonylimino)]-dipentanedioic acid ;
CAS:1802552-04-0
PMT02 :
Pemetrexed EP Impurity B ; Pemetrexed (5R)-Dimer ; Supplied as a mixture of (5R) & (5S)-isomer ;

(2S)-2,2GÇÖ-[[(5S)-2,2GÇÖ-Diamino-4,4GÇÖ,6-trioxo-1,4,4GÇÖ,6,7,7GÇÖ-hexahydro-1GÇÖH,5H-5,6GÇÖ-bipyrrolo[2,3-d]pyrimidine-5,5GÇÖ-diyl]bis(ethane-2,1-diylbenzene-4,1-diylcarbonylimino)]-dipentanedioic acid ;
CAS:1802552-16-4
PMT03 :
Pemetrexed EP Impurity C ; Pemetrexed (5S)-Dimer ; Supplied as a mixture of (5R) & (5S)-isomer ;

(2S)-2-((2-Amino-6-oxo-1,6-dihydropurin-9-yl)methoxy)-3-hydroxypropyl 2-(benzyloxycarbonyl)-3-methylbutanoate ;
CAS:194154-40-0
VGC50 :
Valganciclovir N-Benzyloxycarbonyl Impurity ; N-Carbobenzyloxy Valganciclovir ;

(2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid ;
CAS:361442-00-4
SXG62 :
Saxagliptin RC 2 ; Boc-3-hydroxy-1-adamantyl-D-glycine ;

(2S)-2-(2-Oxopyrrolidin-1-yl)butanoic acid ;
CAS:102849-49-0
LET41 :
Levetiracetam Carboxylic Acid ; (S)-Levetiracetam Acid ;

(2S)-2-(3-Benzoylphenyl)propanoic acid ;
CAS:22161-81-5
KTP40 :
Ketoprofen S-Isomer ; (S)-(+)-Ketoprofen ; Dexketoprofen ;

(2S)-2-(4-(1-(2,4-Diaminopteridin-6-yl)pent-4-yn-2-yl)benzamido)-5-methoxy-5-oxopentanoic acid ;
CAS:1548618-62-7
PXT58 :
Pralatrexate RC 8 ;

(2S)-2-(4-(1-(2-Amino-4-hydroxypteridin-6-yl)pent-4-yn-2-yl)benzamido)pentanedioic acid ;
CAS:1548618-61-6
PXT56 :
Pralatrexate RC 6 ;

(2S)-2-(4-(3-Amino-1-oxo-5,6,6a,7-tetrahydroimidazo[1,5-f]pteridin-8(1H,4H,9H)-yl)benzamido)pentanedioic acid ;
CAS:3432-99-3
LFL50A :
Levofolinate Methylene Impurity ; Folitixorin ;

(2S)-2-(5-Bromo-6-methoxynaphthalen-2-yl)propanoic acid ;
CAS:84236-26-0
NPX03 :
Naproxen EP Impurity C ; (S)-5-Bromo Naproxen ;

(2S)-2-(5-Chloro-6-methoxynaphthalen-2-yl)propanoic acid ;
CAS:89617-86-7
NPX02 :
Naproxen EP Impurity B ; (S)-5-Chloro Naproxen ;

(2S)-2-(5-Iodo-6-methoxynaphthalen-2-yl)propanoic acid ;
CAS:116883-62-6
NPX04 :
Naproxen EP Impurity D ; (S)-5-Iodo Naproxen ;

(2S)-2-(6-Hydroxynaphthalen-2-yl)propanoic acid ;
CAS:52079-10-4
NPX01 :
Naproxen EP Impurity A ; (S)-O-Desmethyl Naproxen ;

(2S)-2-(6-Methoxynaphthalen-2-yl)propanoic acid ;
CAS:22204-53-1
NPX00A :
Naproxen (Acid) ; (S)-Naproxen ;

(2S)-2-(6-Methoxynaphthalen-2-yl)propanoic acid sodium salt ;
CAS:26159-34-2
NPX00N :
Naproxen (Sodium) ; (S)-Naproxen Sodium ;

(2S)-2-[(1R)-(2-Ethoxyphenoxy)(phenyl)methyl]morpholine ;
RBX52 :
Reboxetine (1R,2S)-Isomer ;

(2S)-2-[(1S)-(2-Ethoxyphenoxy)(phenyl)methyl]morpholine ;
CAS:98819-76-2
RBX54 :
Reboxetine (1S,2S)-Isomer ;

(2S)-2-[(3S,5aS,8aS,9aS)-3-Methyl-1,4-dioxodecahydro-2H-cyclopenta[4,5] pyrrolo[1,2-a]pyrazin-2-yl]-4-phenylbutanoic acid ;
CAS:108736-10-3
RMP11 :
Ramipril EP Impurity K ; Ramiprilat Diketopiperazine ; Ramipril Diketopiperazine Acid ; Ramipril Diacid Dione ;

(2S)-2-[(3S,5aS,9aS,10aR)-3-Methyl-1,4-dioxodecahydropyrazino[ 1,2-a]indol-2(1H)-yl]pentanoic acid ;
CAS:130061-28-8
PRD04 :
Perindopril EP Impurity D ; Perindopril USP RC D ; Perindopril BP Impurity D ; Perindoprilat Lactam B ;

(2S)-2-[(3S,5aS,9aS,10aS)-3-Methyl-1,4-dioxodecahydropyrazino[1,2-a] indol- 2(1H)-yl]pentanoic acid ;
CAS:129970-99-6
PRD03 :
Perindopril EP Impurity C ; Perindopril BP Impurity C ; Perindoprilat Lactam A ; Perindopril (10aS)-Dione Acid ;

(2S)-2-[(3S,8aR)-3-(4-Aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4-phenylbutanoic acid ;
CAS:219677-82-4
LSN04 :
Lisinopril EP Impurity D ; Lisinopril (S,S,R)-Diketopiperazine ;

(2S)-2-[(3S,8aRS)-3-(4-Aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4-phenylbutanoic acid ;
CAS:1092813-99-4
LSN34 :
Lisinopril Diketopiperazine (= Lisinopril EP Imp. C + D) ; Lisinopril (8aRS)-Diketopiperazine (Mixture of Diastereomers) ;

(2S)-2-[(3S,8aS)-3-(4-Aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4-phenylbutanoic acid ;
CAS:328385-86-0
LSN03 :
Lisinopril EP Impurity C ; Lisinopril USP RC A ; Lisinopril (S,S,S)-Diketopiperazine ;

(2S)-2-[(4-Aminobenzoyl)amino]pentanedioic acid ;
CAS:4271-30-1
FCD01 :
Folic Acid EP Impurity A ; Methotrexate EP Impurity K ; Levofoliate EP Impurity A ; Leucovorin USP Impurity B ;

(2S)-2-[(4-Aminobenzoyl)amino]pentanedioic acid ; N-(4-Aminobenzoyl)-L-glutamic acid ;
CAS:4271-30-1
MTX11 :
Methotrexate EP Impurity K ; Folic Acid EP Impurity A ;

(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino] propanoic acid ;
CAS:82717-96-2
QPR02 :
Quinapril EP Impurity B ; Enalapril EP Impurity B ; Moexipril USP RC F ; Ramipril EP Impurity F ; Trandolapril ECPPA Impurity ; Spirapril EP Impurity C ;

(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]propanoic acid ;
CAS:82717-96-2
SPP03 :
Spirapril EP Impurity C ; Moexipril USP RC F ; Enalapril EP Impurity B ; Quinapril EP Impurity B ; Ramipril EP Impurity F ; Trandolapril ECPPA Impurity ;

(2S)-2-[[(4S-4-[[[4-[2-(2-Amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl] carbonyl]amino]-4-carboxybutanoyl)amino] pentanedioic acid ;
CAS:144051-68-3
PMT04A :
Pemetrexed EP Impurity D (Acid) ; Pemetrexed Triacid ; Pemetrexed L-Glutamic Acid ;

(2S)-2-[[(4S-4-[[[4-[2-(2-Amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl] carbonyl]amino]-4-carboxybutanoyl)amino] pentanedioic acid trisodium salt ;
CAS:1265908-59-5
PMT04N :
Pemetrexed EP Impurity D (Trisodium) ; Pemetrexed Trisodium ; Pemetrexed L-Glutamic Acid Trisodium Salt ;

(2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] amino] propanoic acid ;
CAS:1233335-78-8
SFS54A :
Sofosbuvir O-Desisopropyl O-Desphenyl Acid ; Uridine Alanine Phosphate ;

(2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] amino] propanoic acid ammonium salt ;
SFS54N :
Sofosbuvir O-Desisopropyl O-Desphenyl Ammonium Salt ; Uridine Alanine Phosphate Ammonium Salt ;

(2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] amino] propanoic acid sodium salt ;
SFS54X :
Sofosbuvir O-Desisopropyl O-Desphenyl Sodium Salt ; Uridine Alanine Phosphate Sodium Salt ;

(2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydrofuran-2-yl]methoxy-phenoxy-phosphoryl] amino] propanoic acid ;
SFS40 :
Sofosbuvir O-Desisopropyl Impurity ; Sofosbuvir Carboxylic Acid ;

(2S)-2-[[4-(Methylamino)benzoyl]amino]pentanedioic acid ;
CAS:52980-68-4
MTX12A :
Methotrexate EP Impurity L (Acid) ;

(2S)-2-[[4-(Methylamino)benzoyl]amino]pentanedioic acid disodium salt ;
CAS:57444-71-0
MTX12N :
Methotrexate EP Impurity L (Sodium) ;

(2S)-2-[[4-[[(2,4-Diaminopteridin-6-yl)methyl]methylamino]benzoyl]amino]-5-methoxy-5-oxopentanoic acid ;
CAS:67022-39-3
MTX08 :
Methotrexate EP Impurity H ; Methotrexate USP RC H ; Methotrexate 5-Methyl Ester ; Methotrexate +¦-Methyl Ester ;

(2S)-2-[[4-[[(2,4-Diaminopteridin-6-yl)methyl]methylamino]benzoyl]amino]pentanedioic acid ;
CAS:59-05-2
MTX00A :
Methotrexate (Acid) ; (+)-Amethopterin ; 4-Amino-N10-Methylfolic Acid ;

(2S)-2-[[4-[[(2,4-Diaminopteridin-6-yl)methyl]methylamino]benzoyl]amino]pentanedioic acid disodium salt ;
CAS:7413-34-5
MTX00N :
Methotrexate (Disodium Salt) ; (+)-Amethopterin Disodium ; 4-Amino-N10-Methylfolic Acid Disodium ;

(2S)-2-[[4-[[(2-Amino-4-oxo-1,4-dihydropteridin-7-yl)methyl]amino]benzoyl]amino] pentanedioic acid ;
CAS:47707-78-8
FCD03 :
Folic Acid EP Impurity C ; Isofolic Acid ;

(2S)-2-[[4-[[4-[[(2,4-Diaminopteridin-6-yl)methyl]methylamino]benzoyl]methylamino]benzoyl] amino]pentanedioic acid ;
CAS:2519848-42-9
MTX07 :
Methotrexate EP Impurity G ; Methotrexate USP RC G ;

(2S)-2-[[4-[Bis[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoyl]amino] pentanedioic acid ;
CAS:1391068-26-0
FCD05 :
Folic Acid EP Impurity E ; 6-Pterinylfolic Acid ;

(2S)-2-[4-[(4S)-4-[4-[[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzamido]-4-carboxybutan amido]benzamido]pentanedioic acid ;
CAS:2366274-27-1
FCD08A :
Folic Acid EP Impurity H ;

(2S)-2-Amino-2-(3-hydroxyadamantan-1-yl)acetic acid ;
CAS:709031-29-8
SXG70 :
Saxagliptin RC 10 ;

(2S)-2-Amino-3-(2,4,5-trihydroxyphenyl)propanoic acid; 3-(3,4,6-Trihydroxyphenyl)-alanine ;
CAS:27244-64-0
LDP01B :
Levodopa EP Impurity A ; Levodopa USP RC A ; 2-Hydroxy Levodopa ;

(2S)-2-Amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid ;
CAS:555-30-6
MTD00A :
Methyldopa (Anhydrous) ; L-Methyldopa ; Carbidopa EP Impurity A (Anhydrous) ;

(2S)-2-Amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid sesquihydrate ;
CAS:41372-08-1
MTD00H :
Methyldopa (Sesquihydrate) ; L-Methyldopa Sesquihydrate ; Carbidopa EP Impurity A (Sesquihydrate) ;

(2S)-2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid ;
CAS:59-92-7
LDP00B :
Levodopa ; L-Dopa ;

(2S)-2-Amino-3-(3,4-dimethoxyphenyl)-2-methylpropanoic acid ;
CAS:39948-18-0
MTD03B :
Methyldopa EP Impurity C (Base) ; Methyldopa USP RC C ; Methyldopa Dimethyl Ether ;

(2S)-2-Amino-3-(3,4-dimethoxyphenyl)-2-methylpropanoic acid HCl ;
CAS:5486-79-3
MTD03H :
Methyldopa EP Impurity C (HCl) ; Methyldopa USP RC C ; Methyldopa Dimethyl Ether HCl ;

(2S)-2-Amino-3-(3,4-dimethoxyphenyl)propanoic acid ;
CAS:32161-30-1
LDP50B :
Levodopa Dimethyl Ether (Base) ; L-Dopa Dimethyl Ether ;

(2S)-2-Amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid ;
CAS:300-39-0
LTN02B :
Liothyronine EP Impurity B ; Diiodotyrosine ;

(2S)-2-Amino-3-(4-hydroxy-3-methoxyphenyl)-2-methylpropanoic acid ;
CAS:6739-31-7
MTD01 :
Methyldopa EP Impurity A ; 3-O-Methyl Methyldopa ;

(2S)-2-Amino-3-(4-hydroxy-3-methoxyphenyl)propanoic acid ;
CAS:300-48-1
LDP63B :
Levodopa EP Impurity C (S)-Isomer (Anhydrous) ; 3-O-Methyl L-Dopa ; 3-Methoxy L-Tyrosine ;

(2S)-2-Amino-3-(4-hydroxy-3-methoxyphenyl)propanoic acid HCl ;
CAS:63302-24-9
LDP63H :
Levodopa EP Impurity C (S)-Isomer (HCl) ; 3-O-Methyl L-Dopa HCl ; 3-Methoxy L-Tyrosine HCl ;

(2S)-2-Amino-3-(4-hydroxy-3-methoxyphenyl)propanoic acid monohydrate ;
CAS:200630-46-2
LDP63M :
Levodopa EP Impurity C (S)-Isomer (Monohydrate) ; 3-O-Methyl L-Dopa Monohydrate ; 3-Methoxy L-Tyrosine Monohydrate ;

(2S)-2-Amino-3-(4-hydroxyphenyl)propanoic acid ;
CAS:60-18-4
LDP02B :
Levodopa EP Impurity B ; L-Tyrosine ;

(2S)-2-Amino-3-(4-morpholin-4-ylphenyl)propanoic acid ;
CAS:1270153-04-2
MLP02B :
Melphalan EP Impurity B ;

(2S)-2-Amino-3-[4-(3-chloro-4-hydroxy-5-iodophenoxy)-3,5-diiodophenyl] propanoic acid ;
CAS:1628720-66-0
LTX02 :
Levothyroxine EP Impurity B ; 3-Chloro Thyroxine ; Levothyroxine Chloro Impurity ;

(2S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic acid ;
CAS:51-48-9
LTN01A :
Liothyronine EP Impurity A (Acid) ; Levothyroxine ;

(2S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic acid sodium salt pentahydrate ;
CAS:25416-65-3
LTN01N :
Liothyronine EP Impurity A (Sodium) ; Levothyroxine Sodium ;

(2S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid ;
CAS:51-48-9
LTX00A :
Levothyroxine (Acid) ;

(2S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3-iodophenyl] propanoic acid ;
CAS:5817-39-0
LTX11 :
Levothyroxine EP Impurity K ; 3,3GÇÖ,5GÇÖ-Triiodo-L-Thyronine ;

(2S)-2-Amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid ;
CAS:6893-02-03 00:00:00
LTN00A :
Liothyronine (Acid) ; Levothyroxine EP Impurity A ;

(2S)-2-Amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid ;
CAS:6893-02-03 00:00:00
LTX01A :
Levothyroxine EP Impurity A (Acid) ; Liothyronine (Acid) ;

(2S)-2-Amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid sodium salt ;
CAS:55-06-1
LTX01N :
Levothyroxine EP Impurity A (Sodium) ; Liothyronine Sodium ;

(2S)-2-Amino-3-[4-(4-hydroxy-3-iodophenoxy)-3-iodophenyl] propanoic acid ;
CAS:4604-41-5
LTX10 :
Levothyroxine EP Impurity J ; 3,3GÇÖ-Diiodo-L-Thyronine ;

(2S)-2-Amino-3-[4-(4-hydroxyphenoxy)-3,5-diiodophenyl]-propanoic acid ;
CAS:1041-01-6
LTX05 :
Levothyroxine EP Impurity E ; Liothyronine EP Impurity E ; Diiodothyronine ; 3,5-Diiodo-L-thyronine ;

(2S)-2-Amino-3-[4-(4-hydroxyphenoxy)-3,5-diiodophenyl]propanoic acid ;
CAS:1041-01-6
LTN05B :
Liothyronine EP Impurity E ; Levothyroxine EP Impurity E ; Diiodothyronine ; 3,5-Diiodo-L-thyronine ;

(2S)-2-Amino-3-methyl-3-sulfanylbutanoic acid ;
CAS:52-67-5
PCL00 :
Penicillamine ;

(2S)-2-Amino-3-methyl-3-sulfinobutanoic acid ;
CAS:23315-18-6
SBT01 :
Sulbactam EP Impurity A ; Sulbactam USP RC A ; 3-Sulfino-D-Valine ;

(2S)-2-Amino-3-phenylpropanoic acid ;
CAS:63-91-2
NTG04 :
Nateglinide EP Impurity D ; L-Phenylalanine ; Aspartame EP Impurity C ;

(2S)-2-Amino-6-[[[[[(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracen-2-yl]carbonyl]amino]-methyl]amino]hexanoic acid ;
CAS:992-21-2
LMC00 :
Lymecycline ;

(2S)-2-Methylbutanoic acid (1S,3S,7S,8S,8aR)-8-[2-[(2R)-3,6-dihydro-6-oxo-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydro-3-hydroxy-7-methyl-1-naphtha lenyl ester ;
CAS:1114834-63-7
PVS38 :
Pravastatin 2,3-Anhydro Lactone ; 2,3-Anhydro Pravastatin Lactone ;

(2S)-2-Methylbutanoic acid (1S,6R,7R,8S,8aR)-1,2,6,7,8,8a-hexahydro-6-hydroxy-7-methyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester ;
CAS:87984-67-6
PVS44 :
Pravastatin 3-beta-Hydroxy Lactone ; 3-beta-Hydroxy Isocompactin Lactone ;

(2S)-2-Methylbutanoic acid (1S,6S,7R,8S,8aR)-1,2,6,7,8,8a-hexahydro-6-hydroxy-7-methyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester ;
CAS:85798-96-5
PVS43 :
Pravastatin 3-alpha-Hydroxy Lactone ; 3-alpha-Hydroxy Isocompactin Lactone ;

(2S)-3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-carboxylic acid ;
CAS:53174-06-4
TLX60 :
Trolox (S)-Isomer ; (S)-Trolox ;

(2S)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol ;
CAS:99291-25-5
LDZ00B :
Levodropropizine ; Dropropizine S-Isomer ;

(2S)-3-Acetoxy-2-((2-amino-6-oxo-1,6-dihydropurin-9-yl)methoxy)propyl 2-(benzyloxycarbonyl)-3-methylbutanoate ;
CAS:194159-22-3
VGC52 :
Valganciclovir O-Acetyl N-Benzyloxycarbonyl Impurity ; O-Acetyl N-Carbobenzyloxy Valganciclovir ;

(2S)-3-Methyl-2-[[methyl[[2-(1-methylethyl)thiazol-4-yl]methyl]carbamoyl] amino]butanoicacid ;
CAS:154212-61-0
RTN01 :
Ritonavir EP Impurity A ; Ureidovaline Ritonavir (USP) ;

(2S)-4-Amino-4-oxo-2-[(quinolin-2-ylcarbonyl)amino]butanoic acid ;
CAS:136465-98-0
SQN01 :
Saquinavir EP Impurity A ;

(2S)-5-Hydroxy-N-propyl-N-[2-(thiophen-2-yl)ethyl]-1,2,3,4-tetrahydronaphthalen-2-amine N-oxide ;
CAS:2708278-87-7
RTG05B :
Rotigotine EP Impurity E (Base) ; Rotigotine N-Oxide ;

(2S)-5-Hydroxy-N-propyl-N-[2-(thiophen-2-yl)ethyl]-1,2,3,4-tetrahydronaphthalen-2-amine N-oxide hydrochloride ;
CAS:2708278-88-8
RTG05H :
Rotigotine EP Impurity E (HCl) ; Rotigotine N-Oxide (HCl) ;

(2S)-7-[(2S,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one ;
CAS:10236-47-2
NRN00A :
Naringin (Anhydrous) ;

(2S)-7-[[6-O-(6-Deoxy-+¦-L-mannopyranosyl)-+¦-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one ;
CAS:14259-46-2
NGX56 :
Naringenin 7-O-Rutinoside ; Isonaringin ;

(2S)-Dimethyl 2-(4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzamido)pentanedioate ;
CAS:374777-77-2
PXT57 :
Pralatrexate RC 7 ;

(2S)-Ethyl 2-(((((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate ;
CAS:2164516-85-0
SFS75 :
Sofosbuvir IP Impurity E ; Sofosbuvir Ethyl Analog ; Sofosbuvir O-Desisopropyl O-Ethyl Ester ; Ethyl Sofosbuvir (USP) ;

(2S)-Methyl 2-(((((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate ;
CAS:1015255-46-5
SFS68 :
Sofosbuvir O-Desisopropyl O-Methyl Ester ; PSI 7672 ;

(2S)-N-[(1R,3S,4S)-1-Benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2oxotetrahydropyrimidin-1(2H)-yl]butanamide ;
CAS:1217628-64-2
LPN16 :
Lopinavir EP Impurity P ; Lopinavir (2R)-Epimer (USP) ; (2R,4S,5S)-Lopinavir ;

(2S)-N-[(1S,2S,4S)-1-benzyl-2-hydroxy-4-[[(2S)3-methyl-2-[[methyl[[2-(1-methylethyl)thiazol-4yl]methyl]carbamoyl]amino]butanoyl]amino]-5-phenylpentyl]-3-methyl-2-[[methyl[[2-(1-methylethyl)thiazol-4-yl]methyl] carbamoyl]amino]butanamide ;
CAS:869368-48-9
RTN20 :
Ritonavir EP Impurity T ; Ritonavir Divalinyl analog (USP) ;

(2S)-N-[(1S,2S,4S)-1-Benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-2-hydroxy-5-phenylpentyl]-3-methyl-2-[2oxotetrahydropyrimidin-1(2H)-yl]butanamide ;
LPN09 :
Lopinavir EP Impurity I ; Lopinavir Isomer ; Isolopinavir (USP) ;

(2S)-N-[(1S,3S,4S)-1-Benzyl-4-({[4-(2-{[(1S,2S,4S)-1-benzyl-2-hydroxy-4-{[(2S)-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanoyl]amino}-5-phenylpentyl]amino}-2-oxoethyl)-2,6-dimethylphenoxy]acetyl}amino)-3-hydroxy-5-phenylpentyl]-3-met
LPN54 :
Lopinavir IP Impurity D ;

(2S)-N-[(1S,3S,4S)-1-Benzyl-4-(formylamino)-3-hydroxy5-phenylpentyl]-3-methyl-2-[2-oxotetrahydropyrimidin1(2H)-yl]butanamide ;
LPN02 :
Lopinavir EP Impurity B ; Lopinavir N-Formyl Amino Alcohol (USP) ;

(2S)-N-[(1S,3S,4S)-1-Benzyl-4-[[2-(2,4-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2oxotetrahydropyrimidin-1(2H)-yl]butanamide ;
LPN10 :
Lopinavir EP Impurity J ; Lopinavir 2,4-Phenoxy Isomer (USP) ; Lopinavir 2,4-Dimethylphenoxy Isomer ;

(2S)-N-[(1S,3S,4S)-1-Benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-2-[3-[2-(2,6dimethylphenoxy)acetyl]-2-oxotetrahydropyrimidin1(2H)-yl]-3-methylbutanamide ;
CAS:943250-66-6
LPN18 :
Lopinavir EP Impurity R ; Lopinavir IP Impurity I ; Lopinavir N-Acyl Impurity (USP) ;

(2S)-N-[(1S,3S,4S)-1-Benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2-oxotetrahydropyrimidin-1(2H)-yl]butanamide ;
CAS:192725-17-0
LPN00 :
Lopinavir ;

(2S)-N-[(1S,3S,4S)-1-Benzyl-4-{[(2,6-dimethylphenoxy)acetyl]amino}-3-hydroxy-5-phenylpentyl]-4-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)pentanamide ;
LPN57 :
Lopinavir IP Impurity G ;

(2S)-N-[(1S,3S,4S)-1-Benzyl-4-amino-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2-oxotetrahydropyrimidin- 1(2H)-yl]butanamide ;
CAS:192726-05-9
LPN01B :
Lopinavir EP Impurity A (Base) ; Lopinavir Free Amine ;

(2S)-N-[(1S,3S,4S)-1-Benzyl-4-amino-3-hydroxy-5-phenylpentyl]-3-methyl-2-[2-oxotetrahydropyrimidin- 1(2H)-yl]butanamide hydrochloride ;
LPN01H :
Lopinavir EP Impurity A (HCl) ; Lopinavir Free Amine HCl ;

(2S)-N-propyl-5-[2-(thiophen-2-yl)ethoxy]-N-[2-(thiophen-2-yl)ethyl]-1,2,3,4-tetrahydronaphthalen-2-amine ;
RTG10B :
Rotigotine EP Impurity J ; Rotigotine Thienylethyl Ether ; O-Thienylethyl Rotigotine (USP) ;

(2S)-N1-[(1S,2R)-1-Benzyl-3-[(3S,4aS,8aS)-3-[(1,1-dimethylethyl)carbamoyl]octahydroisoquinolin-2(1H)-yl]-2-hydroxypropyl]-2-[(quinolin-2-ylcarbonyl)amino]-butanediamide ;
CAS:127779-20-8
SQN00B :
Saquinavir (Base) ;

(2S, 3S, 5R)-3-Methyl-4,4,7-trioxo-3-(1H -1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:89786-04-9
TZB00A :
Tazobactam (Acid) ;

(2S, 4S)-1-((S)-3-(1-Ethyl-2,5-dioxopyrrolidin-3-ylthio)-2-methylpropanoyl)-4-(phenylthio)pyrrolidine-2-carboxylic acid ;
CAS:1217526-22-1
ZFP51 :
Zofenoprilat N-Ethyl Succinimide ; Zofenoprilat NES Adduct ;

(2S,+¦R,+¦GÇÖR,2GÇÖR)-+¦,+¦GÇÖ-[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol] ;
CAS:213132-06-0
NBV59 :
Nebivolol (S,R,R,R)-Isomer ;

(2S,+¦R,+¦GÇÖR,2GÇÖS)-+¦,+¦GÇÖ-[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol] ;
CAS:119365-23-0
NBV02 :
Nebivolol EP Impurity B ; Nebivolol (S,R,R,S)-Isomer ;

(2S,+¦R,+¦GÇÖS,2GÇÖR)-+¦,+¦GÇÖ-[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol] ;
NBV61 :
Nebivolol (S,R,S,R)-Isomer ;

(2S,+¦R,+¦GÇÖS,2GÇÖS)-+¦,+¦GÇÖ-[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol] ;
NBV62 :
Nebivolol (S,R,S,S)-Isomer ;

(2S,+¦S,+¦GÇÖR,2GÇÖR)-+¦,+¦GÇÖ-[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol] ;
NBV63 :
Nebivolol (S,S,R,R)-Isomer ;

(2S,+¦S,+¦GÇÖR,2GÇÖS)-+¦,+¦GÇÖ-[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol] ;
NBV64 :
Nebivolol (S,S,R,S)-Isomer ;

(2S,+¦S,+¦GÇÖS,2GÇÖR)-+¦,+¦GÇÖ-[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol] ;
NBV65 :
Nebivolol (S,S,S,R)-Isomer ;

(2S,+¦S,+¦GÇÖS,2GÇÖS)-+¦,+¦GÇÖ-[Iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol] ;
CAS:119365-28-5
NBV66 :
Nebivolol (S,S,S,S)-Isomer ;

(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[[(4-methylpiperazin-1-yl)imino]methyl]-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienimino)naphto[2,1-b]furan-21
CAS:13292-46-1
RFP00 :
Rifampicin ; Rifampin ;

(2S,16Z,18E,20R,21S,22R,23R,24R,25S,26R,27S,28E)-5,6,20, 21,23- Pentahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-1,15-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]-trienoimino)[1]benzofuro[4,5-e] pyrido[1,2-a]benzimidazol-25-yl ace
RFX04 :
Rifaximin EP Impurity D ; Rifaximin Y ;

(2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,6,21,23-Tetrahydroxy-16-(hydroxymethyl)-27-methoxy-2,4,11,20,22,24,26-heptamethyl-1,15-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13] trienoimino)[1]benzofuro-[4,5-e]pyrido[1,2-a]benzimidaz
CAS:1210022-90-4
RFX08 :
Rifaximin EP Impurity H ; 16-Desmethyl-16-Hydroxymethyl Rifaximin ;

(2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,6,21,23-Tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-1,15-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)[1]benzofuro[4,5-e] pyrido[1,2-a] benzimidazol-25-yl acetate
CAS:80621-81-4
RFX00 :
Rifaximin ;

(2S,2'S)-1,1'-[[(3-Hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)imino]bis(1-oxo-2,1-ethanediyl)]di(2-pyrrolidinecarbonitrile) ;
CAS:1036959-23-5
VDG45B :
Vildagliptin Dimer Impurity (Base) ; Vildagliptin Tertiary-Amine ; Vildagliptin Impurity B ;

(2S,2'S)-1,1'-[[(3-Hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)imino]bis(1-oxo-2,1-ethanediyl)]di(2-pyrrolidinecarbonitrile) hydrochloride ;
VDG45H :
Vildagliptin Dimer Impurity (HCl) ; Vildagliptin Tertiary-Amine HCl ; Vildagliptin Impurity B (HCl) ;

(2S,3aR,7aS)-1-((S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)(nitroso)amino)propanoyl)-octahydro-1H-indole-2-carboxylic acid ;
CAS:1026154-51-7
TDL48 :
Trandolapril N-Nitroso ;

(2S,3aR,7aS)-1-((S)-2-((S)-4-Cyclohexyl-1-ethoxy-1-oxobutan-2-ylamino)propanoyl)-octahydro-1H-indole-2-carboxylic acid ;
TDL55 :
Trandolapril Hexahydro Impurity ;

(2S,3aR,7aS)-1-(tert-Butoxycarbonyl)-octahydro-1H-indole-2-carboxylic acid ;
CAS:811420-46-9
TDL64 :
Trandolapril RC 4 ;

(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl] amino] propanoyl] octahydro-1H-indole-2-carboxylic acid ;
CAS:87679-37-6
TDL00 :
Trandolapril ;

(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-(Methoxycarbonyl)-3-phenylpropyl] amino] propanoyl] octahydro-1H-indole-2-carboxylic acid ;
CAS:118194-41-5
TDL01 :
Trandolapril EP Impurity A ; Trandolapril USP RC A ; Trandolapril Methyl Ester Analog ;

(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-[(1-Methylethoxy) carbonyl]-3-phenylpropyl] amino] propanoyl] octahydro-1H-indole-2-carboxylic acid ;
TDL02 :
Trandolapril EP Impurity B ; Trandolapril USP RC B ; Trandolapril Isopropyl Ester Analog ; Isopropyl Trandolaprilat ;

(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-Carboxy-3-phenylpropyl] amino] propanoyl] octahydro-1H-indole-2-carboxylic acid ;
CAS:87679-71-8
TDL05A :
Trandolapril EP Impurity E (Acid) ; Trandolapril USP RC E ; Trandolapril Diacid ; Trandolaprilat ;

(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-Carboxy-3-phenylpropyl] amino] propanoyl] octahydro-1H-indole-2-carboxylic acid monohydrate ;
CAS:951393-55-8 951393-57-0
TDL05H :
Trandolapril EP Impurity E (Monohydrate) ; Trandolapril USP RC E ; Trandolapril Diacid Monohydrate ; Trandolaprilat Monohydrate ;

(2S,3aR,7aS)-1-[N(S)-1-Carboxy-3-cyclohexyl propyl]- L-alanyl]hexahydro-2-ndolinecarboxylic acid 1-ethyl ester HCl ;
TDL03H :
Trandolapril EP Impurity C (HCl) ; Trandolapril USP RC C ; Cyclohexyl Trandolapril HCl ; Hexahydro Trandolapril HCl ;

(2S,3aR,7aS)-Benzyl 1-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-octahydro-1H-indole-2-carboxylate ;
CAS:98677-37-3
TDL53 :
Trandolapril Benzyl Ester ;

(2S,3aR,7aS)-Benzyl octahydro-1H-indole-2-carboxylate ;
CAS:144540-71-6
TDL65B :
Trandolapril RC 5 (Base) ;

(2S,3aR,7aS)-Benzyl octahydro-1H-indole-2-carboxylate hydrochloride ;
CAS:145641-35-6
TDL65H :
Trandolapril RC 5 (HCl) ;

(2S,3aS,6aS)-1-(N-((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)-N-nitroso-L-alanyl)octahydrocyclopenta[b]pyrrole-2-carboxylic acid ;
RMP48 :
Ramipril N-Nitroso Impurity ;

(2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid ;
CAS:87333-19-5
RMP00 :
Ramipril ;

(2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-(Isopropyloxy carbonyl)-3-phenylpropyl] amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid ;
CAS:295328-72-2
RMP02 :
Ramipril EP Impurity B ; Ramipril USP RC B ; Ramipril Isopropyl Ester ;

(2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-(Methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid ;
CAS:108313-11-7
RMP01 :
Ramipril EP Impurity A ; Ramipril USP RC A ; Ramipril Methyl Ester Analog ;

(2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-Carboxy-3-phenyl propyl]amino]-1-oxopropyl] octahydrocyclo penta [b]pyrrole-2-carboxylic acid ;
CAS:87269-97-4
RMP05A :
Ramipril EP Impurity E (Acid) ; Ramipril Diacid ; Ramiprilat ;

(2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-Carboxy-3-phenyl propyl]amino]-1-oxopropyl] octahydrocyclo penta [b]pyrrole-2-carboxylic acid disodium salt ;
RMP05N :
Ramipril EP Impurity E (Disodium Salt) ; Ramipril Diacid Disodium Salt ; Ramiprilat Disodium Salt ;

(2S,3aS,6aS)-1-[(R)-2-[[(S)-1-(Ethoxycarbonyl)-3-phenylpropyl] amino] propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid ;
CAS:104195-90-6
RMP08 :
Ramipril EP Impurity H ; Ramipril (R,S-S,S,S)-Isomer ; (1R)-Ramipril ; Ramipril 1-Epimer ;

(2S,3aS,6aS)-1-[(S)-2-[[(R)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino] propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid ;
CAS:129939-65-7
RMP09B :
Ramipril EP Impurity I (Base) ; Ramipril (S,R-S,S,S)-Isomer ; (2R)-Ramipril ; Ramipril 2-Epimer ;

(2S,3aS,6aS)-1-[(S)-2-[[(R)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino] propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid hydrochloride ;
RMP09H :
Ramipril EP Impurity I (HCl) ; Ramipril HCl (S,R-S,S,S)-Isomer ; (2R)-Ramipril HCl ; Ramipril HCl 2-Epimer ;

(2S,3aS,6aS)-Octahydrocyclopenta[b]pyrrole-2-carboxylic acid ;
CAS:87679-21-8
RMP36 :
Ramipril Bicyclic Acid ;

(2S,3aS,6aS)1-[(S)-2-[[(S)-3-Cyclohexyl-1-(ethoxycarbonyl)propyl]amino] propanoyl]octahydrocyclopenta[b] pyrrole-2-carboxylic acid hydrochloride ;
CAS:99742-35-5
RMP03H :
Ramipril EP Impurity C ; Ramipril USP RC C ; Ramipril Cyclohexyl Analog HCl ; Hexahydro Ramipril Hydrochloride ;

(2S,3aS,7aS)-1-((S)-2-((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-octahydro-1H-indole-2-carboxylic acid ;
CAS:80876-01-3
TDL66B :
Trandolapril RC 6 (Base) ; Trandolapril (3a)-Epimer ;

(2S,3aS,7aS)-1-((S)-2-((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-octahydro-1H-indole-2-carboxylic acid hydrochloride ;
CAS:80828-32-6
TDL66H :
Trandolapril RC 6 (HCl) ; Trandolapril HCl (3a)-Epimer ;

(2S,3aS,7aS)-1-[(2S)-2-[(5RS)-3-Cyclohexyl-2,4-dioxo-5-propylimidazolidin-1-yl]propanoyl]octahydro-1H-indole-2-carboxylic acid ;
CAS:353777-66-9
PRD07 :
Perindopril EP Impurity G ;

(2S,3aS,7aS)-1-[(2S)-2-[(5RS)-3-Cyclohexyl-2-(cyclohexylimino)-4-oxo-5-propylimidazolidin-1-yl]propanoyl]octahydro-1H-indole-2-carboxylic acid ;
CAS:353777-64-7
PRD08 :
Perindopril EP Impurity H ;

(2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl) butyl]-N-nitrosoamino]propanoyl] octahydro-1H-indole-2-carboxylic acid ;
CAS:3036581-82-2
PRD48 :
Perindopril N-Nitroso Impurity ; N-Nitroso Perindopril ;

(2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl) butyl]amino]propanoyl] octahydro-1H-indole-2-carboxylic acid ;
CAS:82834-16-0
PRD00A :
Perindopril (Acid) ;

(2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)butyl]amino]-1-oxopropyl]octahydro-1H-indole-2-carboxylic acid benzyl ester ;
CAS:122454-52-8
PRD38 :
Perindopril Benzyl Ester ;

(2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-Carboxybutyl]amino]propanoyl] octahydro-1H-indole-2-carboxylic acid ;
CAS:95153-31-4
PRD02 :
Perindopril EP Impurity B ; Perindopril USP RC B ; Perindopril BP Impurity B ; Perindoprilat ; Perindopril Diacid ;

(2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-Carboxybutyl]amino]propanoyl] octahydro-1H-indole-2-carboxylic acid methyl ester ;
PRD13 :
Perindopril EP Impurity M ; Perindoprilat Methyl Ester ;

(2S,3aS,7aS)-1-[(2S)-2-[[1-[(1-Methylethoxy)carbonyl]butyl] amino]propanoyl]octahydro-1H-indole-2-carboxylic acid ; (supplied as a mixture of 2 diastereomers)
CAS:1356837-89-2 (1S)
PRD05 :
Perindopril EP Impurity E ; Perindopril USP RC E ; Perindopril BP Impurity E ; Perindoprilat Isopropyl Ester tert-Butylamine Salt ;

(2S,3aS,7aS)-1-[(2S)-2-Aminopropanoyl]octahydro-1H-indole-2-carboxylic acid ;
CAS:685523-06-2
PRD10 :
Perindopril EP Impurity J ;

(2S,3aS,7aS)-1-Acetyloctahydro-1H-indole-2-carboxylic acid ;
CAS:111836-22-7
PRD12 :
Perindopril EP Impurity L ; Perindopril Bicyclic Acid N-Acetyl Impurity ;

(2S,3aS,7aS)-Octahydro-1H-indole-2-carboxylic acid ;
CAS:80875-98-5
PRD01 :
Perindopril EP Impurity A ; Perindopril USP RC A ; Perindopril BP Impurity A ;

(2S,3aS,7aS)-Octahydro-1H-indole-2-carboxylic acid benzyl ester ;
CAS:129939-67-9
RMP37B :
Ramipril Bicyclic Acid Benzyl Ester (Base) ;

(2S,3aS,7aS)-Octahydro-1H-indole-2-carboxylic acid benzyl ester HCl ;
CAS:87269-87-2
RMP37H :
Ramipril Bicyclic Acid Benzyl Ester (HCl) ;

(2S,3R)-2-(2,4-Difluorophenyl)-3-pyrimidin-4-yl-1-(1H-1,2,4-triazol-1-yl) butan-2-ol ;
CAS:137234-63-0
VRC04 :
Voriconazole EP Impurity D ; Voriconazole USP RC B ; Voriconazole Enantiomer ; Voriconazole (2S,3R)-Isomer ;

(2S,3R)-2-Ethyl-3-(hydroxymethyl)-4-(1-methyl-1H-imidazol-5-yl)butanoic acid ;
CAS:28406-15-7
PCP02A :
Pilocarpine EP Impurity B ; Pilocarpic Acid ;

(2S,3R)-2-Ethyl-3-(hydroxymethyl)-4-(1-methyl-1H-imidazol-5-yl)butanoic acid sodium salt ;
CAS:92598-79-3
PCP02N :
Pilocarpine EP Impurity B (Sodium) ; Pilocarpic Acid Sodium Salt ;

(2S,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanenitrile ;
CAS:241479-74-3
ISV61 :
Isavuconazole RC 1 ;

(2S,3R)-Allyl 2-(3-bromo-2-oxopropyl)-3-methoxypiperidine-1-carboxylate ;
CAS:117348-70-6
HLF61 :
Halofuginone RC 1 ; Alloc Bromoridane ;

(2S,3R)-Benzyl 3-(benzyloxycarbonyloxy)-2-(2-oxopropyl)piperidine-1-carboxylate ;
CAS:1091605-46-7
HLF63 :
Halofuginone RC 3 ;

(2S,3R)-Benzyl 3-hydroxy-2-(2-oxopropyl)piperidine-1-carboxylate ;
CAS:1091605-42-3
HLF62 :
Halofuginone RC 2 ;

(2S,3R)-Methyl 2-(tert-butoxycarbonyl)-3-hydroxy-3-phenylpropanoate ;
CAS:136620-75-2
VBG63 :
Vibegron RC 3 ;

(2S,3R,4R,5R)-2-(4-Aminopyrrolo[1,2-f][1,2,4]triazin-7-yl)-3,4-bis(benzyloxy)-5-(benzyloxymethyl)-tetrahydrofuran-2-ol ;
CAS:1911578-73-8
RDV69 :
Remdesivir Impurity 9 ;

(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,1
CAS:52286-59-6
GSN56 :
Ginsenoside Re ; Panaxoside Re ;

(2S,3R,4S,5R)-2-(4-Aminopyrrolo[1,2-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-carbonitrile ;
CAS:1355049-95-4
RDV70 :
Remdesivir Impurity 10 ;

(2S,3R,4S,5R,6R)-2-(((S)-7-Acetamido-1,2-dimethoxy-9-(methylthio)-10-oxo-5,6,7,10-tetrahydrobenzo[a]heptalen-3-yl)oxy)-6-(acetoxymethyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate ;
TCS61 :
Thiocolchicoside Tetraacetate Isomer ; Isothiocolchicoside Tetraacetate ;

(2S,3R,4S,5S,6R)-2-(((2R,3S,4R,5R,6R)-4,5-Dihydroxy-2-(hydroxymethyl)-6-(2-(phthalazin-1-yl)hydrazinyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl) tetrahydro-2H-pyran-3,4,5-triol ;
HDL50 :
Hydralazine N-Lactose Impurity ;

(2S,3R,4S,5S,6R)-6-(Hydroxymethyl)oxane-2,3,4,5-tetrol hydrate ;
CAS:14431-43-7
GCS00 :
Glucose Monohydrate ; D-(+)-Glucose Monohydrate ;

(2S,3R,4S,5S,6S)-2-((4-(2-((2,4-Dimethylphenyl)thio)phenyl)piperazin-1-yl)oxy)-6-(methoxycarbonyl) tetrahydro-2H-pyran-3,4,5-triyl Triacetate ;
VXT81 :
Vortioxetine Glucuronide Triacetate ;

(2S,3R,5R)-Benzhydryl 3-(chloromethyl)-3-methyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylate ;
CAS:85573-73-5
TZB66 :
Tazobactam RC 6 ;

(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid ;
CAS:130793-28-1
OLS40 :
Orlistat Open-Ring (2S,3R,5S)-Isomer ;

(2S,3RS,5R)-3-Hydroxy-5-methyl-2-[[(1r,2R,3S,4r,5R,6S)-2,4,6-trihydroxy-3,5-bis(methylamino)cyclohexyl]oxy]tetrahydrofuran-3-carboxylic acid ;
CAS:3736-78-5
SMC02B :
Spectinomycin EP Impurity B ; Actinospectinoic Acid ;

(2S,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol ;
VRC52 :
Voriconazole 2-Epimer ; (2S,3S)-Voriconazole ;

(2S,3S)-2-(3,4-Difluorophenyl)-3-(3-((1S,2S,3S,4S)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-ylamino)cyclopropanone ;
TCG66 :
Ticagrelor DP6 ;

(2S,3S)-2-Amino-3-methyl-3-sulfino-4-(1H-1,2,3-triazol-1-yl)butyric acid ;
CAS:120701-87-3
TZB21A :
Tazobactam USP RC A ;

(2S,3S)-4-[(1E)-3-[(1R)-1-Carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxo-1-propen-1-yl]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-7-hydroxy-3-benzofurancarboxylic acid 3-[(1R)-1-carboxy-2-(3,4-dihydroxyphenyl)ethyl]ester ;
CAS:121521-90-2
SVN02
Salvianolic Acid B ;

(2S,3S)-Ethyl 3-((1H-1,2,3-triazol-1-yl)methyl)-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide ;
TZB57 :
Tazobactam Acid Impurity T-7 ;

(2S,3S)-Methyl 2-(tert-butoxycarbonyl)-3-hydroxy-3-phenylpropanoate ;
CAS:136620-82-1
VBG62 :
Vibegron RC 2 ;

(2S,3S)-N-((2S,4S,5S)-5-(2-(2,6-Dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenylhexan-2-yl)-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)pentanamide ;
CAS:1132765-59-3
LPN56 :
Lopinavir IP Impurity F ; Lopinavir Pentanamide Analog ;

(2S,3S)-N-(5-tert-Butyl-2-methoxybenzyl)-2-benzhydrylquinuclidin-3-amine ;
CAS:147116-67-4
MPN00B :
Maropitant ;

(2S,3S)-N-(5-tert-Butyl-2-methoxybenzyl)-2-benzhydrylquinuclidin-3-amine citrate salt ;
CAS:862543-54-2
MPN00C :
Maropitant Citrate ;

(2S,3S,4R)-Methyl 3,4-diacetoxy-3,4-dihydro-2H-pyran-2-carboxylate ;
CAS:57690-62-7
MTZ64 :
Mirtazapine Impurity 4 ;

(2S,3S,4R,5R)-2-((2R,3S,4S,5S)-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-17-((S)-2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-6-yloxy)-4,5-dihydroxy-6-(hydroxymethyl)-tetrahyd
CAS:52286-74-5
GSN59 :
Ginsenoside Rg2 ;

(2S,3S,4R,5R)-2-((2R,3S,4S,5S)-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-4,4,8,10,14-pentamethyl-17-(6-methylhepta-1,5-dien-2-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-6-yloxy)-4,5-dihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyr
CAS:147419-93-0
GSN62 :
Ginsenoside Rg6 ;

(2S,3S,4R,5S)-3,4-Dihydroxy-6-(hydroxymethyl)-5-((2S,3S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-tetrahydro-2H-pyran-2-yl 2-(2-(4-((R)-(4-chlorophenyl)(phenyl) methyl)piperazin-1-yl)ethoxy)acetate hydrochloride
LCZ60H :
Levocetirizine Lactose Ester (HCl) ;

(2S,3S,4S,5R,6R)-6-(1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)ureido)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic Acid ;
RGR54 :
Regorafenib N-+¦-D-Glucuronide ;

(2S,3S,4S,5R,6R)-6-(1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-(2-(methylcarbamoyl)pyridin-4-yloxy)phenyl)ureido)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid
CAS:1130164-93-0
SRF60 :
Sorafenib-+¦-D-Glucuronide ;

(2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-[2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carbonyl]oxyoxane-2-carboxylic acid ;
NRP52B :
Niraparib Carboxylic Acid Glucuronide ;

(2S,3S,4S,5R,6S)-6-((((R)-2,3-Dihydro-1H-inden-1-yl)(prop-2-yn-1-yl)carbamoyl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid ;
RSG54 :
Rasagiline N-Carbamoyl +¦-D-Glucuronide ;

(2S,3S,4S,5R,6S)-6-((2-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepin-7-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid ;
LXN52 :
Loxapine 7-Hydroxy Glucuronide ;

(2S,3S,4S,5R,6S)-6-((2-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepin-8-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid ;
LXN55 :
Loxapine 8-Hydroxy Glucuronide ;

(2S,3S,4S,5R,6S)-Methyl 3,4,5-trihydroxy-6-((5-hydroxy-2-(4-hydroxyphenyl)-4-oxochroman-7-yl)oxy)tetrahydro-2H-pyran-2-carboxylate ;
NGX55 :
Naringenin 7-O-+¦-D-Glucuronide Methyl Ester ;

(2S,3S,4S,5R,Z)-6-(3-((4-((2-(Diethylamino)ethyl)carbamoyl)-3,5-dimethyl-1H-pyrrol-2-yl)methylene)-5-fluoro-2-oxoindolin-1-yl)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
SNT50 :
Sunitnib N-Glucuronide ;

(2S,3S,4S,5S)-2-((2R,3S,4S,5S)-2-((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-17-((S)-2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-6-yloxy)-4,5-dihydroxy-6-(hydroxymethyl)-tetra
CAS:52286-58-5
GSN57 :
Ginsenoside Rf ;

(2S,3S,4S,5S)-2-((2R,3S,4S,5S)-4,5-Dihydroxy-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-((R)-2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)-6-(hydroxymethyl)-tetrahydro-2
CAS:38243-03-7
GSN70 :
Ginsenoside Rg3 R-Isomer ; 20(R)-Ginsenoside Rg3 ;

(2S,3S,4S,5S)-2-((2R,3S,4S,5S)-4,5-Dihydroxy-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-((S)-2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)-6-(hydroxymethyl)-tetrahydro-2
CAS:14197-60-5
GSN60 :
Ginsenoside Rg3 ; 20(S)-Ginsenoside Rg3 ;

(2S,3S,4S,5S)-2-((2R,3S,4S,5S)-4,5-Dihydroxy-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((E)-6-methylhepta-2,5-dien-2-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyr
CAS:186763-78-0
GSN61 :
Ginsenoside Rg5 ;

(2S,3S,4S,5S)-2-((2R,3S,4S,5S)-4,5-Dihydroxy-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-(6-methylhepta-1,5-dien-2-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3
CAS:494753-69-4
GSN67 :
Ginsenoside Rk1 ;

(2S,3S,4S,5S)-2-((S)-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-4,4,8,10,14-pentamethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-methylhept-5-en-2-yloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol ;
CAS:39262-14-1
GSN81 :
Ginsenoside CK ;

(2S,3S,5R)-Ethyl 3-((1H-1,2,3-triazol-1-yl)methyl)-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide ;
TZB42 :
Tazobactam Ethyl Ester

(2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl)amino-3-hydroxy-5-trifluromethylcarbonylamino-1,6-diphenylhexane ;
LPN83 :
Lopinavir TFA Impurity ;

(2S,3S,5S)-2-[2-(2,6-Dimethylphenoxy)acetamido]-5-{(S)-3-methyl-2-[2-oxotetrahydropyrimidin-1(2H)-yl]butanamido}-1,6-diphenylhexan-3-yl hydrogen sulfate ;
LPN34 :
Lopinavir Sulfo Impurity ; Sulfolopinavir (USP) ;

(2S,3S,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid ;
CAS:130676-66-3
OLS41 :
Orlistat Open-Ring (2S,3S,5S)-Isomer ; Orlistat Impurity M1 ;

(2S,3S,6R)-3,4,5-Trihydroxy-6-(1-(4-hydroxy-2-(3-phenylpropanoyl)phenoxy)-3-(propylamino)propan-2-yloxy)-tetrahydro-2H-pyran-2-carboxylic acid ;
PRP60 :
Propafenone 5-Hydroxy +¦-D-Glucuronide ;

(2S,3S,6R)-6-(3-Carboxy-4-hydroxyphenylamino)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
MSL50 :
Mesalazine N-+¦-D-Glucuronide ;

(2S,3S,6R)-6-[10-(4,5-Dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)decoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid ;
IBN52A :
Idebenone Glucuronide ;

(2S,3S,6R,Z)-6-(2-(4-(4-Chloro-1,2-diphenylbut-1-enyl)phenoxy)ethoxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
OPF57 :
Ospemifene O-+¦-D-Glucuronide ;

(2S,3S,6S)-3,4,5-Trihydroxy-6-(2-(3-(hydroxy(phenyl)methyl)phenyl)propanoyloxy)-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:849104-47-8
KTP55 :
Ketoprofen Dihydro +¦-D-Glucuronide ;

(2S,3S,6S)-3,4,5-Trihydroxy-6-(6-oxo-6H-benzo[c]chromen-3-yloxy)-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:823806-74-2
ULT53 :
Urolithin B Glucuronide ;

(2S,3S,6S)-6-((3S,5S)-1-(2-((S)-((S)-2-Methyl-1-(propionyloxy)propoxy)(4-phenylbutyl) phosphoryl)acetyl)-3-cyclohexylpyrrolidine-5-carbonyloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
FSN50 :
Fosinopril Acyl-+¦-D-Glucuronide ;

(2S,3S,6S)-6-((R)-4-((3R,7S,8R,9S,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:208038-28-2
UDC44 :
Ursodeoxycholic Acid Acyl-B-D-Glucuronide ;

(2S,3S,6S)-6-(2,4-Di-tert-butyl-5-(4-oxo-1,4-dihydroquinoline-3-carboxamido)phenoxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
IVC57 :
Ivacaftor Carboxylic Acid O-Glucuronide ;

(2S,3S,6S)-6-(2-(3-tert-Butyl-4-(4-oxo-1,4-dihydroquinoline-3-carboxamido)phenyl)-2-methylpropanoyloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
IVC54 :
Ivacaftor Acyl-Glucuronide ;

(2S,3S,6S)-6-(2-Amino-6-imino-4-(piperidin-1-yl)pyrimidin-1(6H)-yloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:56828-40-1
MNX50 :
Minoxidil +¦-D-Glucuronide ;

(2S,3S,6S)-Allyl 6-(5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoyloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylate ;
GFZ54 :
Gemfibrozil 1-O-+¦-D-Glucuronide Allyl Ester ;

(2S,3S,6S)-Benzyl 6-(5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoyloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylate ;
GFZ55 :
Gemfibrozil 1-O-+¦-D-Glucuronide Benzyl Ester ;

(2S,3S,6S)-Methyl 6-(2-amino-6-imino-4-(piperidin-1-yl)pyrimidin-1(6H)-yloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylate ;
MNX51 :
Minoxidil +¦-D-Glucuronide Methyl Ester ;

(2S,3S,6S,Z)-6-(2-(3-(4-(Methylsulfinyl)benzylidene)-6-fluoro-2-methyl-3H-inden-1-yl)acetoxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:60018-36-2
SDC50 :
Sulindac Acyl-+¦-D-Glucuronide ;

(2S,3S,6S,Z)-6-(2-(3-(4-(Methylthio)benzylidene)-6-fluoro-2-methyl-3H-inden-1-yl)acetoxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:59973-78-3
SDC53 :
Sulindac Sulfide Acyl-+¦-D-Glucuronide ;

(2S,4R)-1-Methyl-4-propylpyrrolidine-2-carboxylic acid ;
CAS:13380-36-4
LCM05B :
Lincomycin EP Impurity E (Base) ; Lincomycin BP Impurity E ; 4-Propyl Hygric Acid ;

(2S,4R)-1-Methyl-4-propylpyrrolidine-2-carboxylic acid HCl ;
CAS:6734-79-8
LCM05H :
Lincomycin EP Impurity E (HCl) ; Lincomycin BP Impurity E ; 4-Propyl Hygric Acid HCl ;

(2S,4R)-1-Methyl-4-propylpyrrolidine-2-carboxylic acid sodium salt ;
LCM05N :
Lincomycin EP Impurity E (Sodium) ; Lincomycin BP Impurity E ; 4-Propyl Hygric Acid Sodium Salt ;

(2S,4R)-1-tert-Butyl 2-methyl 4-(3-chloro-7-methoxyquinoxalin-2-yloxy)pyrrolidine-1,2-dicarboxylate ;
CAS:1206524-79-9
GRZ64B :
Grazoprevir RC 4 ;

(2S,4R)-4-((3-Chloro-7-methoxyquinoxalin-2-yl)oxy)-2-(methoxycarbonyl)pyrrolidinium methanesulfonate ;
CAS:1425038-20-5
GRZ63M :
Grazoprevir RC 3 (Mesylate Salt) ;

(2S,4R)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid ;
CAS:1012341-54-6
SCT86 :
Sacubitril RC 16 ;

(2S,4R)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester ;
CAS:761373-05-1
SCT52A :
Sacubitril (2S,4R)-Isomer (Acid) ; Sacubitril Enantiomer ; (2S,4R)-Sacubitril (USP) ;

(2S,4R)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester calcium salt ;
SCT52C :
Sacubitril (2S,4R)-Isomer (Calcium) ; Sacubitril Calcium Enantiomer ; (2S,4R)-Sacubitril Calcium (USP) ;

(2S,4R)-N-((1R,2R)-2-Hydroxy-1-((3R,4R,5S,6R)-3,4,5-trihydroxy-6-(methylsulfinyl)-tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide ;
CAS:22083-92-7
LCM55 :
Lincomycin Sulfoxide ;

(2S,4R)-N-((1R,2R)-2-Hydroxy-1-((3R,4R,5S,6R)-3,4,5-trihydroxy-6-(methylsulfonyl)-tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide ;
CAS:198080-68-1
LCM54 :
Lincomycin Sulfone ;

(2S,4R)-N-(2,6-Dimethylphenyl)-4-methyl-5-oxo-3-propyl-1-o-tolylimidazolidine-2-carboxamide ;
CAS:2815498-43-0
PLC70 :
Prilocaine RC 10 ;

(2S,4S)-1-[(2S)-3-Benzoylsulfanyl-2-methylpropanoyl]-4-phenylsulfanyl pyrrolidine-2-carboxylic acid calcium salt ;
CAS:81938-43-4
ZFP00C :
Zofenopril Calcium ;

(2S,4S)-4-(4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidine-2-carboxylic acid ;
TGT54 :
Teneligliptin Carboxylic Acid Impurity ;

(2S,4S)-4-Cyclohexyl-1-(3-oxopentanoyl)pyrrolidine-2-carboxylic acid ;
CAS:149760-14-5
FSN63A :
Fosinopril Impurity 3 (USP) ;

(2S,4S)-4-cyclohexyl-1-[[(2S,4S)-4-cyclohexyl-1[[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidin-2-yl]carbonyl]pyrrolidine-2-carboxylic acid ;
FSN14A :
Fosinopril EP Impuirty N ;

(2S,4S)-4-Cyclohexyl-1-pivaloylpyrrolidine-2-carboxylic acid ;
FSN11A :
Fosinopril EP Impurity K ; Fosinopril Impurity 1 (USP) ;

(2S,4S)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid ;
CAS:1012341-52-4
SCT77 :
Sacubitril RC 7 ;

(2S,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester ;
CAS:149709-63-7
SCT53A :
Sacubitril (2S,4S)-Isomer (Acid) ; Sacubitril 2-Epimer ;

(2S,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester calcium salt ;
CAS:3081732-57-9
SCT53C :
Sacubitril (2S,4S)-Isomer (Calcium) ; Sacubitril Calcium 2-Epimer ;

(2S,4S)-Benzyl 4-cyclohexylpyrrolidine-2-carboxylate ;
CAS:126110-99-4
FSN64 :
Fosinopril Impurity 4 ;

(2S,4S)-N-(2-Mercaptoethyl)-4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidine-2-carboxamide ;
TGT63 :
Teneligliptin Impurity C ;

(2S,4S)-tert-Butyl 4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate ;
CAS:401566-80-1
TGT62 :
Teneligliptin Impurity B ;

(2S,4S,6R)-4-Hydroxy-6-methyl-2-[[(1r,2R,3S,4r,5R,6S)-2,4,6-trihydroxy-3,5-bis(methylamino)cyclohexyl]oxy]dihydro-2H-pyran-3(4H)-one ;
CAS:1323437-06-4
SMC06B :
Spectinomycin EP Impurity F ;

(2S,5R)-((1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl) 5-hydroxy-1,3-oxathiolane-2-carboxylate ;
CAS:147126-64-5
LMV62 :
Lamivudine Impurity 2 ;

(2S,5R)-2,5-Dimethyl-1-propyl-3-o-tolylimidazolidin-4-one ;
CAS:780037-66-3
PLC61B :
Prilocaine RC 1 (Base) ;

(2S,5R)-2,5-Dimethyl-1-propyl-3-o-tolylimidazolidin-4-one hydrochloride ;
CAS:677029-53-7
PLC61H :
Prilocaine RC 1 (HCl) ;

(2S,5R)-3,3-DIMETHYL-7-OXO-4-OXIDE-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID DIPHENYLMETHYL ESTER
CAS:87579-78-0
TZB68 :
Tazobactam RC 8 ;

(2S,5R)-3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (2,2-dimethyl-1-oxopropoxy)methyl ester 4,4-dioxide ;
CAS:69388-79-0
SBT50 :
Sulbactam Pivoxil ;

(2S,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylic acid ;
CAS:2165593-53-1
LMV73 :
Lamivudine Acid (2S,5R)-Isomer ; (2S,5R)-Lamivudine Acid ;

(2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:24158-88-1
SBT06 :
Sulbactam EP Impurity F ; Sulbactam USP RC F ; 6,6-Dibromopenicillanic Acid ;

(2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide ;
CAS:76646-91-8
SBT05 :
Sulbactam EP Impurity E ; Sulbactam USP RC E ; 6,6-Dibromopenicillanic Acid Sulfone ;

(2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4-oxide phenylmethyl ester ;
CAS:153833-41-1
TZB67 :
Tazobactam RC 7 ;

(2S,5R,6R)-3,3-dimethyl-6-[[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:66-79-5
OXL00A :
Oxacillin (Acid) ;

(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:87-08-1
PNV00A :
Penicillin V (Acid) ; Phenoxymethylpenicillin (Acid) ;

(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid potassium salt ;
CAS:132-98-9
PNV00K :
Penicillin V (Potassium) ; Phenoxymethylpenicillin Potassium ;

(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:61-33-6
PNV01A :
Penicillin V EP Impurity A ; Phenoxymethylpenicillin EP Impurity A ; Penicillin G ; Benzylpenicillin ;

(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(phenylacetyl)-amino]-4-thia- 1-azabicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:61-33-6
PNC00A :
Penicillin G (Acid) ; Benzylpenicillin (Acid) ;

(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[[(thiophen-3-yl)acetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:36041-93-7
TCC01A :
Ticarcillin EP Impurity A (Acid) ; Decarboxy Ticarcillin ;

(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[[(thiophen-3-yl)acetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid sodium salt ;
TCC01N :
Ticarcillin EP Impurity A (Sodium) ; Decarboxy Ticarcillin Sodium ;

(2S,5R,6R)-6-((2S,5R,6R)-3,3-Dimethyl-6-(5-methyl-3-phenylisoxazole-4-carboxamido)-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid ;
OXL09A :
Oxacillin EP Impurity I ; 6-APA Oxacillin Amide ;

(2S,5R,6R)-6-((R)-2-((2R,4S)-4-Carboxy-5,5-dimethylthiazolidin-2-yl)-2-(5-methyl-3-phenylisoxazole-4-carboxamido)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid disodium salt ;
OXL10N :
Oxacillin EP Impurity J ; Ozolamide of 6-APA Dimer ;

(2S,5R,6R)-6-((R)-2-(3-(2-(Carboxy-N-ethylformamido)ethyl)ureido)-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:64844-70-8
PPR13 :
Piperacillin EP Impurity M ; Piperacillin Impurity 1 ; Piperacillin Oxalylamide ;

(2S,5R,6R)-6-(1-Ethoxy-1-naphthamido)-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid ;
NFC54 :
Nafcillin 4-Ethoxy Analog ;

(2S,5R,6R)-6-(2-(4-Hydroxyphenoxy)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:20880-67-5
PNV50A :
Penicillin V p-Hydroxy Impurity ; Phenoxymethylpenicillin EP Impurity D ; 4-Hydroxy Phenoxymethylpenicillin ; Penicillin V EP Impurity D ;

(2S,5R,6R)-6-(2-Methoxy-1-naphthamido)-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:983-86-8
NFC62A :
Nafcillin Desmethyl Impurity (Acid) ; Nafcillin 2-Methoxy Analog ;

(2S,5R,6R)-6-[(2-Ethoxy-1-naphthoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:147-52-4
NFC00A :
Nafcillin (Acid) ;

(2S,5R,6R)-6-[(2-Ethoxy-1-naphthoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid sodium salt ;
CAS:985-16-0
NFC00N :
Nafcillin Sodium ;

(2S,5R,6R)-6-[(2-Ethoxy-1-naphthoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid sulfoxide ;
CAS:41061-20-5
NFC50 :
Nafcillin Sulfoxide ;

(2S,5R,6R)-6-[[(2R)-2-[[(4-Ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino]-2-phenylacetyl] amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:61477-96-1
PPR00X :
Piperacillin (Anhydrous) ;

(2S,5R,6R)-6-[[(2R)-2-[[(4-Ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino]-2-phenylacetyl] amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid monohydrate ;
CAS:66258-76-2
PPR00A :
Piperacillin (Monohydrate) ; Piperacillin Monohydrate ;

(2S,5R,6R)-6-[[(2R)-2-[[[(2S,5R,6R)-6-[[(2R)-2-[[(4-Ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-yl]carbonyl]amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1
CAS:65772-67-0
PPR04 :
Piperacillin EP Impurity D ; N-Piperacillinyl Ampicillin ;

(2S,5R,6R)-6-[[(2R)-2-Amino-2-phenylacetyl]amino]-3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:69-53-4
PPR01 :
Piperacillin EP Impurity A ; Ampicillin ; Sultamicillin EP Impurity C ;

(2S,5R,6R)-6-[[(2R)-2-Amino-2-phenylacetyl]amino]-3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:69-53-4
STM03A :
Sultamicillin EP Impurity C (Anhydrous) ; Ampicillin Acid ; Piperacillin EP Impurity A ;

(2S,5R,6R)-6-[[(2R)-2-Amino-2-phenylacetyl]amino]-3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid sodium ;
CAS:69-52-3
STM03N :
Sultamicillin EP Impurity C (Sodium) ; Ampicillin Sodium ; Piperacillin EP Impurity A (Sodium) ;

(2S,5R,6R)-6-[[(2R)-2-Amino-2-phenylacetyl]amino]-3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate ;
CAS:7177-48-2
STM03T :
Sultamicillin EP Impurity C (Trihydrate) ; Ampicillin (Trihydrate) ; Piperacillin EP Impurity A (Trihydrate) ;

(2S,5R,6R)-6-[[[3-(Chlorophenyl)-5-methylisoxazol-4-yl]carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:724695-30-1
OXL07A :
Oxacillin EP Impurity G ; Cloxacillin Isomer ;

(2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:551-16-6
PHP03A :
Phenoxymethylpenicillin EP Impurity C ; Benzylpenicillin EP Impurity A ; 6-Aminopenicillanic Acid ; 6-APA ; Piperacillin EP Impurity H ;

(2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:551-16-6
SBT02 :
Sulbactam EP Impurity B ; Ampicillin EP Impurity A ; Amoxicillin EP Impurity A ; Cloxacillin EP Impurity C ; Piperacillin EP Impurity H ; 6-Aminopenicillanic Acid ; 6-APA ;

(2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:551-16-6
PNV03A :
Penicillin V EP Impurity C ; Ampicillin EP Impurity A ; Amoxicillin EP Impurity A ; Pivampicillin Impurity A ; 6-Aminopenicillanic Acid ; 6-APA ;

(2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:551-16-6
PPR08 :
Piperacillin EP Impurity H ; Benzylpenicillin EP Impurity A ; 6-Aminopenicillanic Acid ; 6-APA ;

(2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:551-16-6
OXL01A :
Oxacillin EP Impurity A ; Dicloxacillin EP Impurity C ; Cloxacillin EP Impurity C ; Sulbactam EP Impurity B ; Ampicillin EP Impurity A ; Amoxicillin EP Impurity A ; 6-Aminopenicillanic Acid ; 6-APA ;

(2S,5R,6R)-6-Bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:26631-90-3
SBT04A :
Sulbactam EP Impurity D (Acid) ; Sulbactam USP RC D ; 6-Bromopenicillanic Acid ;

(2S,5R,6R)-6-Bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide ;
CAS:75527-87-6
SBT03A :
Sulbactam EP Impurity C (Acid) ; 6-Bromopenicillanic Acid Sulfone ; Brobactam S,S-Dioxide ;

(2S,5R,6R)-6-Bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide sodium salt ;
CAS:76517-23-2
SBT03N :
Sulbactam EP Impurity C (Sodium) ; 6-Bromopenicillanic Acid Sulfone Sodium Salt ; Brobactam S,S-Dioxide Sodium Salt ;

(2S,5R,6R)-6-Bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid potassium salt ;
CAS:4027-64-9
SBT04K :
Sulbactam EP Impurity D (Potassium) ; Sulbactam USP RC D ; 6-Bromopenicillanic Acid Potassium Salt ;

(2S,5R,6R)-6-Bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid sodium salt ;
CAS:73335-78-1
SBT04N :
Sulbactam EP Impurity D (Sodium) ; Sulbactam USP RC D ; 6-Bromopenicillanic Acid Sodium Salt ;

(2S,5R,6R)-Pivaloyloxymethyl 6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylate ;
CAS:33817-20-8
PVA00B :
Pivampicillin (Base) ;

(2S,5R,6R)-Pivaloyloxymethyl 6-((R)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylate hydrochloride ;
CAS:26309-95-5
PVA00H :
Pivampicillin (HCl) ; Pivampicillin Hydrochloride ;

(2S,5R,6S)-6-Bromo-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid ;
CAS:24138-28-1
TZB65 :
Tazobactam RC 5 ;

(2S,5R,6S)-Benzhydryl 6-bromo-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylate ;
CAS:74189-25-6
TZB64 :
Tazobactam RC 4 ;

(2S,5S)-((1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl) 5-hydroxy-1,3-oxathiolane-2-carboxylate ;
LMV63 :
Lamivudine Impurity 3 ;

(2S,5S)-1-(4-tert-Butylphenyl)-2,5-bis(4-nitrophenyl)pyrrolidine ;
CAS:1258232-92-6
OTV62 :
Ombitasvir RC 2 ;

(2S,5S,6R)-2-(1-([1,2,4]Triazolo[3,4-a]phthalazin-3-yl)-1,2,4,5-tetrahydroxypentan-3-yloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol ;
HDL57 :
Hydralazine Lactosone Ring-Opened Adduct ;

(2S,5S,8R,9S,10S,13S,14S,16S,17R)-10,13-Dimethyl-2-morpholino-3-oxo-16-(pyrrolidin-1-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate ;
RCR53 :
Rocuronium 3-Oxo Desallyl ;

(2S,7Z,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,21,23-Trihydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-1,6,15-trioxo-1,2,6,7-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienonitrilo)[1]benzofuro-[4,5-e]pyrido[1,2-a]benzimidazol-25-y
CAS:80621-76-7
RFX07 :
Rifaximin EP Impurity G ; 6-O,14-Didehydro Rifaximin ; Dehydro Rifaximin ;

(2S-trans)-Methyl 6,8-Dideoxy-6-[[(4-ethyl-1-methyl-2-pyrrolidinyl)carbonyl]amino]- 1-thio-D-erythro-+¦-D-galactooctopyranoside ;
CAS:2520-24-3
LCM50B :
Lincomycin B (Base) ;

(2S-trans)-Methyl 6,8-Dideoxy-6-[[(4-ethyl-1-methyl-2-pyrrolidinyl)carbonyl]amino]- 1-thio-D-erythro-+¦-D-galactooctopyranoside hydrochloride ;
CAS:11021-35-5
LCM50H :
Lincomycin B HCl ;

(2SR,3RS)-3-(2-ethoxyphenoxy)-2-(methylsulfonyloxy)-3-phenylpropyl 4-nitrobenzoate
CAS:98854-88-7
RBX66 :
Reboxetine RC 6 ;

(2SR,3RS)-3-(2-Ethoxyphenoxy)-2-hydroxy-3-phenylpropyl 4-nitrobenzoate ;
CAS:98769-70-1
RBX65 :
Reboxetine RC 5 ;

(2SR,3RS)-3-(2-ethoxyphenoxy)-3-phenylpropane-1,2-diol ;
CAS:98769-69-8
RBX64 :
Reboxetine RC 4 ;

(2Z)-[2-(Diaminomethylidene)diazanylidene](2,3-dichlorophenyl)acetonitrile ;
CAS:84689-20-3 (Z/E)
LMT03 :
Lamotrigine EP Impurity C ;

(2Z)-1-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)but-2-en-1-one ;
CAS:1803026-54-1
SGT94 :
Sitagliptin FP Impurity D (Z)-Isomer ;

(2Z)-2-(2-Oxopyrrolidin-1-yl)but-2-enamide ;
CAS:358629-47-7
LET02 :
Levetiracetam EP Impurity B ; Levetiracetam Dehydro Amide ;

(2Z)-2-(2-Oxopyrrolidin-1-yl)but-2-enoic acid ;
CAS:358629-39-7
LET32 :
Levetiracetam Dehydro Acid ;

(2Z)-2-Cyano-3,4-dihydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide ;
CAS:1058722-45-4
TFM54 :
Teriflunomide 4-Hydroxy ;

(2Z)-4-[(1S)-1-[[(1,1-Dimethylethyl)amino]methyl]-2-[[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy]ethoxy]-4-oxobut-2-enoic acid ;
CAS:1026075-53-5
TML05B :
Timolol EP Impurity E (Base) ; Timolol BP Impurity E ; Timolol USP RC E ; Timolol Maleate Ester ;

(2Z)-4-[(1S)-1-[[(1,1-Dimethylethyl)amino]methyl]-2-[[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy]ethoxy]-4-oxobut-2-enoic acid maleate salt ;
TML05M :
Timolol EP Impurity E (Maleate) ; Timolol BP Impurity E ; Timolol USP RC E ; Timolol Maleate Ester Maleate Salt ;

(2Z)-4-Oxo-4-[3-(trifluoroMethyl)-5,6-dihydro-[1,2,4] triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one ;
CAS:764667-65-4
SGT36 :
Sitagliptin Keto Amide Impurity ;

(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine ;
CAS:767340-03-4
SGT35B :
Sitagliptin Enamine Impurity ;

(2Z)-N,6,6-Trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine ;
TBN02B :
Terbinafine EP Impurity B (Base) ; Terbinafine USP RC B ; Terbinafine BP Impurity B ; cis-Terbinan¼üne ;

(2Z)-N,6,6-Trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine HCl ;
CAS:176168-78-8
TBN02H :
Terbinafine EP Impurity B (HCl) ; Terbinafine USP RC B ; Terbinafine BP Impurity B ; cis-Terbinan¼üne HCl ;

(2Z)-N,6,6-Trimethyl-N-(naphthalen-2-ylmethyl)hept-2-en-4-yn-1-amine ;
CAS:926281-74-5
TBN06B :
Terbinafine EP Impurity F ; Terbinafine BP Impurity F ; cis-Isoterbinan¼üne ;

(2Z,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid ;
CAS:71748-58-8
ITN08 :
Isotretinoin EP Impurity H ; 4-Oxo 13-cis Retinoic Acid ;

(2Z,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid ;
CAS:4759-48-2
TNN01 :
Tretinoin EP Impurity A ; Isotretinoin ; 13-Cis Retinoic Acid ;

(2Z,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid ;
CAS:4759-48-2
ITN00 :
Isotretinoin ; Tretinoin EP Impurity A ; 13-Cis Retinoic Acid ;

(2Z,4E,6E,8E)-3,7-Dimethyl-9-[(1RS,6SR)-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl]nona-2,4,6,8-tetraenoic acid ;
CAS:81444-57-7
ITN07 :
Isotretinoin EP Impurity G ; 5,6-Epoxy-13-cis-Retinoic Acid ;

(2Z,4E,6E,8E)-9-[(3RS)-3-Hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7-dimethylnona-2,4,6,8-tetraenoic acid ;
CAS:75281-25-3
ITN09 :
Isotretinoin EP Impurity I ; 4-Hydroxy 13-cis Retinoic Acid ;

(2Z,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid ;
CAS:5352-74-9
TNN02 :
Tretinoin EP Impurity B ; Isotretinoin EP Impurity B ; 9,13-Di-Cis-Retinoic Acid ;

(2Z,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid ;
CAS:5352-74-9
ITN02 :
Isotretinoin EP Impurity B ; Tretinoin EP Impurity B ; 9,13-Dicis Retinoic Acid ;

(2Z,4Z,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid ;
CAS:3555-80-4
TNN03 :
Tretinoin EP Impurity C ; Isotretinoin EP Impurity C ; 11,13-Di-Cis-Retinoic Acid ;

(2Z,4Z,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid ;
CAS:3555-80-4
ITN03 :
Isotretinoin EP Impurity C ; Tretinoin EP Impurity C ; 11,13-Dicis Retinoic Acid ;

(2Z,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-hept-2,6-dienoic acid ;
CAS:1422954-12-8
RSV11A :
Rosuvastatin EP Impurity K (Acid) ; 2,3-Anhydro Rosuvastatin ; Rosuvastatin 2,6-Diene Impurity ; Rosuvastatin Dehydro Analog ;

(2Z,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-hept-2,6-dienoic acid calcium salt ;
CAS:1659301-59-3
RSV11N :
Rosuvastatin EP Impurity K (Sodium) ; 2,3-Anhydro Rosuvastatin Sodium ; Rosuvastatin Sodium 2,6-Diene Impurity ;

(2Z,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-hept-2,6-dienoic acid calcium salt ;
RSV11C :
Rosuvastatin EP Impurity K (Calcium) ; 2,3-Anhydro Rosuvastatin Calcium ; Rosuvastatin Calcium 2,6-Diene Impurity ;

(3'S)-1',2',5,7-Tetrahydro-2'-oxo-spiro[6H-cyclopenta[b]pyridine-6,3'-[3H]pyrrolo[2,3-b]pyridine]-3-carboxylic acid ;
CAS:1375541-21-1
UBG61 :
Ubrogepant RC 1 ;

(3'S)-1',2',5,7-Tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl]-2'-oxo-spiro[6H-cyclopenta[b]pyridine-6,3'-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide ;
CAS:1374248-77-7
UBG00 :
Ubrogepant ;

(3+¦,12+¦)-12-(Acetyloxy)-3-hydroxy-7,11,15,23-tetraoxolanost-8-en-26-oic acid ; (6R)-6-((3S,5R,10S,12S,13R,14R)-12-acetoxy-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]p
CAS:98665-19-1
GDR58 :
Ganoderic Acid H ;

(3+¦,12+¦)-20-(+¦-D-Glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-+¦-D-glucopyranosyl-+¦-D-glucopyranoside ;
CAS:52705-93-8
GSN55 :
Ginsenoside Rd ;

(3+¦,12+¦)-20-[(6-O-+¦-L-Arabinopyranosyl-+¦-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 2-O-+¦-D-glucopyranosyl-+¦-D-glucopyranoside ;
CAS:11021-13-9
GSN52 :
Ginsenoside Rb2 ;

(3+¦,12+¦)-3-[(2-O-+¦-D-Glucopyranosyl-+¦-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-20-yl 6-O-+¦-D-xylopyranosyl-+¦-D-glucopyranoside ;
CAS:68406-26-8
GSN53 :
Ginsenoside Rb3 ;

(3+¦,5+¦,12+¦)-24-[(Carboxymethyl)amino]-12-hydroxy-24-oxocholan-3-yl, +¦-D-glucopyranosiduronic acid ;
CAS:79252-51-0
GDC53A :
Glycodeoxycholic Acid 3-O-+¦-Glucuronide (Base) ;

(3+¦,5+¦,12+¦)-24-[(Carboxymethyl)amino]-12-hydroxy-24-oxocholan-3-yl, +¦-D-glucopyranosiduronic acid disodium salt ;
CAS:75672-36-5
GDC53N :
Glycodeoxycholic Acid 3-O-+¦-Glucuronide (Disodium) ;

(3+¦,5+¦,6+¦,7+¦)-6-Ethyl-3,7-dihydroxy-cholan-24-oic acid (3+¦,5+¦,6+¦,7+¦)-23-carboxy-6-ethyl-7-hydroxy-24-norcholan-3-yl ester ; (R)-4-((3R,5S,6R,7S,8S,9S,10S,13R,14S,17R)-6-Ethyl-3-((R)-4-((3R,5S,6R,7S,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydro
CAS:1908444-28-9
OBT55 :
Obeticholic Acid Dimer ;

(3+¦,5+¦,7+¦)-23-Carboxy-7-hydroxy-24-norcholan-3-yl,+¦-D-glucopyranosiduronic acid ;
CAS:129121-77-3
UDC43A :
Ursodeoxycholic Acid 3-O-+¦-D-Glucuronide (Acid) ;

(3+¦,5+¦,7+¦)-23-Carboxy-7-hydroxy-24-norcholan-3-yl,+¦-D-glucopyranosiduronic acid disodium salt ;
CAS:75672-30-9
UDC43N :
Ursodeoxycholic Acid 3-O-+¦-D-Glucuronide (Disodium Salt) ;

(3+¦,5+¦,7+¦)-24-[(Carboxymethyl)amino]-7-hydroxy-24-oxocholan-3-yl,+¦-D-glucopyranosiduronic acid ;
CAS:99794-77-1
UDC57A :
Ursodeoxycholic Acid RC 7 ; Glycoursodeoxycholic Acid-3-O-+¦-Glucuronide ;

(3+¦,5+¦,7+¦)-24-[(Carboxymethyl)amino]-7-hydroxy-24-oxocholan-3-yl,+¦-D-glucopyranosiduronic acid disodium salt ;
CAS:75672-31-0
UDC57N :
Ursodeoxycholic Acid RC 7 (Disodium) ; Glycoursodeoxycholic Acid-3-O-+¦-Glucuronide Disodium Salt ;

(3+¦,5+¦,7+¦)-3,7-Dihydroxy-cholan-24-oic acid ethyl ester ; (R)-Ethyl 4-((3R,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate ;
CAS:69519-36-4
UDC54 :
Ursodeoxycholic Acid RC 4 ; Ethyl Ursodeoxycholate ;

(3+¦,6+¦,12+¦)-3,12-Dihydroxydammar-24-ene-6,20-diyl bis-+¦-D-glucopyranoside ;
CAS:22427-39-0
GSN58 :
Ginsenoside Rg1 ;

(3+¦,7+¦,15+¦,25R)-3,7,15-Trihydroxy-11,23-dioxolanost-8-en-26-oic acid ; (2R,6R)-2-methyl-4-oxo-6-((3S,5R,7S,10S,13R,14R,15S)-3,7,15-trihydroxy-4,4,10,13,14-pentamethyl-11-oxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a
CAS:103773-62-2
GDR54 :
Ganoderic Acid D ;

(3+¦,7+¦,25R)-3,7-Dihydroxy-11,15,23-trioxolanost-8-en-26-oic acid ; (2R,6R)-6-((3S,5R,7S,10S,13R,14R)-3,7-Dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-
CAS:81907-61-1
GDR52 :
Ganoderic Acid B ;

(3+¦,GÇï12+¦)GÇï-GÇï20-GÇï[(6-GÇïO-GÇï+¦-GÇïL-GÇïArabinofuranosyl-GÇï+¦-GÇïD-GÇïglucopyranosyl)GÇïoxy]GÇï-GÇï12-GÇïhydroxydammar-GÇï24-GÇïen-GÇï3-GÇïyl 2-GÇïO-GÇï+¦-GÇïD-GÇïglucopyranosyl-+¦-GÇïD-glucopyranoside ;
CAS:11021-14-0
GSN54 :
Ginsenoside Rc ; Panaxoside Rc ;

(3,4-Diaminophenyl)(p-tolyl)methanone ;
CAS:42754-53-0
MBD51 :
Mebendazole Impurity 1 ;

(3,4-Diaminophenyl)(phenyl)methanone ;
CAS:39070-63-8
MBD54B :
Mebendazole Impurity 4 (Base) ;

(3,4-Diaminophenyl)(phenyl)methanone HCl ;
CAS:57070-71-0
MBD54H :
Mebendazole Impurity 4 (HCl) ;

(3,4-Dimethoxyphenyl)methanol ;
CAS:93-03-8
VRP05 :
Verapamil EP Impurity E ; Verapamil USP RC F ;

(3,5-Difluorophenyl)(piperidin-4-yl)methanone ;
CAS:1226154-13-7
PPD92 :
Paliperidone RC 32 ;

(3,6-Dimethyl-5-((1E,3E)-2-methyl-4-(2,6,6-trimethylcyclohex-1-en-1-yl)buta-1,3-dien-1-yl)-6-((1E,3E,5E)-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hexa-1,3,5-trien-1-yl)cyclohex-3-ene-1,2-diyl)dimethanol ;
CAS:22555-09-5
VTA51 :
Vitamin A Kitol ;

(3-(1-(1H-Imidazol-5-yl)ethyl)-2-methylphenyl)methanol ;
CAS:128366-50-7
MDT64 :
Medetomidine RC4 ; Hydroxy Medetomidine ;

(3-(2-(Dimethylamino)ethyl)-2-((3-(2-(dimethylamino)ethyl)-1H-indol-2-yl)methyl)-1H-indol-5-yl)-N-methylmethanesulfonamide ;
SMT51 :
Sumatriptan RC 1 ;

(3-(2-Chloroethyl)-1-cyclohexyl-1-nitrosourea) ;
CAS:54749-91-6
LMS24 :
Lomustine USP RC D ;

(3-(3-Chlorophenethyl)pyridin-2-yl)(1-methylpiperidin-4-yl)methanone hydrochloride ;
CAS:119770-60-4
LRT45H :
Loratadine Methanone Impurity (HCl) ; Desloratadine Methanone Impurity (HCl) ;

(3-(Hydroxymethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide ;
CAS:179636-97-6
SMT54 :
Sumatriptan RC 4 ;

(3-Benzoylphenyl)acetic acid ;
CAS:22071-22-3
KTP02 :
Ketoprofen EP Impurity B ; Desmethyl Ketoprofen ;

(3-Benzoylphenyl)ethanenitrile ;
CAS:21288-34-6
KTP09 :
Ketoprofen EP Impurity I ;

(3-Fluoro-4-morpholin-4-ylphenyl)carbamic acid benzyl ester ;
CAS:168828-81-7
LNZ32 :
Linezolid Benzyl Impurity ;

(3-Hydroxytricyclo[3.3.1.13,7]dec-2-yl)-(S)-1-imino-hexahydropyrrolo[1,2-a]pyrazin-4(1H)-one ;
CAS:1710765-32-4
VDG74 :
Vildagliptin Imine S-Isomer ; Vildagliptin Impurity L ;

(3-Hydroxytricyclo[3.3.1.13,7]dec-2-yl)-(S)-1-oxo-hexahydropyrrolo[1,2-a]pyrazin-4(1H)-one ;
CAS:1844894-70-7
VDG43 :
Vildagliptin Dione ; Vildagliptin Cyclo Dione ; Vildagliptin Lactam ; Vildagliptin Impurity M ;

(3-Hydroxytricyclo[3.3.1.13,7]dec-2-yl)-1-imino-hexahydropyrrolo[1,2-a]pyrazin-4(1H)-one ;
CAS:1789703-37-2
VDG44B :
Vildagliptin Imine Impurity (Base) ; Vildagliptin Cyclo Imidamide ; Vildagliptin Impurity A ;

(3-Hydroxytricyclo[3.3.1.13,7]dec-2-yl)-1-imino-hexahydropyrrolo[1,2-a]pyrazin-4(1H)-one HCl ;
CAS:2663700-61-4
VDG44H :
Vildagliptin Imine Impurity (HCl) ; Vildagliptin Cyclo Imidamide (HCl) ; Vildagliptin Impurity A (HCl) ;

(3-Hydroxytricyclo[3.3.1.13,7]dec-2-yl)-1-oxo-hexahydropyrrolo[1,2-a]pyrazin-4(1H)-one ;
CAS:1789703-36-1
VDG73 :
Vildagliptin Dione Racemate ; Vildagliptin Diketopiperazine ;

(3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl acetate ;
CAS:112525-75-4
LSP61 :
Lansoprazole Impurity 1 ;

(3-Methyl-4-nitropyridin-2-yl)methanol ;
CAS:168167-49-5
LSP66 :
Lansoprazole Impurity 6 ;

(3-Methyl-4-nitropyridin-2-yl)methyl acetate ;
CAS:166521-98-8
LSP62 :
Lansoprazole Impurity 2 ;

(3-Phenoxyphenyl)methanol ;
CAS:13826-35-2
PMR03 :
Permethrin EP Impurity C ;

(3-Phenoxyphenyl)methyl (1RS,2RS)-2-(2,2-dichloroethenyl)-3,3-dimethylcyclopropane-1-carboxylate ;
CAS:52645-53-1
PMR00 :
Permethrin ;

(3aR)-2-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one ;
CAS:149653-99-6
PLN42B :
Palonosetron (R,R)-Isomer (Base) ;

(3aR)-2-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one HCl ;
CAS:135729-75-8
PLN42H :
Palonosetron (R,R)-Isomer (HCl) ;

(3aR)-2-[(3S)-1-Azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one ;
CAS:135729-73-6
PLN24B :
Palonosetron USP RC D (Base) ; Palonosetron (R,S)-Isomer ;

(3aR)-2-[(3S)-1-Azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one formate ;
PLN24F :
Palonosetron USP RC D (Formate) ; Palonosetron (R,S)-Isomer (Formate) ;

(3aR)-2-[(3S)-1-Azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one HCl ;
CAS:135755-51-0
PLN24H :
Palonosetron USP RC D (HCl) ; Palonosetron (R,S)-Isomer (HCl) ;

(3aR,4R,5R,7S,8S,9R,9aS,12R)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((8-methyl-8-azabicyclo[3.2.1]oct-2-en-3-yl)thio)acetate ;
RTP63 :
Retapamulin RC 3 ;

(3aR,4R,5R,7S,8S,9R,9aS,12R)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((R)-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)sulfinyl)acetate ;
RTP64 :
Retapamulin RC 4 ; Retapamulin S-Oxide ;

(3aR,4R,5S,5aR,10bR,13aR)-4-(Acetyloxy)-3a-ethyl-9-[(6R,8S)-4-ethyl-8-(methoxy carbonyl)-1,3,6,7,8,9-hexahydro-2,6-methano-2H-azacyclodecino[4,3-b]indol-8-yl]-5-hydroxy-8-methoxy-6-methyl-3a,4,5,5a,6,11,12,13a-octahydro-1H-indolizino[8,1-cd
CAS:220137-33-7
VNR08B :
Vinorelbine EP Impurity H (Base) ; 23-O-Desmethyl Vinorelbine ;

(3aR,4R,5S,5aR,10bR,13aR)-4-(Acetyloxy)-3a-ethyl-9-[(6R,8S)-4-ethyl-8-(methoxy carbonyl)-1,3,6,7,8,9-hexahydro-2,6-methano-2H-azacyclodecino[4,3-b]indol-8-yl]-5-hydroxy-8-methoxy-6-methyl-3a,4,5,5a,6,11,12,13a-octahydro-1H-indolizino[8,1-cd
VNR08T :
Vinorelbine EP Impurity H (Tartrate) ; 23-O-Desmethyl Vinorelbine L-Tartrate Salt ;

(3aR,4R,6R,6aR)-4-(4-Aminopyrrolo[1,2-f][1,2,4]triazin-7-yl)-6-(hydroxymethyl)-2,2-dimethyl-tetrahydrofuro[3,4-d][1,3]dioxole-4-carbonitrile ;
CAS:1191237-80-5
RDV66 :
Remdesivir Impurity 6 ; Remdesivir O-Desphosphate Acetonide ;

(3aR,4R,6S,6aS)-Methyl 4-(tert-butoxycarbonyl)-3-(pentan-3-yl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-6-carboxylate ;
CAS:229613-93-8
PMV51 :
Peramivir Impurity 1 ;

(3aR,4R,7R,7aS)-Hexahydro-4,7-Methano-1H-isoindole-1,3(2H)-dione ;
CAS:1932418-38-6
LRS73 :
Lurasidone Impurity 13 ;

(3aR,4R,7S,7aR)- Hexahydro--4,7-Methano-1H-isoindole-1,3(2H)-dione ;
CAS:1928713-81-8
LRS80 :
Lurasidone Impurity 20 ;

(3aR,4S,6R,6aS)-6-Amino-2,2-dimethyl-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ol ;
CAS:155899-66-4
TCG84B :
Ticagrelor Impurity 14 (Base) ;

(3aR,4S,6R,6aS)-6-Amino-2,2-dimethyl-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ol mandelate salt ;
CAS:1392909-30-6
TCG84M :
Ticagrelor Impurity 14 (Mandelate) ;

(3aR,4S,6R,6aS)-methyl 6-(tert-butoxycarbonyl)-3-(pentan-3-yl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-4-carboxylate ;
CAS:383910-24-5
PMV53 :
Peramivir Impurity 3 ;

(3aR,4S,7R,7aS)-2-(((1R,2R)-2-((4-(1,1-Dioxidobenzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione ;
CAS:1807607-99-3
LRS43 :
Lurasidone Sulfone ; Lurasidone Impurity 9 ; Lurasidone DP5 ;

(3aR,4S,7R,7aS)-2-(((1R,2R)-2-((4-(1,1-Dioxidobenzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione and enantiomer ;
CAS:1644295-09-9
LRS53 :
Lurasidone Sulfone Racemate ; Lurasidone Impurity 9 (Racemate) ;

(3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-yl methyl] cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione ;
CAS:367514-87-2
LRS00B :
Lurasidone (Base) ;

(3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-yl methyl] cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione hydrochloride ;
CAS:367514-88-3
LRS00H :
Lurasidone (HCl) ;

(3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-yl methyl] cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione N-oxide ;
CAS:1574569-32-6
LRS60 :
Lurasidone Piperazine N-Oxide ;

(3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1-Oxido-1,2-benzisothiazol-3-yl)piperazin-1-yl methyl] cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione ;
CAS:1809325-45-8
LRS44 :
Lurasidone Sulfoxide ; Lurasidone DP4 ;

(3aR,4S,7R,7aS)-2-{(1R,2S)-2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-yl methyl] cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione hydrochloride ;
CAS:1318074-18-8
LRS50H :
Lurasidone 2-Epimer (HCl) ;

(3aR,4S,7R,7aS)-2-{(1S,2S)-2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-yl methyl] cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione ;
CAS:1448443-35-3
LRS40B :
Lurasidone Enantiomer (Base) ; ent-Lurasidone ; Lurasidone (1S,2S)-Isomer ;

(3aR,4S,7R,7aS)-2-{(1S,2S)-2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-yl methyl] cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione hydrochloride ;
LRS40H :
Lurasidone Enantiomer (HCl) ; ent-Lurasidone HCl ; Lurasidone (1S,2S)-Isomer (HCl) ;

(3aR,4S,7R,7aS)-Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione ;
CAS:14805-29-9
LRS72 :
Lurasidone Impurity 12 ; exo-2,3-Norbornanedicarboximide ;

(3aR,4S,7S,7aS)-Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione ;
CAS:1932773-70-0
LRS79 :
Lurasidone Impurity 19 ;

(3aR,6R)-2-(3S)-1-Azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-6-hydroxy-1H-benz[de]isoquinolin-1-one ;
CAS:175873-26-4
PLN51 :
Palonosetron (6R)-Hydroxy (R,S)-Isomer ;

(3aR,6R,7S,7aS)-6-(Hydroxymethyl)-2,2-dimethyl-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-6,7-diol ;
CAS:912456-61-2
TPM67 :
Topiramate Impurity 7 ; Topiramate Triol Impurity ;

(3aR,6S)-2-(3S)-1-Azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-6-hydroxy-1H-benz[de]isoquinolin-1-one ;
PLN53 :
Palonosetron (6S)-Hydroxy (R,S)-Isomer ;

(3aR,7aR)-4'-(Benzo[d]isothiazol-3-yl)octahydrospiro[isoindole-2,1'-piperazin]-1'-ium methanesulfonate ;
CAS:186204-37-5
LRS71M :
Lurasidone Impurity 11 (Mesylate) ; Lurasidone Impurity B ;

(3aR,7aS)-Hexahydroisobenzofuran-1,3-dione ;
CAS:13149-00-3
PRG80 :
Pregabalin Impurity 20 ;

(3aR,9R,9aR)-5-Bromo-6,7-dihydroxy-9-(3,4,5-trimethoxyphenyl)-3a,4,9,9a-tetrahydronaphtho[2,3-c]furan-1(3H)-one ;
CAS:93108-15-7
PPT55 :
Podophyllotoxin 4-Deoxy 5-Bromo 6,7-Dihydroxy ;

(3aR,9R,9aR)-6,7-Dihydroxy-9-(3,4,5-trimethoxyphenyl)-3a,4,9,9a-tetrahydronaphtho[2,3-c]furan-1(3H)-one ;
CAS:1173-42-8
PPT56 :
Podophyllotoxin 4-Deoxy 6,7-Dihydroxy ;

(3aS)-2-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one ;
CAS:149654-00-2
PLN23B :
Palonosetron USP RC C (Base) ; Palonosetron (S,R)-Isomer ;

(3aS)-2-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one formate ;
PLN23F :
Palonosetron USP RC C (Formate) ; Palonosetron (S,R)-Isomer (Formate) ;

(3aS)-2-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one HCl ;
CAS:135729-76-9
PLN23H :
Palonosetron USP RC C (HCl) ; Palonosetron (S,R)-Isomer (HCl) ;

(3aS)-2-[(3S)-1-Azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one HCl ;
CAS:135729-62-3
PLN00H :
Palonosetron HCl ;

(3aS)-2-[(3S)-1-Azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one N-Oxide ;
CAS:813425-83-1
PLN21 :
Palonosetron USP RC A ; Palonosetron N-Oxide ;

(3aS)-2-[(3S)-1-Azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinoline ;
CAS:1796933-62-4
PLN41B :
Palonosetron Desoxy Impurity (Base) ; Palonosetron Impurity A ;

(3aS)-2-[(3S)-1-Azabicyclo[2.2.2]oct-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinoline dihydrochloride ;
PLN41H :
Palonosetron Desoxy Impurity (HCl) ; Palonosetron Impurity A (HCl) ;

(3aS,4R,5S,6R,8R,9R,9aR)-5-Hydroxy-4,6,9,10-tetramethyl-6-(oxiran-2-yl)-1-oxodecahydro-3a,9-propanocyclopenta[8]annulen-8-yl 2-((8-methyl-8-azabicyclo[3.2.1]octan-3-yl)thio)acetate ;
RTP61 :
Retapamulin RC 1 ;

(3aS,4R,5S,6S,8R,9R,10R)-6-Ethenyl-2,5-dihydroxy-4,6,9,10-tetramethyl-2,3,4,5,6,7,8,9-octahydro-3a,9-propano-3aH-cyclopentacycloocten-8-yl [[2-(diethylamino)ethyl]sulfanyl]acetate ;
TMU17 :
Tiamulin EP Impurity Q ; Tiamulin 2-Hydroxy 3,4-Didehydro Impurity ;

(3aS,4R,5S,6S,8R,9R,9aR)-4,6,9,10-Tetramethyl-5-((methylsulfonyl)oxy)-1-oxo-6-vinyldecahydro-3a,9-propanocyclopenta[8]annulen-8-yl 2-((8-methyl-8-azabicyclo[3.2.1]octan-3-yl)thio)acetate ;
RTP66 :
Retapamulin RC 6 ;

(3aS,4R,5S,6S,8R,9R,9aR)-5-Hydroxy-4,6,9,10-tetramethyl-1-oxo-6-vinyldecahydro-3a,9-propanocyclopenta[8]annulen-8-yl 2-(((3aR,4R,5R,7S,8S,9R,9aS,12R)-5-(2-hydroxyacetoxy)-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]
RTP67 :
Retapamulin RC 7 ;

(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-Ethenyl-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propano-3aH-cyclopentacycloocten-5,8-diyl acetate ;
CAS:14431-61-9
TMU13 :
Tiamulin EP Impurity M ; Mutilin 11,14-Diacetate ;

(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-Ethenyl-5,8-dihydroxy-4,6,9,10-tetramethyloctahydro-3a,9-propano-3aH-cyclopentacycloocten-1(4H)-one ;
CAS:6040-37-5
TMU01 :
Tiamulin EP Impurity A ; Mutilin ;

(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-Ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propano-3aH-cyclopentacycloocten-8-yl [(phenylsulfonyl)oxy]acetate ;
CAS:848129-54-4
TMU16 :
Tiamulin EP Impurity P ;

(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-Ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propano-3aH-cyclopentacycloocten-8-yl [[(4-methylphenyl)sulfonyl]oxy]acetate ;
CAS:31716-01-5
TMU12 :
Tiamulin EP Impurity L ; Tiamulin USP RC A ; Pleuromutilin 22-Tosylate ; Tosyl Pleuromutilin ;

(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-Ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propano-3aH-cyclopentacycloocten-8-yl hydroxyacetate ;
CAS:125-65-5
TMU07 :
Tiamulin EP Impurity G ; Pleuromutilin ; Pleuromulin; Valnemulin EP Impurity E ;

(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-Ethenyl-8-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propano-3aH-cyclopentacycloocten-5-yl acetate ;
CAS:31716-11-7
TMU11 :
Tiamulin EP Impurity K ; Mutilin 11-Acetate ;

(3aS,4R,5S,6S,8R,9S,9aR,10R)-6-Ethenyl-4,6,9,10-tetramethyl-1,5-dioxodecahydro-3a,9-propano-3aH-cyclopentacycloocten-8-yl [[2-(diethylamino)ethyl]sulfanyl]acetate ;
CAS:113323-39-0
TMU05 :
Tiamulin EP Impurity E ; 11-Oxo Tiamulin ; Dehydro Tiamulin ; Tiamulone ;

(3aS,4R,5S,6S,8R,9S,9aR,10R)-6-Ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propano-3aH-cyclopentacycloocten-8-yl [[2-(diethylamino)ethyl]sulfanyl]acetate ;
CAS:55297-95-5
TMU00B :
Tiamulin (Base) ;

(3aS,4R,5S,6S,8R,9S,9aR,10R)-6-Ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propano-3aH-cyclopentacycloocten-8-yl acetate ;
CAS:31771-36-5
TMU10 :
Tiamulin EP Impurity J ; Mutilin 14-Acetate ;

(3aS,4R,5S,6S,8R,9S,9aR,10R)-6-Ethenylhydroxy-4,6,9,10-tetramethyl-5-oxodecahydro-3a,9-propano-3aH-cyclopentacycloocten-8-yl [[2-(diethylamino)ethyl]sulfanyl]acetate ;
TMU04 :
Tiamulin EP Impurity D ;

(3aS,4R,6S,6aR)-Methyl 4-(tert-butoxycarbonyl)-3-(pentan-3-yl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-6-carboxylate ;
CAS:383910-25-6
PMV54 :
Peramivir Impurity 4 ;

(3aS,4S,6R,6aR)-Methyl 6-(tert-butoxycarbonyl)-3-(pentan-3-yl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-4-carboxylate ;
CAS:383910-22-3
PMV52 :
Peramivir Impurity 2 ;

(3aS,6R)-2-(3S)-1-Azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-6-hydroxy-1H-benz[de]isoquinolin-1-one ;
CAS:176019-33-3
PLN52 :
Palonosetron (6R)-Hydroxy (S,S)-Isomer ;

(3aS,6S)-2-(3S)-1-Azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-6-hydroxy-1H-benz[de]isoquinolin-1-one ;
CAS:848074-08-8
PLN54 :
Palonosetron (6S)-Hydroxy (S,S)-Isomer ;

(3E)-1-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)but-3-en-1-one ;
CAS:1675201-14-5 (Z/E) 1803026-58-5 (E)
SGT43 :
Sitagliptin FP Impurity C ; 3-Desamino-3,4-Dehydro Sitagliptin ; Sitagliptin Styrylacetyl Analog (USP) ;

(3E)-13+¦-Ethyl-3-(hydroxyimino)-18,19-dinor-17+¦-pregn-4-en-20-yn-17-ol ;
CAS:74183-55-4
NGM03 :
Norgestimate EP Impurity C ; (E)-Norelgestromin ; (3E)-17-Deacetylnorgestimate ;

(3E)-4-Phenylbut-3-en-2-one ;
CAS:122-57-6
WFR03 :
Warfarin EP Impurity C ; Benzalacetone ; Benzylideneacetone ;

(3E,5E,7E,9Z)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-2-enylidene)nona-3,5,7-trien-1-ol ;
CAS:16729-22-9
VTA03 :
Vitamin A EP Impurity C ; Retro-Vitamin A ;

(3EZ)-13+¦-Ethyl-3-(hydroxyimino)-18,19-dinor-17+¦-pregn-4-en-20-yn-17-ol ;
CAS:53016-31-2
NGM50 :
Norgestimate 17-Desacetyl (EZ)-Mixture ; (EZ)-Norelgestromin ; 17-Desacetyl Norgestimate ;

(3EZ)-13+¦-Ethyl-3-(hydroxyimino)-18,19-dinor-17+¦-pregn-4-en-20-yn-17-yl acetate ;
CAS:35189-28-7
NGM00 :
Norgestimate ;

(3EZ)-13+¦-Ethyl-6alpha-hydroxy-3-(hydroxyimino)-18,19-dinor-17+¦-pregn-4-en-20-yn-17-ol ;
NGM61 :
Norgestimate 6alpha-Hydroxy Desacetate ; 6alpha-Hydroxy Desacetyl Norgestimate ;

(3EZ)-13+¦-Ethyl-6beta-hydroxy-3-(hydroxyimino)-18,19-dinor-17+¦-pregn-4-en-20-yn-17-ol ;
NGM62 :
Norgestimate 6beta-Hydroxy Desacetate ; 6beta-Hydroxy Desacetyl Norgestimate ;

(3EZ)-N-Acetyl-13+¦-ethyl-3-(hydroxyimino)-18,19-dinor-17+¦-pregn-4-en-20-yn-17-ol ;
NGM51 :
Norgestimate 17-Desacetyl N-Acetate ;

(3EZ)-N-Acetyl-13+¦-ethyl-3-(hydroxyimino)-18,19-dinor-17+¦-pregn-4-en-20-yn-17-yl acetate ;
CAS:1060384-93-1
NGM52 :
Norgestimate N-Acetate ;

(3H-Benzo[d]imidazol-5-yl)(1-methyl-1H-indol-3-yl)methanone ;
CAS:183613-77-6
RMS61 :
Ramosetron RC 1 ;

(3R)-1-[4,4-Bis(3-Methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid ;
CAS:115103-54-3
TGB00B :
Tiagabine ;

(3R)-1-[4,4-Bis(3-Methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid HCl ;
CAS:145821-59-6 (anhydrous) 145821-57-4 (monohydrate)
TGB00H :
Tiagabine HCl ;

(3R)-2-[(2S)-2-[[(1R)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]propanoyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid ;
QPR08 :
Quinapril EP Impurity H ;

(3R)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]propanoyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid ;
CAS:103775-06-0 103833-16-5
QPR07 :
Quinapril EP Impurity G ; Quinapril 3-Epimer ;

(3R)-3-((1H-1,2,3-Triazol-1-yl)methyl)-3-methyl-4-thia-1-azabicyclo[3.2.0]heptan-7-one 4,4-dioxide ;
TZB52 :
Tazobactam Acid Impurity T-2 ;

(3R)-3-(3-Hydroxyhexadecanoyloxy)-4-(trimethylammonio)butanoate ;
CAS:195207-76-2
LCT68 :
Levocarnitine RC 8 ; 3-Hydroxy Hexadecanoyl L-Carnitine ;

(3R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-(3-hydroxycyclopentyl)propanenitrile ;
CAS:1092973-94-8
RLT37 :
Ruxolitinib M7 ; 3-Hydroxycyclopentyl Ruxolitinib ;

(3R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-(3-oxocyclopentyl)propanenitrile ;
CAS:1092973-96-0
RLT39 :
Ruxolitinib M9 ; 3-Oxocyclopentyl Ruxolitinib ;

(3R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanamide ;
RLT59B :
Ruxolitinib Amide R-Isomer ;

(3R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanoic acid ;
CAS:2102675-40-9
RLT57B :
Ruxolitinib Acid ;

(3R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanoic acid methyl ester ;
CAS:2950130-23-9
RLT58B :
Ruxolitinib Methyl Ester ;

(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid ;
CAS:936630-57-8
SGT45B :
Sitagliptin FP Impurity E (Base) ; Sitagliptin Acid ; Sitagliptin STA Impurity F ;

(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid HCl ;
CAS:1204818-19-8
SGT45H :
Sitagliptin FP Impurity E (HCl) ; Sitagliptin Acid (HCl) ;

(3R)-3-Cyclopentyl-3-(4-(5-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile ;
RLT55B :
Ruxolitinib 5-Hydroxymethyl Impurity ;

(3R)-3-Cyclopentyl-3-(4-(7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile ;
CAS:1236033-03-6
RLT56B :
Ruxolitinib 7-Hydroxymethyl Impurity ; N-Hydroxymethyl Ruxolitinib ;

(3R)-3-Cyclopentyl-3-(5-(dimethylamino)-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanamide ;
RLT68 :
Ruxolitinib RC 8 ;

(3R)-3-Cyclopentyl-3-(5-(dimethylamino)-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile ;
RLT69 :
Ruxolitinib RC 9 ;

(3R)-3-Cyclopentyl-3-(5-(dimethylamino)-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanoic acid ;
RLT67 :
Ruxolitinib RC 7 ;

(3R)-3-Formyl-7-oxo-3-(1H-1,2,3-triazole-1-carbonyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide ;
TZB54 :
Tazobactam Acid Impurity T-4 ;

(3R)-3-Hydroxy-4-(trimethylammonio)butanoate ;
CAS:541-15-1
LCT00 :
Levocarnitine ; L-Carnitine ;

(3R)-5-Methyl-3-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]hexanoic acid ;
CAS:930585-94-7
PRG07 :
Pregabalin EP Impurity G ;

(3R)-N-Methyl-3-phenyl-3-[4-(trin¼éuoromethyl)phenoxy]propan-1-amine ;
CAS:100568-03-4
FXT51B :
Fluoxetine R-Isomer ; (-)-Fluoxetine ;

(3R)-N-Methyl-3-phenyl-3-[4-(trin¼éuoromethyl)phenoxy]propan-1-amine hydrochloride ;
CAS:114247-09-5
FXT51H :
Fluoxetine R-Isomer (HCl) ; (-)-Fluoxetine HCl ;

(3R, 6E)-7-[2-Cyclopropyl-4-(4-flurophenyl)-3- quinolinyl]-3-hydroxy-5-oxo-6-heptenoic acid ;
CAS:222306-15-2
PTV12A :
Pitavastatin 5-Oxo (Acid) ;

(3R,11bR)-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one ;
CAS:1026016-83-0
TBZ54 :
Tetrabenazine (R,R)-Isomer ;

(3R,11bR)-rel-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one ;
CAS:58-46-8
TBZ00 :
Tetrabenazine ;

(3R,11bR)-rel-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one N-oxide ;
TBZ50 :
Tetrabenazine N-Oxide ;

(3R,3'R)-3,3'-(Cyclobuta[1,2-d:3,4-d']bis([1,2,3]triazole)-1,4(3aH,3bH,6aH,6bH)-diylbis(methylene))bis(3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide) ;
TZB51 :
Tazobactam Acid Impurity T-1 ;

(3R,3aS,6S,6aS)-Hexahydrofuro[3,2-b]furan-3,6-diyl dinitrate ;
CAS:87-33-2
ISD00 :
Isosorbide Dinitrate ;

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine ;
CAS:477600-70-7
TFC95B :
Tofacitinib RC 5 (Base) ;

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride ;
CAS:1062580-52-2
TFC95H :
Tofacitinib RC 5 (2HCl) ;

(3R,4R)-3-Ethyl-4-[(1-methyl-1H-imidazol-5-yl)-methyl]dihydrofuran-2(3H)-one ;
CAS:531-35-1
PCP01B :
Pilocarpine EP Impurity A (Base) ; Isopilocarpine ;

(3R,4R)-3-Ethyl-4-[(1-methyl-1H-imidazol-5-yl)-methyl]dihydrofuran-2(3H)-one hydrochloride ;
CAS:28958-85-2
PCP01H :
Pilocarpine EP Impurity A (HCl) ; Isopilocarpine HCl ; Pilocarpine 3-Epimer HCl ;

(3R,4R)-4-((1H-1,2,4-Triazol-1-yl)methyl)-4-(2,5-difluorophenyl)-3-methyloxetan-2-one ;
CAS:483340-20-1
ISV73 :
Isavuconazole RC 13 ;

(3R,4R)-4-Methyl-3-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-+¦-oxo-1-piperidinepropanenitrile ;
CAS:1527525-58-1
TFC61B :
Tofacitinib M1 ; N-Desmethyl Tofacitinib ;

(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-+¦-oxo-1-piperidineethanol ;
TFC62B :
Tofacitinib M2 ;

(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-+¦-oxo-1-piperidinepropanenitrile ;
CAS:477600-75-2
TFC00B :
Tofacitinib (Base) ;

(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-+¦-oxo-1-piperidinepropanenitrile citrate salt ;
CAS:540737-29-9
TFC00C :
Tofacitinib (Citrate) ;

(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-+¦-oxo-1-piperidinepropanenitrile; 1-(Cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo [2,3-d]pyrimidin-4-yl-3-piperidinamine N-oxide ;
CAS:2028267-73-2
TFC70 :
Tofacitinib N-Oxide ; CP-690550 N-Oxide ;

(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidine ;
CAS:477600-74-1
TFC60B :
Tofacitinib N-Descyanoacetyl Impurity (Base) ;

(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidine dihydrochloride ;
CAS:1655430-59-3
TFC60X :
Tofacitinib N-Descyanoacetyl Impurity (2HCl) ;

(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidine HCl ;
CAS:1260590-51-9
TFC60H :
Tofacitinib N-Descyanoacetyl Impurity (HCl) ;

(3R,4R)-N,4-Dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine ;
CAS:2097982-05-1
TFC84 :
Tofacitinib Impurity X ;

(3R,4R)-N,4-Dimethylpiperidin-3-amine ;
CAS:1354469-76-3
TFCA4B :
Tofacitinib RC 14 ;

(3R,4R,5R)-3,4-bis(Benzyloxy)-5-(benzyloxymethyl)-dihydrofuran-2(3H)-one ;
CAS:55094-52-5
RDV63 :
Remdesivir Impurity 3 ;

(3R,4R,5R)-6-{[(2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexane-1,2,3,4,5-pentol ;
CAS:64519-82-0
MNT03 :
Mannitol EP Impurity C ; Isomalt ;

(3R,4R,5S)-4-(Acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester formate salt ;
OST00F :
Oseltamivir Formate ;

(3R,4R,5S)-4-(Acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester phosphate salt ;
CAS:204255-11-8
OST00P :
Oseltamivir Phosphate ;

(3R,4R,5S)-4-Acetamido-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid ;
CAS:187227-45-8
OST03B :
Oseltamivir EP Impurity C (Base) ; Oseltamivir BP Impurity C ; Oseltamivir Acid ;

(3R,4R,5S)-4-Acetamido-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid hydrochloride ;
CAS:1415963-60-8
OST03H :
Oseltamivir EP Impurity C (HCl) ; Oseltamivir Acid (HCl) ;

(3R,4R,5S)-4-Acetamido-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid potassium salt ;
CAS:1363339-68-7
OST03K :
Oseltamivir EP Impurity C (Potassium) ; Oseltamivir Acid Potassium ;

(3R,4R,5S)-5-Acetamido-4-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid ;
CAS:1391047-93-0 1364932-19-3
OST01B :
Oseltamivir EP Impurity A (Base) ; Oseltamivir BP Impurity A ;

(3R,4R,5S)-5-Acetamido-4-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid formate ;
OST01F :
Oseltamivir EP Impurity A (Formate) ; Oseltamivir BP Impurity A ;

(3R,4R,5S)-Ethyl 4-acetamido-5-amino-3-isopropoxycyclohex-1-enecarboxylate ;
CAS:1052063-36-1
OST61B :
Oseltamivir RC 1 ;

(3R,4S)-(+)-3-[(1,3-Benzodioxol-5-yloxy) methyl]-4-(4-fluorophenyl) piperidine ;
CAS:112058-85-2
PRX04B :
Paroxetine HCl Hemihydrate EP Impurity D (Base) ; Paroxetine HCl Anhydrous EP Impurity D ; Paroxetine USP RC C ; trans-(+)-Paroxetine ; ent-Paroxetine ;

(3R,4S)-(+)-3-[(1,3-Benzodioxol-5-yloxy) methyl]-4-(4-fluorophenyl) piperidine HCl ;
CAS:130855-30-0
PRX04H :
Paroxetine HCl Hemihydrate EP Impurity D (HCl) ; Paroxetine HCl Anhydrous EP Impurity D ; Paroxetine HCl USP RC C ; trans-(+)-Paroxetine HCl ; ent-Paroxetine HCl ;

(3R,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine ;
CAS:1638499-31-6
TFC97B :
Tofacitinib RC 7 (Base) ;

(3R,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride ;
CAS:1431697-80-1
TFC97H :
Tofacitinib RC 7 (2HCl) ;

(3R,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-+¦-oxo-1-piperidinepropanenitrile ;
CAS:1092578-46-5
TFC51B :
Tofacitinib (3R,4S)-Isomer ; 4-Epi Tofacitinib ; Tofacitinib Impurity A ; Tofacitinib (3R,4S)-Diastereomer ;

(3R,4S)-trans-(+)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methyl piperidine ;
PRX32 :
Paroxetine (3R,4S)-N-Methyl Paroxol Impurity ;

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-+¦-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[(3,4,6-trideoxy-3-dimethylamino-+¦-D-xylo-hexopyranosyl)-oxy]oxacyclotetradecane-2,
CAS:114-07-8
RTM01 :
Roxithromycin EP Impurity A ; Erythromycin ; Erythromycin A ;

(3R,4S,6S)-6-((R)-Hydroxy(6-methoxyquinolin-4-yl)methyl)-3-vinylquinuclidin-3-ol ;
CAS:128241-59-8
QNN51B :
Quinine (3R)-Hydroxy ;

(3R,5R)-((2R,4R)-2-(2-((1S,2S,6R,8S)-8-(2,2-Dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)ethyl)-6-oxo-tetrahydro-2H-pyran-4-yl) 7-((2S,6R,8S)-8-(2,2-dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthal
CAS:476305-24-5
SVS04 :
Simvastatin EP Impurity D ; Simvastatin USP RC D ; Simvastatin Dimer ;

(3R,5R)-2,3-Dihydroxypropyl 7-((1S,2S,6R,8S)-8-(2,2-dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoate ;
SVS52 :
Simvastatin Acid Glycerol Ester ; Simvastatin Hydroxy Acid Glycerol Ester ;

(3R,5R)-2-Oxo-2-(pyren-1-yl)ethyl 7-((1S,2S,6R,8S)-8-(2,2-dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoate ;
CAS:193682-18-7
SVS62
Simvastatin RC 2 ; Simvastatin 1-Pyreneacetyl Ester ;

(3R,5R)-3,5-bis(tert-Butyldimethylsilyloxy)-7-((1S,2S,6R,8S)-8-(2,2-dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoic acid
CAS:1094101-38-8
SVS64
Simvastatin RC 4 ;

(3R,5R)-3,5-Dihydroxy-7-((1S,2S)-6-hydroxy-2-methyl-1,2-dihydronaphthalen-1-yl)heptanoic acid ;
CAS:136590-28-8
PVS07A :
Pravastatin EP Impurity G (Acid) ; Pravastatin Oxidation Impurity (Acid) ; Desacyl Dehydro Pravastatin ;

(3R,5R)-3,5-dihydroxy-7-[(1S,2R,3R,8S,8aR)-3-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydro naphthalen-1-yl] heptanoic acid ;
CAS:145842-18-8
PVS41A :
Pravastatin 3-beta-Hydroxy Acid ; 3-beta-Hydroxy Isocompactin Acid ;

(3R,5R)-3,5-dihydroxy-7-[(1S,2R,3R,8S,8aR)-3-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydro naphthalen-1-yl] heptanoic acid sodium salt ;
CAS:1246814-88-9
PVS41N :
Pravastatin 3-beta-Hydroxy Sodium ; 3-beta-Hydroxy Isocompactin Sodium ;

(3R,5R)-3,5-dihydroxy-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydro naphthalen-1-yl] heptanoic acid ;
CAS:81131-74-0
PVS21A :
Pravastatin USP RC A (Acid) ; 3-alpha-Hydroxy Isocompactin ; Pravastatin 3-alpha-Hydroxy Acid ;

(3R,5R)-3,5-dihydroxy-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydro naphthalen-1-yl] heptanoic acid sodium salt ;
CAS:81093-43-8
PVS21N :
Pravastatin USP RC A (Sodium) ; 3-alpha-Hydroxy Isocompactin Sodium ; Pravastatin 3-alpha-Hydroxy Sodium ;

(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid ;
CAS:250737-12-3
PVS01A :
Pravastatin EP Impurity A (Acid) ; Pravastatin USP RC B (Acid) ; 6GÇ¦-epi-Pravastatin ;

(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid sodium salt ;
CAS:81176-41-2
PVS01N :
Pravastatin EP Impurity A (Sodium) ; Pravastatin USP RC B (Sodium) ; 6GÇ¦-epi-Pravastatin Sodium ;

(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[[(2S)-2-methylpentanoyl]oxy]-1,2,6,7,8,8ahexahydronaphthalen-1-yl]heptanoic acid ;
CAS:159345-66-1
PVS03A :
Pravastatin EP Impurity C (Acid) ; Methyl Pravastatin ; Homopravastatin ; Pravastatin Pentanoyl Impurity ;

(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[[(2S)-2-methylpentanoyl]oxy]-1,2,6,7,8,8ahexahydronaphthalen-1-yl]heptanoic acid sodium salt ;
CAS:159225-12-4
PVS03N :
Pravastatin EP Impurity C (Sodium) ; Methyl Pravastatin Sodium ; Homopravastatin Sodium ; Pravastatin Sodium Pentanoyl Impurity ;

(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-8-[[(2S,3R)-3-hydroxy-2-methylbutanoyl]oxy]-2-methyl-1,2,6,7,8,8a-hexahydro naphthalen-1-yl] heptanoic acid ;
CAS:773073-26-0
PVS02A :
"Pravastatin EP Impurity B (Acid) ; 3""-(R)-Hydroxy Pravastatin Acid ;"

(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-8-[[(2S,3R)-3-hydroxy-2-methylbutanoyl]oxy]-2-methyl-1,2,6,7,8,8a-hexahydro naphthalen-1-yl] heptanoic acid sodium salt ;
CAS:722504-46-3
PVS02N :
"Pravastatin EP Impurity B (Sodium) ; 3""-(R)-Hydroxy Pravastatin Sodium ;"

(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-8-[[(2S,3S)-3-hydroxy-2-methylbutanoyl]oxy]-2-methyl-1,2,6,7,8,8a-hexahydro naphthalen-1-yl] heptanoic acid ;
CAS:136657-41-5
PVS05A :
"Pravastatin EP Impurity E (Acid) ; 3""-(S)-Hydroxy Pravastatin ;"

(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-8-[[(2S,3S)-3-hydroxy-2-methylbutanoyl]oxy]-2-methyl-1,2,6,7,8,8a-hexahydro naphthalen-1-yl] heptanoic acid sodium salt ;
CAS:722504-45-2
PVS05N :
"Pravastatin EP Impurity E (Sodium) ; 3""-(S)-Hydroxy Pravastatin Sodium ;"

(3R,5R)-7-((1S,2S,6R,8S)-2,6-Dimethyl-8-((R)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoic acid ;
CAS:1329793-55-6
LVS65A :
Lovastatin Impurity 5 (Acid) ;

(3R,5R)-7-((1S,2S,6R,8S)-8-(2,2-dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoic acid ;
CAS:121009-77-6
SVS01A :
Simvastatin EP Impurity A (Acid) ; Simvastatin USP RC A ; Simvastatin Hydroxy Acid ; Tenivastatin ;

(3R,5R)-7-((1S,2S,6R,8S)-8-(2,2-dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoic acid ammonium salt ;
CAS:139893-43-9
SVS60N :
Simvastatin Acid Ammonium Salt ; Simvastatin Hydroxy Acid Ammonium Salt ;

(3R,5R)-7-((1S,2S,6R,8S)-8-(2,2-dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoic acid sodium salt ;
CAS:101314-97-0
SVS01N :
Simvastatin EP Impurity A (Sodium) ; Simvastatin USP RC A ; Simvastatin Hydroxy Acid Sodium Salt ; Tenivastatin Sodium Salt ;

(3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-dimethyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7, 8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid sodium salt ;
CAS:75225-50-2
LVS02N :
Lovastatin EP Impurity B ; Lovastatin Hydroxy Acid Sodium Salt ; Mevinolinic Acid Sodium Salt ;

(3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-Dimethyl-8-hydroxy-1,2,6,7,8,8a-hexahydro naphthalen-1-yl]-3,5-dihydroxyheptanoic acid ;
CAS:132748-10-8
LVS32A :
Lovastatin Triol Acid ; Simvastatin Triol Acid ; Des(2-methylbutyryl) Lovastatin Hydroxy Acid ;

(3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-Dimethyl-8-hydroxy-1,2,6,7,8,8a-hexahydro naphthalen-1-yl]-3,5-dihydroxyheptanoic acid sodium salt ;
CAS:132294-94-1
LVS32N :
Lovastatin Triol Acid Sodium Salt ; Simvastatin Triol Acid Sodium Salt ; Des(2-methylbutyryl) Lovastatin Hydroxy Acid Sodium Salt ;

(3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-Dimethyl-8-hydroxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid ;
CAS:132748-10-8
SVS53A :
Simvastatin Triol Acid ; Lovastatin Triol Acid ; Des(2-methylbutyryl) Lovastatin Hydroxy Acid ;

(3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-Dimethyl-8-hydroxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid sodium salt ;
CAS:132294-94-1
SVS53N :
Simvastatin Triol Acid Sodium Salt ; Lovastatin Triol Acid Sodium Salt ; Des(2-methylbutyryl) Lovastatin Hydroxy Acid Sodium Salt ;

(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6,8-Dihydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid ;
CAS:151006-03-0
PVS06A :
Pravastatin EP Impurity F (Acid) ; Des(2-methylbutyryl) Pravastatin ;

(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6,8-Dihydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid sodium salt ;
CAS:151061-28-8
PVS06N :
Pravastatin EP Impurity F (Sodium) ; Des(2-methylbutyryl) Pravastatin Sodium ;

(3R,5R)-Ethyl 7-((1S,2S,6R,8S)-8-(2,2-dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoate ;
CAS:864357-87-9
SVS13 :
Simvastatin EP Impurity M ; Simvastatin Acid Ethyl Ester ; Simvastatin Hydroxy Acid Ethyl Ester ;

(3R,5R)-Methyl 7-((1S,2S,6R,8S)-8-(2,2-dimethylbutanoyloxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoate ;
CAS:145576-26-7
SVS50 :
Simvastatin Acid Methyl Ester ; Simvastatin Hydroxy Acid Methyl Ester ; Tenivastatin Methyl Ester ;

(3R,5R)-tert-Butyl 6-(benzyloxy)-3,5-dihydroxyhexanoate ;
CAS:215876-09-8
RSVB5 :
Rosuvastatin Impurity 15 ;

(3R,5R)-tert-Butyl 6-chloro-3,5-dihydroxyhexanoate ;
CAS:404958-69-6
RSVA8 :
Rosuvastatin Impurity 8 ;

(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid ;
CAS:769908-13-6
PTV30A :
Pitavastatin (3R,5R)-Isomer (Acid) ; Pitavastatin Anti-Isomer ;

(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid calcium salt ;
CAS:254452-96-5
PTV30C :
Pitavastatin (3R,5R)-Isomer Calcium ; Pitavastatin Calcium Anti-Isomer ;

(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid ethyl ester ;
PTV40 :
Pitavastatin (3R,5R)-Isomer Ethyl Ester ; Pitavastatin Anti-Isomer Ethyl Ester ;

(3R,5R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl) amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid ;
CAS:1094100-06-7
RSV52A :
Rosuvastatin (3R,5R)-Isomer (Acid) ; (3R,5R)-Rosuvastatin ; Rosuvastatin Anti-Isomer ;

(3R,5R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl) amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid calcium salt ;
CAS:1422515-55-6
RSV52C :
Rosuvastatin (3R,5R)-Isomer (Calcium) ; (3R,5R)-Rosuvastatin Calcium ; Rosuvastatin Calcium Anti Isomer ;

(3R,5R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl) amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid ethyl ester ;
RSV61 :
Rosuvastatin (3R,5R)-Isomer Ethyl Ester ;

(3R,5R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl) amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid methyl ester ;
CAS:1776088-23-3
RSV62 :
Rosuvastatin (3R,5R)-Isomer Methyl Ester ;

(3R,5R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methyl sulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid t-butyl ester ;
CAS:2162136-65-2
RSV63 :
Rosuvastatin (3R,5R)-Isomer t-Butyl Ester ;

(3R,5R,E)-7-(3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid ;
CAS:94061-83-3
FLV52 :
Fluvastatin Lactone ;

(3R,5RS)-5-[8-Fluoro-4-isopropyl-2-(N-methylmethylsulfonamido)-5,6-dihydrobenzo[h]quinazolin-6-yl]-3,5-dihydroxypentanoic acid calcium salt ;
CAS:1335110-44-5
RSV08C :
Rosuvastatin EP Impurity H (Calcium) ; Rosuvastatin EP Impurity FP-B ;

(3R,5S)-3-Benzyl-5-[[(2S)-2-[(1,1-dimethylethyl)-carbamoyl]-4-(pyridin-3-ylmethyl)piperazin-1-yl]methyl]-4,5-dihydrofuran-2(3H)-one ;
IDN04 :
Indinavir EP Impurity D ; Indinavir Lactone (USP) ;

(3R,5S)-5-(6-Cyclopropyl-10-fluoro-7,8-dihydrobenzo[k]phenanthridin-8-yl)-3,5-dihydroxypentanoic acid ;
CAS:1187966-91-1
PTV68A :
Pitavastatin Dihydrobenzophenanthridine (Acid) ;

(3R,5S)-5-(6-Cyclopropyl-10-fluoro-7,8-dihydrobenzo[k]phenanthridin-8-yl)-3,5-dihydroxypentanoic acid calcium salt ;
PTV68C :
Pitavastatin Dihydrobenzophenanthridine (Calcium Salt) ;

(3R,5S)-5-(6-Cyclopropyl-10-fluorobenzo[k]phenanthridin-8-yl)-3,5-dihydroxypentanoic acid ;
CAS:1187966-93-3
PTV69A :
Pitavastatin Benzophenanthridine Impurity (Acid) ;

(3R,5S)-5-(6-Cyclopropyl-10-fluorobenzo[k]phenanthridin-8-yl)-3,5-dihydroxypentanoic acid calcium salt ;
PTV69C :
Pitavastatin Benzophenanthridine Impurity (Calcium) ;

(3R,5S)-5-(6-Cyclopropyl-10-fluorobenzo[k]phenanthridin-8-yl)-3,5-dihydroxypentanoic acid sodium salt ;
PTV69N :
Pitavastatin Benzophenanthridine Impurity (Sodium) ;

(3R,5S)-5-[(6R)-8-Fluoro-4-isopropyl-2-(N-methylmethylsulfonamido)-5,6-dihydrobenzo[h]quinazolin-6-yl]-3,5-dihydroxypentanoic acid ;
CAS:854898-48-9
RSV58A :
Rosuvastatin (6R)-Isomer (Acid) ; Rosuvastatin Dihydrobenzoquinazoline (6R)-Isomer ;

(3R,5S)-5-[(6R)-8-Fluoro-4-isopropyl-2-(N-methylmethylsulfonamido)-5,6-dihydrobenzo[h]quinazolin-6-yl]-3,5-dihydroxypentanoic acid calcium salt ;
CAS:854898-49-0
RSV58C :
Rosuvastatin (6R)-Isomer (Calcium) ; Rosuvastatin Dihydrobenzoquinazoline (6R)-Isomer (Calcium) ; Rosuvastatin FP-B (Calcium) ;

(3R,5S)-5-[(6R)-8-Fluoro-4-isopropyl-2-(N-methylmethylsulfonamido)-5,6-dihydrobenzo[h]quinazolin-6-yl]-3,5-dihydroxypentanoic acid methyl ester ;
RSV81 :
Rosuvastatin (6R)-Isomer Methyl Ester ;

(3R,5S)-5-[(6R)-8-Fluoro-4-isopropyl-2-(N-methylmethylsulfonamido)-5,6-dihydrobenzo[h]quinazolin-6-yl]-3,5-dihydroxypentanoic acid sodium salt ;
RSV58N :
Rosuvastatin (6R)-Isomer (Sodium) ; Rosuvastatin Dihydrobenzo quinazoline (6R)-Isomer (Sodium) ; Rosuvastatin FP-B (Sodium) ;

(3R,5S)-5-[(6S)-8-Fluoro-4-isopropyl-2-(N-methylmethylsulfonamido)-5,6-dihydrobenzo[h]quinazolin-6-yl]-3,5-dihydroxypentanoic acid ;
CAS:854898-53-6
RSV68A :
Rosuvastatin (6S)-Isomer (Acid) ; Rosuvastatin Dihydrobenzoquinazoline (6S)-Isomer ; Rosuvastatin Benzoquinazoline Analog (USP) ;

(3R,5S)-5-[(6S)-8-Fluoro-4-isopropyl-2-(N-methylmethylsulfonamido)-5,6-dihydrobenzo[h]quinazolin-6-yl]-3,5-dihydroxypentanoic acid calcium salt ;
CAS:854898-50-3
RSV68C :
Rosuvastatin (6S)-Isomer (Calcium) ; Rosuvastatin Dihydrobenzoquinazoline (6S)-Isomer Calcium Salt ; Rosuvastatin Calcium Benzoquinazoline Analog (USP)

(3R,5S)-5-[(6S)-8-Fluoro-4-isopropyl-2-(N-methylmethylsulfonamido)-5,6-dihydrobenzo[h]quinazolin-6-yl]-3,5-dihydroxypentanoic acid methyl ester ;
RSV82 :
Rosuvastatin (6S)-Isomer Methyl Ester ;

(3R,5S)-5-[(6S)-8-Fluoro-4-isopropyl-2-(N-methylmethylsulfonamido)-5,6-dihydrobenzo[h]quinazolin-6-yl]-3,5-dihydroxypentanoic acid sodium salt ;
RSV68N :
Rosuvastatin (6S)-Isomer (Sodium) ; Rosuvastatin Dihydrobenzoquinazoline (6S)-Isomer Sodium Salt ; Rosuvastatin Sodium Benzoquinazoline Analog (USP) ;

(3R,5S)-5-[(Biphenyl-4-yl)methyl]-3-methylpyrrolidin-2-one ;
CAS:1038924-70-7
SCT54 :
Sacubitril (3R,5S)-Pyrrolidinone Impurity ;

(3R,5S)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl) amino]-5-pyrimidinyl]-3,5-dihydroxy-heptanoic acid ;
CAS:1347797-73-2
RSV12A :
Rosuvastatin EP Impurity L (Acid) ; Rosuvastatin 6,7-Dihydro Acid ;

(3R,5S)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl) amino]-5-pyrimidinyl]-3,5-dihydroxy-heptanoic acid calcium salt ;
CAS:1024064-70-7
RSV12C :
Rosuvastatin EP Impurity L (Calcium) ; Rosuvastatin 6,7-Dihydro Calcium ;

(3R,5S)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl) amino]-5-pyrimidinyl]-3,5-dihydroxy-heptanoic acid sodium salt ;
CAS:1347362-67-7
RSV12N :
Rosuvastatin EP Impurity L (Sodium) ; Rosuvastatin 6,7-Dihydro Sodium ;

(3R,5S)-tert-Butyl 6-chloro-3,5-dihydroxyhexanoate ;
CAS:154026-93-4
RSVB2 :
Rosuvastatin Impurity 12 ;

(3R,5S,6E)-7-[1-Ethyl-3-(4-n¼éuorophenyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid ;
CAS:779995-42-5
FLV03A :
Fluvastatin EP Impurity C (Acid) ; Fluvastatin BP Impurity C ; Fluvastatin N-Ethyl Analog (USP) ; N-Ethyl Fluvastatin ;

(3R,5S,6E)-7-[1-Ethyl-3-(4-n¼éuorophenyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid sodium salt ;
CAS:93936-64-2
FLV03N :
Fluvastatin EP Impurity C (Sodium) ; Fluvastatin BP Impurity C ; Fluvastatin N-Ethyl Analog (USP) ; N-Ethyl Fluvastatin Sodium ;

(3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) -quinolin-3-yl]-2,2-dimethyl-1,3-dioxane-6-heptenoic acid t-butyl ester ;
CAS:147489-06-3
PTV58 :
Pitavastatin Acetonide t-Butyl Ester ;

(3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid ;
CAS:147511-69-1
PTV00A :
Pitavastatin (Acid) ; (3R,5S,6E)-Pitavastatin (Acid) ;

(3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid 1,1,3,3-tetramethylbutylamine salt ;
PTV78 :
Pitavastatin TMBA Salt ; Pitavastatin 1,1,3,3-Tetramethylbutylamine Salt ; Pitavastatin t-Octylammonium Salt ;

(3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid calcium salt ;
CAS:147526-32-7
PTV00C :
Pitavastatin Calcium ; (3R,5S,6E)-Pitavastatin Calcium ;

(3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid ethyl ester ;
CAS:167073-19-0
PTV05 :
Pitavastatin Ethyl Ester ;

(3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid methyl ester ;
CAS:849811-78-5
PTV06 :
Pitavastatin Methyl Ester ;

(3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid t-butyl ester ;
CAS:586966-54-3
PTV07 :
Pitavastatin t-Butyl Ester ;

(3R,5S,6E)-7-[2-Cyclopropyl-4-phenyl-quinolin-3-yl]-2,2-dimethyl-1,3-dioxane-6-heptenoic acid t-butyl ester ;
PTV70 :
Pitavastatin Desfluoro Acetonide t-Butyl Ester ; Desfluoro Pitavastatin Acetonide t-Butyl Ester ;

(3R,5S,6E)-7-[2-Cyclopropyl-4-phenyl-quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid ;
CAS:847849-67-6
PTV50A :
Pitavastatin Desfluoro (Acid) ; Desfluoro Pitavastatin (Acid) ;

(3R,5S,6E)-7-[2-Cyclopropyl-4-phenyl-quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid calcium salt ;
CAS:1258947-30-6
PTV50C :
Pitavastatin Desfluoro (Calcium) ; Desfluoro Pitavastatin Calcium ;

(3R,5S,6E)-7-[2-Cyclopropyl-4-phenyl-quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid sodium salt ;
PTV50N :
Pitavastatin Desfluoro (Sodium) ;

(3R,5S,6E)-7-[2-Cyclopropyl-4-phenyl-quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid t-butyl ester ; Desfluoro Pitavastatin t-Butyl Ester ;
PTV60 :
Pitavastatin Desfluoro t-Butyl Ester ;

(3R,5S,6E)-7-[3-(4-n¼éuorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid ;
CAS:155229-75-7
FLV35A :
Fluvastatin (3R,5S)-Isomer (Acid) ; (3R,5S)-Fluvastatin ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl-methyl sulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid methyl ester ;
CAS:147118-40-9
RSV59 :
Rosuvastatin Methyl Ester ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl-methyl sulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid t-butyl ester ;
CAS:355806-00-7
RSV60 :
Rosuvastatin t-Butyl Ester ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid ethyl ester ;
CAS:851443-04-4
RSV57 :
Rosuvastatin Ethyl Ester ; Rosuvastatin EP Impurity FP-A ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid isopropyl ester ;
CAS:851440-21-6
RSV38 :
Rosuvastatin Isopropyl Ester ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[(methylsulfonyl) amino]-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid ;
CAS:371775-74-5
RSV31A :
Rosuvastatin N-Desmethyl (Acid) ; N-Desmethyl Rosuvastatin ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[(methylsulfonyl) amino]-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid calcium salt ;
RSV31C :
Rosuvastatin N-Desmethyl Calcium ; N-Desmethyl Rosuvastatin Calcium ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[(methylsulfonyl) amino]-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid t-butyl ester ;
CAS:1283766-30-2
RSV54 :
Rosuvastatin N-Desmethyl t-Butyl Ester ; N-Desmethyl Rosuvastatin Acid t-Butyl Ester ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl (methylsulfonyl)amino]-5-pyrimidinyl]-2-hydroxy-ethylsulfonyl)amino)-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid ;
CAS:2226413-61-0
RSV05A :
Rosuvastatin EP Impurity E (Acid) ; Rosuvastatin USP RC B (Acid) ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl (methylsulfonyl)amino]-5-pyrimidinyl]-2-hydroxy-ethylsulfonyl)amino)-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid calcium salt
RSV05C :
Rosuvastatin EP Impurity E (Calcium) ; Rosuvastatin USP RC B (Calcium) ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl (methylsulfonyl)amino]-5-pyrimidinyl]-ethenylsulfonyl)amino)-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid ;
CAS:2226413-62-1
RSV10A :
Rosuvastatin EP Impurity J (Acid) ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl (methylsulfonyl)amino]-5-pyrimidinyl]-ethenylsulfonyl)amino)-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid calcium salt ;
RSV10C :
Rosuvastatin EP Impurity J (Calcium Salt) ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (2-hydroxy-2-methylpropylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid ;
CAS:1715120-13-0
RSV01A :
Rosuvastatin EP Impurity A (Acid) ; Rosuvastatin USP RC A ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (2-hydroxy-2-methylpropylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid calcium salt ;
CAS:1714147-47-3
RSV01C :
Rosuvastatin EP Impurity A (Calcium) ; Rosuvastatin USP RC A ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (2-hydroxy-2-methylpropylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid sodium salt ;
CAS:1714147-50-8
RSV01N :
Rosuvastatin EP Impurity A (Sodium) ; Rosuvastatin USP RC A ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (2-hydroxy-2-methylpropylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid t-butyl ester ;
CAS:1714147-49-5
RSV41 :
Rosuvastatin EP Impurity A t-Butyl Ester ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl) amino]-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid ;
CAS:287714-41-4
RSV00A :
Rosuvastatin (Acid) ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid allyl ester ;
CAS:1352945-05-1
RSV36 :
Rosuvastatin Allyl Ester ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid calcium salt ;
CAS:147098-20-2
RSV00C :
Rosuvastatin (Calcium) ; (3R,5S)-Rosuvastatin Calcium ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid sodium salt ;
CAS:147098-18-8
RSV00N :
Rosuvastatin (Sodium) ;

(3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid 3-methylbutyl ester ;
CAS:1197348-98-3
RSV56 :
Rosuvastatin Isoamy Ester ;

(3R,5S,6E)-7-[4-Phenyl-6-(1-methylethyl)-2-[methyl (methyl sulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid ;
CAS:847849-66-5
RSV13A :
Rosuvastatin EP Impurity M (Acid) ; Desfluoro Rosuvastatin ;

(3R,5S,6E)-7-[4-Phenyl-6-(1-methylethyl)-2-[methyl (methyl sulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid calcium salt ;
RSV13C :
Rosuvastatin EP Impurity M (Calcium) ; Desfluoro Rosuvastatin Calcium ;

(3R,5S,6Z)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid ;
CAS:1159631-31-8
PTV80A :
Pitavastatin Z-Isomer (Acid) ; (3R,5S,6Z)-Pitavastatin (Acid) ;

(3R,5S,6Z)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid calcium ;
CAS:1159588-21-2
PTV80C :
Pitavastatin Z-Isomer (Calcium) ; (3R,5S,6Z)-Pitavastatin Calcium ;

(3R,5S,6Z)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid sodium ;
PTV80N :
Pitavastatin Z-Isomer (Sodium) ; (3R,5S,6Z)-Pitavastatin Sodium ;

(3R,5S,6Z)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid calcium salt ;
RSV92C :
Rosuvastatin (6Z)-Isomer (Calcium) ; (3R,5S,6Z)-Rosuvastatin Calcium ;

(3R,5S,E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxy-N-(1-phenylethyl)hept-6-enamide ;
PTV51 :
Pitavastatin Phenylethylamide ;

(3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido) pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid 1,1,3,3-tetramethylbutylamine salt ;
CAS:917805-85-7
RSV78 :
Rosuvastatin TMBA Salt ; Rosuvastatin t-Octylammonium Salt ; Rosuvastatin 1,1,3,3-Tetramethylbutylamine Salt ;

(3R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methyl ethyl)-2-[methyl(methylsulfonyl) amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-6-heptenoic acid ;
CAS:1422619-13-3
RSV03A :
Rosuvastatin EP Impurity C (Acid) ; Rosuvastatin USP RC F ; 5-Oxo Rosuvastatin ; 3-Hydroxy-5-Keto Rosuvastatin ; Rosuvastatin B2 ;

(3R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methyl ethyl)-2-[methyl(methylsulfonyl) amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-6-heptenoic acid calcium salt ;
CAS:1422514-05-3
RSV03C :
Rosuvastatin EP Impurity C (Calcium) ; Rosuvastatin USP RC F ; 5-Oxo Rosuvastatin Calcium ; 3-Hydroxy-5-Keto Rosuvastatin Calcium ;

(3R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methyl ethyl)-2-[methyl(methylsulfonyl) amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-6-heptenoic acid sodium salt ;
CAS:1620823-61-1
RSV03N :
Rosuvastatin EP Impurity C (Sodium) ; 5-Oxo Rosuvastatin Sodium ; 3-Hydroxy-5-Keto Rosuvastatin Sodium ;

(3R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methyl ethyl)-2-[methyl(methylsulfonyl) amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-6-heptenoic acid t-butyl ester ;
CAS:615556-96-2
RSV55 :
Rosuvastatin 5-Oxo t-Butyl Ester ; 5-Oxo-Rosuvastatin Acid t-Butyl Ester ;

(3R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl) amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-6-heptenoic acid ethyl ester ;
CAS:1863898-67-2
RSV35 :
Rosuvastatin 5-Oxo Ethyl Ester ; 5-Oxo-Rosuvastatin Acid Ethyl Ester ;

(3R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl) amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-6-heptenoic acid methyl ester ;
CAS:147118-39-6
RSV45 :
Rosuvastatin 5-Oxo Methyl Ester ; 5-Oxo-Rosuvastatin Acid Methyl Ester ;

(3R,6S)-2-Hydroxy-3-[[2-(2-thienyl)acetyl]amino]-1,2-oxaborinane-6-acetic acid ;
CAS:1360457-46-0
VBB00A :
Vaborbactam ;

(3R,7S,8R,9S,10S,13R,14S,17R)-7-Hydroxy-10,13-dimethyl-17-((R)-5-oxo-5-(2-sulfonatoethylamino)pentan-2-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl sulfate disodium ;
CAS:71781-66-3
UDC62N :
Ursodeoxycholic Acid RC 12 (Disodium) ;

(3RS)-1,3-bis[4-(2-Methylpropyl)phenyl]butan-1-one ;
CAS:2143535-25-3
IBP08 :
Ibuprofen EP Impurity H ; Ibuprofen BP Impurity H ;

(3RS)-3-[(1H-Imidazol-1-yl)methyl]-9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one ;
CAS:99614-03-6
ODS07B :
Ondansetron EP Impurity G ; Ondansetron USP RC G ; C-Desmethyl Ondansetron ;

(3RS)-3-[(1H-Imidazol-1-yl)methyl]-9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one HCl ;
CAS:99614-04-7
ODS07H :
Ondansetron EP Impurity G (HCl) ; Ondansetron USP RC G (HCl) ; C-Desmethyl Ondansetron HCl ;

(3RS)-3-[(2-Methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one ;
CAS:99614-14-9
ODS08 :
Ondansetron EP Impurity H ; N-Desmethyl Ondansetron ;

(3RS)-3-[(2RS)-(2-Cyclopentyl-2-hydroxy-2-phenylacetyl)oxy]-1,1-dimethylpyrrolidinium ;
CAS:58493-54-2
GPB14 :
Glycopyrrolate EP Impurity N ;

(3RS)-3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one ;
CAS:153139-56-1
ODS01B :
Ondansetron EP Impurity A (Base) ; Ondansetron USP RC A ;

(3RS)-3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one HCl ;
CAS:119812-29-2
ODS01H :
Ondansetron EP Impurity A (HCl) ; Ondansetron USP RC A (HCl) ;

(3RS)-3-[[[(4-Amino-2-methylpyrimidin-5-yl)methyl]thiocarbamoyl]sulfanyl]-4-oxopentyl acetate ;
CAS:89285-03-0
THM08 :
Thiamine EP Impurity H ; Keto Dithio Darbamate ; Thiamine Thiocarbamate ;

(3RS)-4-[2-(4-Methoxyphenyl)-1H-benzimidazol-5-yl]-3-methyl-4-oxobutanoic acid ;
PMB01 :
Pimobendan EP Impurity A ; Pimobendan USP RC A ;

(3RS)-N,N-Dimethyl-3-phenyl-3-(pyridin-2-yl)propan-1-amine (Z)-butenedioate ;
CAS:132-20-7
PHM00M :
Pheniramine (Maleate) ; Dexchlorpheniramine EP Impurity A (Maleate) ;

(3RS)-N,N-Dimethyl-3-phenyl-3-(pyridin-2-yl)propan-1-amine ;
CAS:86-21-5
PHM00B :
Pheniramine (Base) ; Dexchlorpheniramine EP Impurity A ;

(3RS)-N-Methyl-3-phenyl-3-[3-(trin¼éuoromethyl)phenoxy]propan-1-amine ;
CAS:56161-72-9
FXT03B :
Fluoxetine EP Impurity C (Base) ; Fluoxetine USP RC A ; meta-Fluoxetine ;

(3RS)-N-Methyl-3-phenyl-3-[3-(trin¼éuoromethyl)phenoxy]propan-1-amine HCl ;
CAS:79088-29-2
FXT03H :
Fluoxetine EP Impurity C (HCl) ; Fluoxetine USP RC A ; meta-Fluoxetine HCl ;

(3RS)-N-Methyl-3-phenyl-3-[4-(trin¼éuoromethyl)phenoxy]propan-1-amine ;
CAS:54910-89-3
FXT00B :
Fluoxetine (Base) ;

(3RS)-N-Methyl-3-phenyl-3-[4-(trin¼éuoromethyl)phenoxy]propan-1-amine hydrochloride ;
CAS:56296-78-7
FXT00H :
Fluoxetine (HCl) ; Fluoxetine Hydrochloride ;

(3RS,4RS)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine ;
CAS:1396174-70-1
PRX05B :
Paroxetine HCl Hemihydrate EP Impurity E (Base) ; Paroxetine HCl Anhydrous EP Impurity E ; Paroxetine USP RC D ; cis-Paroxetine ;

(3RS,4RS)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine HCl ;
PRX05H :
Paroxetine HCl Hemihydrate EP Impurity E (HCl) ; Paroxetine HCl Anhydrous EP Impurity E ; Paroxetine HCl USP RC D ; cis-Paroxetine HCl;

(3RS,5RS,6E)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid ;
CAS:174956-43-5
FLV01A :
Fluvastatin EP Impurity A (Acid) ; Fluvastatin BP Impurity A ; Fluvastatin anti-Isomer (USP) ;

(3RS,5RS,6E)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid calcium salt ;
FLV01C :
Fluvastatin EP Impurity A (Calcium) ; Fluvastatin Calcium BP Impurity A ; Fluvastatin Calcium anti-Isomer (USP) ;

(3RS,5RS,6E)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid sodium salt ;
CAS:93957-58-5
FLV01N :
Fluvastatin EP Impurity A (Sodium) ; Fluvastatin Sodium BP Impurity A ; Fluvastatin Sodium anti-Isomer (USP) ;

(3RS,5RS,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid ;
CAS:1007912-86-8
RSV02A :
Rosuvastatin EP Impurity B (Acid) ; (3RS,5RS)-Rosuvastatin ;

(3RS,5RS,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid calcium salt ;
RSV02C :
Rosuvastatin EP Impurity B (Calcium) ; (3RS,5RS)-Rosuvastatin Calcium ; Rosuvastatin Calcium Diastereomers ;

(3RS,5RS,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy- 6-heptenoic acid sodium salt ;
CAS:1007871-86-4
RSV02N :
Rosuvastatin EP Impurity B (Sodium) ; (3RS,5RS)-Rosuvastatin Sodium ;

(3RS,5SR,6E)-7-[3-(4-n¼éuorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid ;
CAS:93957-54-1
FLV00A :
Fluvastatin (Acid) ;

(3S)-10-(2,3-Dihydroxypropanoyl)-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid ;
PZF60 :
Pazufloxacin Impurity 10 ;

(3S)-2,2-Dimethyl-7-oxo-6-(2-phenoxyacetamido)-2,3,4,7-tetrahydro-1,4-thiazepine-3-carboxylic acid ;
PNV07A :
Penicillin V EP Impurity G ;

(3S)-2,3-Dicarboxy-7-oxo-3-(1H-1,2,3-triazole-1-carbonyl)-4-thia-1-azabicyclo[3.2.0]heptane 1-oxide 4,4-dioxide ;
TZB55 :
Tazobactam Acid Impurity T-5 ;

(3S)-2-[(2S)-2-[[(1R)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]propanoyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid ;
CAS:103775-09-3
QPR09 :
Quinapril EP Impurity I ;

(3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylate +¦-D-glucopyranuronic acid ;
MXP50 :
Moexipril Acyl-+¦-D-Glucuronide ;

(3S)-2-[(2S)-N-[(1S)-1-Carboxy-3-phenylpropyl]alanyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3isoquinolinecarboxylic acid, 2-ethyl ester ;
CAS:103775-10-6
MXP00B :
Moexipril (Base) ; Moexipril ;

(3S)-2-[(2S)-N-[(1S)-1-Carboxy-3-phenylpropyl]alanyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3isoquinolinecarboxylic acid, 2-ethyl ester hydrochloride ;
CAS:82586-52-5
MXP00H :
Moexipril (HCl) ; Moexipril Hydrochloride ;

(3S)-2-{(2S)-N-[(1S)-1-Carboxy-3-phenylpropyl]alanyl}-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid ;
CAS:103775-14-0
MXP21B :
Moexipril USP RC A (Base) ; Moexiprilat ;

(3S)-2-{(2S)-N-[(1S)-1-Carboxy-3-phenylpropyl]alanyl}-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid HCl ;
MXP21H :
Moexipril USP RC A (HCl) ; Moexiprilat HCl ;

(3S)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile ;
CAS:941685-37-6
RLT54B :
Ruxolitinib S-Isomer (Base) ; (S)-Ruxolitinib (USP) ;

(3S)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate ;
CAS:2703484-89-1
RLT54P :
Ruxolitinib S-Isomer (Phosphate) ;

(3S)-3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-4,5-dihydro-2-benzoxepin-1(3H)-one ;
CAS:1100617-38-6
MTL39 :
Montelukast Lactone ;

(3S)-3-[4-[7-(Aminocarbonyl)-2H-indazol-2-yl]phenyl]piperidine Tosylate ; (S)-2-(4-(Piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide tosylate ;
CAS:1038915-73-9
NRP00T :
Niraparib (Tosylate) ;

(3S)-3-[bis[(4S)-4-(2-Methylpropyl)-2-oxopyrrolidin-1-yl]methyl]-5-methylhexanoic acid ;
PRG09 :
Pregabalin EP Impurity I ;

(3S)-4-[[(1S,2R)-1-Benzyl-3-[(3S,4aS,8aS)-3-[(1,1-dimethylethyl)carbamoyl]octahydroisoquinolin-2(1H)-yl]-2-hydroxypropyl]amino]-4-oxo-3-[(quinolin-2-ylcarbonyl)amino]butanoic acid ;
SQN05 :
Saquinavir EP Impurity E ;

(3S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid difluoroboryl ester ;
CAS:129306-33-8
LFX65 :
Levofloxacin Impurity 5 ;

(3S)-Benzyl 3-((3-((tert-butoxycarbonyl)methyl)-5-methylhexanamido)methyl)-5-methylhexanoate ;
CAS:1990538-02-7
PRG75 :
Pregabalin Impurity 15 ;

(3S)-Ethyl 10-(1-cyano-2-ethoxy-2-oxoethyl)-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate ;
PZF51 :
Pazufloxacin Impurity 1 ;

(3S)-Ethyl 10-(1-cyano-2-ethoxy-2-oxoethyl)-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate ;
PZF69 :
Pazufloxacin Impurity 19 ;

(3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide ;
CAS:1223403-58-4
LTT00B :
Larotrectinib (Base) ; LOXO 101 ;

(3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide sulfate ;
CAS:1223405-08-0
LTT00S :
Larotrectinib (Sulfate) ; Larotrectinib Sulfate ; LOXO 101 Sulfate ;

(3S)-N-Methyl-3-phenyl-3-[4-(trin¼éuoromethyl)phenoxy]propan-1-amine ;
CAS:100568-02-3
FXT52B :
Fluoxetine S-Isomer (Base) ; (+)-Fluoxetine ;

(3S)-N-Methyl-3-phenyl-3-[4-(trin¼éuoromethyl)phenoxy]propan-1-amine hydrochloride ;
CAS:114247-06-2
FXT52H :
Fluoxetine S-Isomer (HCl) ; (+)-Fluoxetine HCl ;

(3S,11bS)-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one ;
CAS:1026016-84-1
TBZ55 :
Tetrabenazine (S,S)-Isomer ;

(3S,4aS,8aS)-2-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-(1,1-dimethylethyl)decahydroisoquinoline-3-carboxamide ;
CAS:136522-17-3
SQN03 :
Saquinavir EP Impurity C ;

(3S,4aS,8aS)-Decahydro-N-(2-hydroxy-1,1-dimethylethyl)-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide ;
CAS:213135-56-9
NFV50 :
Nelfinavir Hydroxy t-Butylamide ;

(3S,4aS,8aS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfinyl)butyl]-3-isoquinolinecarboxamide ;
CAS:1041389-28-9
NFV21 :
Nelfinavir USP RC A ; Nelfinavir Sulfoxide ;

(3S,4aS,8aS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfonyl)butyl]-3-isoquinolinecarboxamide ;
CAS:1041389-29-0
NFV51 :
Nelfinavir Sulfone ;

(3S,4aS,8aS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide mesylate ;
CAS:159989-65-8
NFV00M :
Nelfinavir Mesylate ;

(3S,4R)- 4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-+¦-oxo-1-piperidinepropanenitrile ;
CAS:1092578-48-7
TFC52B :
Tofacitinib (3S,4R)-Isomer ; 3-Epi Tofacitinib ; Tofacitinib Impurity B ; Tofacitinib (3S,4R)-Diastereomer ;

(3S,4R)-1-(cis-4-Cyano-4-phenylcyclohexyl)-3-methyl-4-phenylpiperidine-4-carboxylic acid ;
CAS:1348822-76-3
LVC01B :
Levocabastine EP Impurity A ;

(3S,4R)-1-[cis-4-Carbamoyl-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid ;
LVC07B :
Levocabastine EP Impurity G ;

(3S,4R)-1-[cis-4-Cyano-4-(2-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid ;
LVC02B :
Levocabastine EP Impurity B ;

(3S,4R)-1-[cis-4-Cyano-4-(3-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid ;
LVC03B :
Levocabastine EP Impurity C ;

(3S,4R)-1-[cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid ;
CAS:79516-68-0
LVC00B :
Levocabastine (Base) ; (3S,4R)-Cabastine ;

(3S,4R)-1-[cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid 1-oxide ;
LVC12 :
Levocabastine EP Impurity L ;

(3S,4R)-1-[cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid hydrochloride ;
CAS:79547-78-7
LVC00H :
Levocabastine (HCl) ; Levocabastine Hydrochloride ; (3S,4R)-Cabastine HCl ;

(3S,4R)-1-[cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl]-4-(3-hydroxyphenyl)-3-methylpiperidine-4-carboxylic acid ;
LVC10B :
Levocabastine EP Impurity J ;

(3S,4R)-1-[trans-4-Cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid ;
CAS:105452-51-5
LVC05B :
Levocabastine EP Impurity E ;

(3S,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine ;
CAS:1638499-33-8
TFC96B :
Tofacitinib RC 6 (Base) ;

(3S,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride ;
CAS:1821769-41-8
TFC96H :
Tofacitinib RC 6 (2HCl) ;

(3S,4R)-1-Methyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4GÇ¦-fluoro biphenyl-3-yl)piperidine ;
PRX70 :
Paroxetine HCl Anhydrous EP Impurity J N-Methyl Analog ;

(3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-nitrosopiperidine ;
CAS:2361294-43-9
PRX48 :
Paroxetine N-Nitroso Impurity ;

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl) piperidine ;
CAS:105813-14-7
PRX53B :
Paroxetine HCl Anhydrous EP Impurity C ; N-Benzyl Paroxetine ;

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl) piperidine hydrochloride ;
PRX53H :
Paroxetine HCl Anhydrous EP Impurity C (HCl) ; N-Benzyl Paroxetine HCl ;

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-1-benzyl-4-phenylpiperidine ;
CAS:105813-40-9
PRX56B :
Paroxetine HCl Anhydrous EP Impurity F (Base) ; N-Benzyl Desfluoro Paroxetine ;

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-1-benzyl-4-phenylpiperidine hydrochloride ;
CAS:105813-39-6
PRX56H :
Paroxetine HCl Anhydrous EP Impurity F (HCl) ; N-Benzyl Desfluoro Paroxetine HCl ;

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-ethoxyphenyl) piperidine ;
CAS:606968-04-1 & 1395408-54-4
PRX03B :
Paroxetine HCl Hemihydrate EP Impurity C ; 4-Ethoxy Paroxetine ;

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-ethoxyphenyl) piperidine HCl ;
CAS:1346597-97-4
PRX03H :
Paroxetine HCl Hemihydrate EP Impurity C (HCl) ; 4-Ethoxy Paroxetine HCl ;

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine ;
CAS:61869-08-7
PRX00B :
Paroxetine (Base) ;

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine acetate ;
CAS:72471-80-8
PRX00A :
Paroxetine (Acetate Salt) ;

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine formate ;
PRX00F :
Paroxetine (Formate Salt) ;

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride ;
CAS:78246-49-8
PRX00X :
Paroxetine (HCl Anhydrous) ;

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride hemihydrate ;
CAS:110429-35-1
PRX00H :
Paroxetine (HCl Hemihydrate) ;

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine maleate ;
CAS:64006-44-6
PRX00M :
Paroxetine (Maleate Salt) ;

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine phosphate ;
PRX00P :
Paroxetine (Phosphate Salt) ;

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine sulphate ;
PRX00S :
Paroxetine (Sulphate Salt) ;

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-methoxyphenyl) piperidine ;
CAS:127017-69-0
PRX02B :
Paroxetine HCl Hemihydrate EP Impurity B ; Paroxetine USP RC A ; 4-Methoxy Paroxetine ;

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-methoxyphenyl) piperidine HCl ;
CAS:127017-74-7 (rac-trans)
PRX02H :
Paroxetine HCl Hemihydrate EP Impurity B (HCl) ; Paroxetine HCl USP RC A ; 4-Methoxy Paroxetine HCl ;

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4GÇ¦-fluorobiphenyl-3-yl) piperidine ;
PRX10B :
Paroxetine HCl Hemihydrate EP Impurity J (Base) ; Paroxetine Anhydrous EP Impurity J ;

(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4GÇ¦-fluorobiphenyl-3-yl) piperidine HCl ;
PRX10H :
Paroxetine HCl Hemihydrate EP Impurity J (HCl) ; Paroxetine HCl Anhydrous EP Impurity J ;

(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-1-pyrrolidine ;
UDT62
Upadacitinib RC 2 ;

(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide ;
CAS:1310726-60-3
UDT00 :
Upadacitinib ;

(3S,4R)-3-Ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]-dihydrofuran-2(3H)-one ;
CAS:92-13-7
PCP00B :
Pilocarpine (Base) ;

(3S,4R)-3-Ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]-dihydrofuran-2(3H)-one hydrochloride ;
CAS:54-71-7
PCP00H :
Pilocarpine (HCl) ;

(3S,4R)-3-Ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]-dihydrofuran-2(3H)-one nitrate ;
CAS:148-72-1
PCP00N :
Pilocarpine (Nitrate) ;

(3S,4R)-3-Methyl-4-phenylpiperidine-4-carboxylic acid ;
LVC06B :
Levocabastine EP Impurity F ;

(3S,4R)-4-(4-Fluorophenyl)-3-(3-hydroxy-4-methoxyphenoxymethyl) piperidine ;
CAS:112058-89-6
PRX39 :
Paroxetine 3-Hydroxy Metabolite ;

(3S,4R)-4-(4-Fluorophenyl)-3-(4-hydroxy-3-methoxyphenoxymethyl) piperidine ;
CAS:112058-90-9
PRX38 :
Paroxetine 4-Hydroxy Metabolite ;

(3S,4R)-4-(4-Fluorophenyl)-3-hydroxymethyl-piperidine ;
CAS:125224-43-3 188869-26-3 (rac-trans)
PRX09B :
Paroxetine HCl Hemihydrate EP Impurity I (Base) ; Paroxetine Anhydrous EP Impurity I ; Paroxol ;

(3S,4R)-4-(4-Fluorophenyl)-3-hydroxymethyl-piperidine HCl ;
CAS:220548-73-2
PRX09H :
Paroxetine HCl Hemihydrate EP Impurity I (HCl) ; Paroxetine HCl Anhydrous EP Impurity I ; Paroxol HCl ;

(3S,4R)-trans-(-)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methyl piperidine ;
CAS:105812-81-5
PRX33 :
Paroxetine (3S,4R)-N-Methyl Paroxol Impurity ;

(3S,4R)-trans-(GÇô)-1-Methyl-3-[1,3-benzodioxol-5-yloxy)methyl]-4-(fluoro phenyl) piperidine ;
CAS:110429-36-2
PRX26 :
Paroxetine USP RC F ; N-Methyl Paroxetine ;

(3S,4R,5S)-4-Amino-5-amino-2-azido-3-(1-ethylpropoxy)cyclohexane-1-carboxylic acid ethyl ester ;
OST21B :
Oseltamivir USP RC A ;

(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-3-{(E)-2-[(1R,3R,4S)-4-Chloro-3-methoxycyclohexyl]-1-methylvinyl}-8-ethyl-5,6,8,11,12,13,14,15, 16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-14,16-dimethoxy-4,10,12,18-tetramethyl-15,19
CAS:137071-32-0
PMC00 :
Pimecrolimus ;

(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,15-Dihydroxy-3-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-3,4,5,6,11,12,13,14,15,16,17,18,24,25,26,26a-hexadeca
TCL06 :
Tacrolimus EP Impurity F ; Tacrolimus Related Compound I ;

(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-3,4,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-oct
CAS:104987-11-3
TCL00A :
Tacrolimus (Anhydrous) ;

(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-Dihydroxy-3-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-14,16-dimethoxy-4,12,18-trimethyl-8-(prop-2-en-1-yl)-3,4,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-octadeca
CAS:132172-14-6
TCL03 :
Tacrolimus EP Impurity C ; Tacrolimus 10-Desmethyl Impurity ;

(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16, 17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-{(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylvinyl}-14,16-dimethoxy-4,10,12,18-tetramethyl-15,19-epoxy-
CAS:104987-30-6
TCL05 :
Tacrolimus EP Impurity E ; Tacrolimus 8-Propyl Analog (USP) ; Dihydrotacrolimus ; Tacrolimus Dihydro Impurity ;

(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19S,26aS)-5,19-dihydroxy-3-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-3,4,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-oct
CAS:144490-63-1
TCL07 :
Tacrolimus EP Impurity G ; Tacrolimus Related Compound II ; Tacrolimus 19-Epimer ;

(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19S,26aS)-8-Ethyl-5,19-dihydroxy-3-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-14,16-dimethoxy-4,10,12,18-tetramethyl-3,4,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-octadecahydro-
TCL02 :
Tacrolimus EP Impurity B ; Tacrolimus Desmethylene 19-Epimer ;

(3S,4R,5S,8S,9E,12S,14S,15R,16S,18R,19R,26aS)-8-Allyl-5,6,8,11,12,13,14, 15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-{(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylvinyl}-14,16-dimethoxy-4,10,12,18-tetramethyl-15,1
CAS:129212-35-7
TCL04 :
Tacrolimus EP Impurity D ; Tacrolimus 8-Epimer (USP) ; Tacrolimus (8S)-Isomer ;

(3S,4R,8R,12S,14S,15R,16S,18R,19R,26aS)-8,11,12,13,14,15,16,17,18,19,24,25, 26,26a-Tetradecahydro-19-hydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxy cyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-15,
CAS:104987-16-8
TCL09 :
Tacrolimus EP Impurity I ; Tacrolimus 5,6-Anhydro Impurity ; 23,24-Anhydro Tacrolimus ; Tacrolimus Diene Impurity (USP) ;

(3S,4S)-1-[cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid ;
LVC09B :
Levocabastine EP Impurity I ;

(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine ;
CAS:1354621-59-2
TFCA1B :
Tofacitinib RC 11 ;

(3S,4S)-2-(2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethoxy)-2-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol ;
HDZ53 :
Hydroxyzine 1-Fructose ;

(3S,4S)-3-Hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone ;
CAS:104872-06-2
OLS21 :
Orlistat USP RC A ;

(3S,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-+¦-oxo-1-piperidinepropanenitrile ;
CAS:1092578-47-6
TFC53B :
Tofacitinib (3S,4S)-Isomer (Base) ; Tofacitinib Enantiomer ; Tofacitinib USP RC B ;

(3S,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-+¦-oxo-1-piperidinepropanenitrile citrate salt ;
CAS:2174011-55-1
TFC53C :
Tofacitinib (3S,4S)-Isomer (Citrate Salt) ; Tofacitinib Citrate Enantiomer ; Tofacitinib USP RC B (Citrate) ;

(3S,4S,5R)-4-[(1R)-4,5-Dihydroxy-9-methyl-3-oxo-1,3-dihydronaphtho[2,3-c]furan-1-yl]-3-(dimethylamino)-2,5-dihydroxy-6-oxocyclohex-1-enecarboxamide ;
CAS:18751-99-0
OTC05 :
Oxytetracycline EP Impurity E ; +¦-Apo-Oxytetracycline ;

(3S,4S,5R,6R)-6-((2R,4S,E)-1-Carboxy-6-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-4-hydroxyhex-5-en-2-yloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:224320-11-0
PTV52 :
Pitavastatin 3-Ether Glucuronide ;

(3S,4S,5R,6S)-3,4,5-Trihydroxy-6-(2-(4-isobutylphenyl)acetoxy)-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:164669-89-0
IBF50 :
Ibufenac Acyl-+¦-D-Glucuronide ;

(3S,4S,5R,6S)-Allyl 3,4,5-trihydroxy-6-(2-(4-isobutylphenyl)acetoxy)-tetrahydro-2H-pyran-2-carboxylate ;
IBF60 :
Ibufenac Acyl-+¦-D-Glucuronide Allyl Ester ;

(3S,4S,5S)-4-[(1R)-4,5-Dihydroxy-9-methyl-3-oxo-1,3-dihydronaphtho[2,3-c]furan-1-yl]-3-(dimethylamino)-2,5-dihydroxy-6-oxocyclohex-1-enecarboxamide ;
CAS:18695-01-7
OTC04 :
Oxytetracycline EP Impurity D ; +¦-Apo-Oxytetracycline ;

(3S,4S,5S,6R)-3,4,5-Trihydroxy-6-(1-(4-hydroxy-2-oxo-2H-chromen-3-yl)-3-oxo-1-phenylbutan-2-yloxy)-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:1007224-61-4
WFR84 :
Warfarin RC24

(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(6-(trifluoromethoxy)benzo[d]thiazol-2-ylamino)-tetrahydro-2H-pyran-2-carboxylic acid ;
RLZ55 :
Riluzole N-+¦-D-Glucuronide ;

(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxy(6-(trifluoromethoxy)benzo[d]thiazol-2-yl)amino)-tetrahydro-2H-pyran-2-carboxylic acid ;
RLZ57 :
Riluzole N-Hydroxy N-+¦-D-Glucuronide ;

(3S,4S,5S,6R)-6-((1-(10H-Phenothiazin-10-yl)propan-2-yl)dimethylammonio)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylate ;
CAS:137908-81-7
PMZ50 :
Promethazine N-+¦-D-Glucuronide ;

(3S,4S,5S,6R)-6-((2S,3S,5S)-2-(2-(2,6-Dimethylphenoxy)acetamido)-5-((S)-3-methyl-2-(2-oxo-tetrahydropyrimidin-1(2H)-yl)butanamido)-1,6-diphenylhexan-3-yloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
LPN50 :
Lopinavir O-+¦-D-Glucuronide ;

(3S,4S,5S,6R)-6-((3,4-Dimethoxyphenethyl)(4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl)amino)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:126883-99-6
VRP51 :
Verapamil N-Desmethyl N-+¦-D-Glucuronide ;

(3S,4S,5S,6R)-6-(1-(4-(3-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)propoxy)-3-methoxyphenyl)ethoxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
ILP56 :
Iloperidone Hydroxy +¦-D-Glucuronide ;

(3S,4S,5S,6R)-6-(2-(4-(Furan-2-carbonyl)piperazin-1-yl)-6,7-dimethoxyquinazolin-4-ylamino)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:944943-73-1
PRZ50 :
Prazosin N-+¦-D-Glucuronide ;

(3S,4S,5S,6R)-6-(2-Chloro-4-((2-(diethylamino)ethyl)carbamoyl)-5-methoxyphenylamino)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:27313-54-8
MCA51 :
Metoclopramide N4-+¦-D-Glucuronide ;

(3S,4S,5S,6R)-6-(3-(2-Acetamidoethyl)-5-methoxy-1H-indol-1-yl)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
MTN61 :
Melatonin Glucuronide ;

(3S,4S,5S,6R)-6-(4-Amino-N-(4-methylpyrimidin-2-yl)phenylsulfonamido)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
SMR50 :
Sulfamerazine N1-Glucuronide ;

(3S,4S,5S,6R)-6-(4-Amino-N-(5-methylisoxazol-3-yl)phenylsulfonamido)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:14365-52-7
SMZ52 :
Sulfamethoxazole +¦-D-Glucuronide ;

(3S,4S,5S,6R)-Methyl 3,4,5-triacetoxy-6-(3-(carbamoyloxy)-1-(2-methoxyphenoxy)propan-2-yloxy)-tetrahydro-2H-pyran-2-carboxylate ;
MTC62 :
Methocarbamol Impurity 2 ; Methocarbamol 2,3,4-Tri-O-Acetyl-+¦-D-Glucuronide Methyl Ester ;

(3S,4S,5S,6R)-Methyl 3,4,5-triacetoxy-6-(4-(6-(tert-butyldimethylsilyloxy)-3-(4-(2-(piperidin-1-yl)ethoxy)benzoyl)benzo[b]thiophen-2-yl)phenoxy)-tetrahydro-2H-pyran-2-carboxylate ;
CAS:174264-48-3
RLX62 :
Raloxifene RC 2 ;

(3S,4S,5S,6R)-Methyl 6-(((R)-2,3-dihydro-1H-inden-1-yl)(prop-2-ynyl)amino)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylate ;
RSG53 :
Rasagiline N-+¦-D-Glucuronide Methyl Ester ;

(3S,4S,5S,6R,E)-6-(2,2-Dimethyl-7-(methyl(naphthalen-1-ylmethyl)amino)hept-5-en-3-ynyloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:99473-12-8
TBN54 :
Terbinafine Hydroxy +¦-D-Glucuronide ;

(3S,4S,5S,6S)-3,4,5-Trihydroxy-6-((5R,6S)-6-phenyl-5-(4-(2-(pyrrolidin-1-yl) ethoxy)phenyl)-5,6,7,8-tetrahydronaphthalen-2-yloxy)-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:1048953-95-2
LSF50 :
Lasofoxifene +¦-D-Glucuronide ;

(3S,4S,5S,6S)-3,4,5-Trihydroxy-6-((R)-4-((3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyloxy)-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:142780-61-8
LCX61 :
Lithocholic Acid RC 1 ; Lithocholic Acid 24-Ac-O-+¦-D-Glucuronide ;

(3S,4S,5S,6S)-3,4,5-Trihydroxy-6-(2-(3-(hydroxymethyl)-2-methylphenylamino)benzoyloxy)-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:152832-29-6
MNM53 :
Mefenamic Acid 3-Hydroxymethyl Acyl-+¦-D-Glucuronide ;

(3S,4S,5S,6S)-3,4,5-Trihydroxy-6-(3-hydroxy-6-oxo-6H-benzo[c]chromen-8-yloxy)-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:1365982-52-0
ULT52 :
Urolithin A Glucuronide ;

(3S,4S,5S,6S)-3,4,5-Trihydroxy-6-(4-(1-(4-(2-(methylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenoxy)-tetrahydro-2H-pyran-2-carboxylic acid ;
TMX59B :
Tamoxifen N-Desmethyl 4-Hydroxy +¦-D-Glucuronide ; (E/Z)-Endoxifen Glucuronide ;

(3S,4S,5S,6S)-3,4,5-Trihydroxy-6-(4-hydroxy-2-oxo-3-(3-oxo-1-phenylbutyl)-2H-chromen-8-yloxy)-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:1007224-60-3
WFR82 :
Warfarin RC22

(3S,4S,5S,6S)-6-((2S,3aR,7aS)-1-((S)-2-((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-octahydro-1H-indole-2-carbonyloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:1260617-50-2
TDL60 :
Trandolapril Acyl-beta-D-Glucuronide ;

(3S,4S,5S,6S)-6-((3S,5S)-1-((S)-3-(Benzoylthio)-2-methylpropanoyl)-3-(phenylthio)pyrrolidine-5-carbonyloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
ZFP52 :
Zofenopril Acyl-+¦-D-Glucuronide ;

(3S,4S,5S,6S)-6-((R)-1-(4,4-bis(3-Methylthiophen-2-yl)but-3-enyl)piperidine-5-carbonyloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:?
TGB50 :
Tiagabine Acyl-+¦-D-Glucuronide ;

(3S,4S,5S,6S)-6-(2,4-Dichloro-3-(2-guanidino-2-oxoethyl)phenoxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:78433-83-7
GFC56 :
Guanfacine 3-Hydroxy O-+¦-D-Glucuronide ;

(3S,4S,5S,6S)-6-(2-(2,3-Dimethylphenylamino)benzoyloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:102623-18-7
MNM54 :
Mefenamic Acid Acyl-+¦-D-Glucuronide ;

(3S,4S,5S,6S)-6-(2-(3-Carboxy-2-methylphenylamino)benzoyloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:152832-30-9
MNM51 :
Mefenamic Acid 3-Carboxy Acyl-+¦-D-Glucuronide ;

(3S,4S,5S,6S)-6-(2-(3-Chloro-2-methylphenylamino)benzoyloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:77605-75-5
TLM50 :
Tolfenamic Acid Acyl-+¦-D-Glucuronide ;

(3S,4S,5S,6S)-6-(3-((2,4-Di-Tert-Butyl-5-hydroxyphenyl)carbamoyl)-4-oxoquinolin-1(4H)-yl)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
IVC53 :
Ivacaftor N-Glucuronide ;

(3S,4S,5S,6S)-6-(3-((2-tert-Butyl-4-(2-carboxypropan-2-yl)-5-hydroxyphenyl)carbamoyl)-4-oxoquinolin-1(4H)-yl)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
IVC56 :
Ivacaftor Carboxylic Acid N-Glucuronide ;

(3S,4S,5S,6S)-6-(3-(2-Acetamidoethyl)-5-methoxy-1H-indol-6-yloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:94840-69-4
MTN60 :
Melatonin 6-Hydroxy Glucuronide ;

(3S,4S,5S,6S)-6-(6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carbonyloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:172040-93-6
UFX43 :
Ulifloxacin Acyl-+¦-D-Glucuronide ;

(3S,4S,5S,6S)-Benzyl 6-(2-(3-chloro-2-methylphenylamino)benzoyloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylate ;
TLM51 :
Tolfenamic Acid Acyl-+¦-D-Glucuronide Benzyl Ester ;

(3S,4S,5S,6S)-Benzyl 6-(2-ethoxy-4-(2-((S)-3-methyl-1-(2-(piperidin-1-yl)phenyl)butylamino)-2-oxoethyl)benzoyloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylate ;
RPG41 :
Repaglinide Acyl-+¦-D-Glucuronide Benzyl Ester ;

(3S,4S,5S,6S)-Methyl 3,4,5-triacetoxy-6-(2-(4-(tert-butyldimethylsilyloxy)phenyl)-3-(4-(2-(piperidin-1-yl)ethoxy)benzoyl)benzo[b]thiophen-6-yloxy)-tetrahydro-2H-pyran-2-carboxylate ;
CAS:174264-49-4
RLX63 :
Raloxifene RC 3 ;

(3S,4S,5S,6S,Z)-3,4,5-Trihydroxy-6-(3-((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenylamino)(phenyl)methylene)-2-oxoindoline-6-carbonyloxy)-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:1352789-50-4
NTD60 :
Nintedanib Desmethyl-O-Glucuronic Acid ;

(3S,4S,5S,6S,Z)-6-(5-(4-(2-(Dimethylamino)ethoxy)phenyl)-5-(4-hydroxyphenyl)-4-phenylpent-4-enoyloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
TMX56B :
Tamoxifen 4-Hydroxy Acyl Glucuronide ;

(3S,4S,6S)-6-((R)-Hydroxy(6-methoxyquinolin-4-yl)methyl)-3-vinylquinuclidin-3-ol ;
CAS:78549-61-8
QNN52B :
Quinine (3S)-Hydroxy ;

(3S,5aS,9aS,10aS)-3-Methyldecahydropyrazino[1,2-a]indole-1,4-dione ;
CAS:2165676-00-4
PRD11 :
Perindopril EP Impurity K ; Perindopril USP RC K ;

(3S,5R)-tert-Butyl 6-chloro-3,5-dihydroxyhexanoate ;
CAS:404958-68-5
RSVA4 :
Rosuvastatin Impurity 4 ;

(3S,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid calcium salt ;
CAS:254452-88-5
PTV31C :
Pitavastatin (3S,5R)-Isomer Calcium ; Pitavastatin Calcium Enantiomer ;

(3S,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid ethyl ester ;
PTV41 :
Pitavastatin (3S,5R)-Isomer Ethyl Ester ;

(3S,5R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl) amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid ;
CAS:1242184-42-4
RSV07A :
Rosuvastatin EP Impurity G (Acid) ; Rosuvastatin USP RC D ; (3S,5R)-Rosuvastatin ; Rosuvastatin Enantiomer ; enti-Rosuvastatin ;

(3S,5R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl) amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid calcium salt ;
CAS:2414245-11-5
RSV07C :
Rosuvastatin EP Impurity G (Calcium) ; Rosuvastatin USP RC D ; (3S,5R)-Rosuvastatin Calcium ; enti-Rosuvastatin Calcium ;

(3S,5R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl) amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid sodium salt ;
RSV07N :
Rosuvastatin EP Impurity G (Sodium) ; Rosuvastatin USP RC D ; (3S,5R)-Rosuvastatin Sodium ; enti-Rosuvastatin Sodium ;

(3S,5R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methyl sulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid ethyl ester ;
CAS:615263-55-3
RSV65 :
Rosuvastatin (3S,5R)-Isomer Ethyl Ester ; ent-Rosuvastatin Ethyl Ester ;

(3S,5R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methyl sulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid methyl ester ;
RSV66 :
Rosuvastatin (3S,5R)-Isomer Methyl Ester ; ent-Rosuvastatin Methyl Ester ;

(3S,5R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methyl sulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid t-butyl ester ;
CAS:615263-60-0
RSV67 :
Rosuvastatin (3S,5R)-Isomer t-Butyl Ester ; ent-Rosuvastatin t-Butyl Ester ; Rosuvastatin EP Impurity G t-Butyl Ester ;

(3S,5RS)-5-[8-Fluoro-4-isopropyl-2-(N-methylmethylsulfonamido)-5,6-dihydrobenzo[h]quinazolin-6-yl]-3,5-dihydroxypentanoicacid calcium salt ;
RSV09C :
Rosuvastatin EP Impurity I (Calcium);

(3S,5S)-5-[(Biphenyl-4-yl)methyl]-3-methylpyrrolidin-2-one ;
CAS:1038925-00-6
SCT55 :
Sacubitril (3S,5S)-Pyrrolidinone Impurity ;

(3S,5S)-tert-Butyl 6-chloro-3,5-dihydroxyhexanoate ;
CAS:325471-28-1
RSVA9 :
Rosuvastatin Impurity 9 ;

(3S,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid ;
CAS:688735-41-3
PTV32A :
Pitavastatin (3S,5S)-Isomer (Acid) ;

(3S,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid calcium salt ;
CAS:254452-92-1
PTV32C :
Pitavastatin (3S,5S)-Isomer (Calcium) ;

(3S,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid ethyl ester ;
PTV42 :
Pitavastatin (3S,5S)-Isomer Ethyl Ester ;

(3S,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl) amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid ;
CAS:1584149-34-7
RSV42A :
Rosuvastatin (3S,5S)-Isomer (Acid) ; (3S,5S)-Rosuvastatin (Acid) ;

(3S,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl (methyl sulfonyl) amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid sodium salt ;
RSV42N :
Rosuvastatin (3S,5S)-Isomer (Sodium) ; (3S,5S)-Rosuvastatin Sodium ;

(3S,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methyl sulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid ethyl ester ;
RSV75 :
Rosuvastatin (3S,5S)-Isomer Ethyl Ester ;

(3S,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methyl sulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid methyl ester ;
RSV76 :
Rosuvastatin (3S,5S)-Isomer Methyl Ester ;

(3S,5S,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methyl sulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid t-butyl ester ;
RSV77 :
Rosuvastatin (3S,5S)-Isomer t-Butyl Ester ;

(3S,5S,6R)-3-Amino-6-methyl-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-2-one ;
CAS:1375794-69-6
UBG62B :
Ubrogepant RC 2 (Base) ;

(3S,5S,6R)-3-Amino-6-methyl-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-2-one HCl ;
CAS:1375470-88-4
UBG62H :
Ubrogepant RC 2 (HCl) ;

(3S,5S,6S)-6-((3R,5S,E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoyloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ;
CAS:574752-66-2
PTV53 :
Pitavastatin Acyl Glucuronide ;

(3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(2-(trifluoromethylsulfonyloxy)acetyl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate ;
PNL51 :
Pregnenolone Acetate 16-Dehydro 21-Triflate ;

(3S,8R,9S,10R,13S,14S)-17-((Z)-1-(Hydroxyimino)ethyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate ;
CAS:2174-13-2
PNL52 :
Pregnenolone Acetate 16-Dehydro Oxime ;

(3S,8R,9S,10R,13S,14S,17R)-17-Acetyl-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate ;
CAS:2381-45-5
PNL61 :
Pregnenolone 17+¦-Acetoxy ;

(3S,8R,9S,10R,13S,14S,17S)-17-(Ethoxymethyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol ;
CAS:855-49-2
SNL61 :
Spironolactone RC 1 ;

(3S,8S,9S,10R,13S,14S)-17-((R)-1-Hydroxyethyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl sulfuric acid ;
CAS:19763-73-6
PNL65A :
Pregnenolone 20+¦-Dihydro 3-Sulfate (Acid) ;

(3S,8S,9S,10R,13S,14S)-17-((S)-1-Hydroxyethyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol ;
CAS:901-56-4
PNL62 :
Pregnenolone 20+¦-Dihydro ;

(3S,8S,9S,10R,13S,14S,16R,17S)-17-Acetyl-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-16-carbonitrile ;
CAS:1434-54-4
PNL68 :
Pregnenolone Carbonitrile ;

(3S,8S,9S,10R,13S,14S,17S)-17-((R)-1-Hydroxyethyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol ;
CAS:901-57-5
PNL64 :
Pregnenolone 20+¦-Dihydro ;

(3S,8S,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate ;
CAS:1778-02-5
PNL50 :
Pregnenolone Acetate ;

(3S,8S,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl isobutyrate ;
PNL66 :
Pregnenolone 3-Isobutyrate ;

(3S,8S,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl sulfate acid ;
CAS:1247-64-9
PNL67A :
Pregnenolone 3-Sulfate (Acid) ;

(3S,9S,10R,13S,14S)-17-Acetyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate ;
CAS:979-02-2
PNL53 :
Pregnenolone Acetate 16-Dehydro ;

(3Z)-1,3-Dihydro-4-(4-methyl-1-piperazinyl)-3-(2-oxopropylidene)-2H-1,5-benzodiazepin-2-one ;
CAS:1017241-34-7
OLZ31 :
Olanzapine Ketolactam ;

(3Z)-13+¦-Ethyl-3-(hydroxyimino)-18,19-dinor-17+¦-pregn-4-en-20-yn-17-ol ;
CAS:74183-54-3
NGM04 :
Norgestimate EP Impurity D ; (Z)-Norelgestromin ; 17-Desacetyl (Z)-Norgestimate ;

(3Z)-2,3-Dihydro-3-[[[4-[methyl[(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylic acid ;
CAS:894783-71-2
NTD02B :
Nintedanib EP Impurity B (Base) ; Nintedanib Carboxylic Acid ;

(3Z)-2,3-Dihydro-3-[[[4-[methyl[(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylic acid HCl ;
NTD02H :
Nintedanib EP Impurity B (HCl) ; Nintedanib Carboxylic Acid (HCl) ;

(3Z)-2,3-Dihydro-3-[[[4-[methyl[2-(1,4-dioxido-4-methylpiperazin-1-yl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-1H-Indole-6-carboxylic acid methyl ester ;
CAS:2734676-68-5
NTD51 :
Nintedanib N,N'-Dioxide ; Nintedanib Impurity A ;

(3Z)-2,3-Dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-1H-Indole-6-carboxylic acid methyl ester ;
CAS:656247-17-5 1160294-26-7
NTD00B :
Nintedanib (Base) ;

(3Z)-2,3-Dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-1H-Indole-6-carboxylic acid methyl ester ethanesulfonate salt ;
CAS:656247-18-6
NTD00E :
Nintedanib (Esylate) ; Nintedanib Esylate ;

(3Z)-4-[2-(Dipropylamino)ethyl]-3-propylideneindolin-2-one HCl ;
CAS:145570-92-9
RPN03H :
Ropinirole EP Impurity C (HCl) ; Ropinirole Propylidene Impurity (HCl) ;

(3Z,4E)-3-(Hydroxymethylene)-4-(4-methylpiperazin-1-yl)-1H-benzo[b][1,4]diazepine-2(3H)-thione ;
CAS:1320360-86-8
OLZ61 :
Olanzapine RC 1 ; Olanzapine Open-Ring Analog (USP) ; Olanzapine Hydroxymethylidene ;

(3ZE)-4-[2-(Dipropylamino)ethyl]-3-propylideneindolin-2-one HCl ;
CAS:221264-43-3
RPN53H :
Ropinirole Propylidene (3ZE)-Impurity ;

(4,6-Diamino-1,3,5-triazin-2-yl)guanidine ;
CAS:4405-08-07 00:00:00
MTF02B :
Metformin EP Impurity B (Base) ; Guanylmelamine ;

(4,6-Diamino-1,3,5-triazin-2-yl)guanidine HCl ;
CAS:2959-04-08 00:00:00
MTF02H :
Metformin EP Impurity B (HCl) ; Guanylmelamine HCl ;

(4,6-Diamino-1,3,5-triazin-2-yl)guanidine hemisulfate ;
MTF02S :
Metformin EP Impurity B (Sulfate) ; Guanylmelamine Hemisulfate ;

(4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methyl acetate ;
CAS:117977-19-2
RBP61 :
Rabeprazole RC 1 ;

(4-(4-(2,4-Difluorobenzoyl)piperidin-1-yl)-2-fluorophenyl)(piperidin-4-yl)methanone ;
PPD96 :
Paliperidone RC 36 ;

(4-(4-(2,4-Difluorobenzoyl)piperidin-1-yl)-3-fluorophenyl)(piperidin-4-yl)methanone ;
PPD65 :
Paliperidone RC 5 ;

(4-(Aminomethyl)naphthalen-1-yl)-N,N-dimethylmethanamine ;
CAS:2514708-08-6
TBN89 :
Terbinafine RC 29 ; Naftifine RC 8 ;

(4-(Aminomethyl)naphthalen-1-yl)-N,N-dimethylmethanamine ;
CAS:2514708-08-6
NTF68B :
Naftifine RC 8 ;

(4-(Methylamino)-3-nitrophenyl)(phenyl)methanone ;
CAS:66353-71-7
MBD53 :
Mebendazole Impurity 3 ;

(4-Amino-2-methylphenyl)(7-chloro-5-hydroxy-2,3,4,5-tetrahydrobenzo[b]azepin-1-yl)methanone ;
CAS:1432725-24-0
TVT74 :
Tolvaptan RC 4 ;

(4-Amino-2-methylpyrimidin-5-yl)methanol ;
CAS:73-67-6
THM57B :
Thiamine Impurity 7 ; Toxopyrimidine ;

(4-Amino-3-iodophenyl)-N-methylmethanesulfonamide ;
CAS:151140-66-8
SMT52 :
Sumatriptan RC 2 ;

(4-Amino-3-nitrophenyl)(p-tolyl)methanone ;
CAS:31431-28-4
MBD52 :
Mebendazole Impurity 2 ;

(4-Aminophenylsulfonyl)guanidine ;
CAS:57-67-0
SDD03A :
Sulfadimidine EP Impurity C ; Sulfadiazine EP Impurity C ; Sulfamethazine USP RC A ; Sulfadimidine USP RC A ; Sulfaguanidine ;

(4-Aminophenylsulfonyl)guanidine monohydrate ;
CAS:6190-55-2
SDD03H :
Sulfadimidine EP Impurity C (Monohydrate) ; Sulfadiazine EP Impurity C ; Sulfamethazine USP RC A ; Sulfadimidine USP RC A ; Sulfaguanidine Monohydrate ;

(4-Benzyl-3-{[(2R, 3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-4,5-dihydro-1H-1,2,4-triazol -1-yl)phosphonic acid ;
FSP56A :
Fosaprepitant Impurity F ; N4-Benzyl Fosaprepitant Acid ;

(4-Butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methylethyl butanedioate ;
SXB02 :
Suxibuzone EP Impurity B ;

(4-Chloro-3-methylpyridin-2-yl)methanol ;
CAS:59886-85-0
LSP63 :
Lansoprazole Impurity 3 ;

(4-Chloro-3-methylpyridin-2-yl)methyl acetate ; 2-Acetoxymethyl-4-chloro-3-methylpyridine ;
CAS:59886-84-9
LSP64 :
Lansoprazole Impurity 4 ;

(4-Chlorophenyl)(phenyl)methanol ; 4-Chlorobenzhydrol ;
CAS:119-56-2
LCP52 :
Levocloperastine CBZ Racemate ; Meclizine EP Impurity B ; Meclozine EP Impurity B ; Meclizine USP RC A ; Cetirizine 4-Chlorobenzhydrol Impurity (USP) ;

(4-Chlorophenyl)(phenyl)methanone ;
CAS:134-85-0
HDZ05 :
Hydroxyzine EP Impurity E ; Hydroxyzine 4-Chlorobenzophenone Impurity (USP) ; Cetirizine 4-Chlorobenzophenone Impurity (USP) ; Meclizine EP Impurity C ;

(4-Chlorophenyl)(phenyl)methanone ; 4-Chlorobenzophenone ;
CAS:134-85-0
LCP51 :
Levocloperastine CBP Intermediate ; Meclizine EP Impurity C ; Meclozine EP Impurity C ; Cetirizine 4-Chlorobenzophenone Impurity ; Hydroxyzine 4-Chlorobenzophenone Impurity ; Hydroxyzine EP Impurity E ;

(4-Chlorophenyl)(phenyl)methanone ; 4-Chlorobenzophenone ;
CAS:134-85-0
MCL03 :
Meclizine EP Impurity C ; Meclozine EP Impurity C ; Cetirizine CBP Impurity ; Hydroxyzine CBP Impurity ; Hydroxyzine EP Impurity E ;

(4-Chlorophenyl)acetonitrile ;
CAS:140-53-4
PMM03 :
Pyrimethamine EP Impurity C ;

(4-Cyclohexyl-1-naphthyl)acetic acid ;
VPF03 :
Vedaprofen EP Impurity C ;

(4-Fluoro-2-hydroxyphenyl)(piperidin-4-yl)methanone ;
CAS:767582-67-2
PPD61B :
Paliperidone RC 1 (Base) ;

(4-Fluoro-2-hydroxyphenyl)(piperidin-4-yl)methanone HCl ;
CAS:81043-50-7
PPD61H :
Paliperidone RC 1 (HCl) ;

(4-Fluorophenyl)(piperidin-4-yl)methanone ;
CAS:56346-57-7
PPD77B :
Paliperidone RC 17 (Base) ;

(4-Fluorophenyl)(piperidin-4-yl)methanone hydrochloride ;
CAS:25519-78-2
PPD77H :
Paliperidone RC 17 (HCl) ;

(4-Isobutoxyphenyl)methanamine ;
CAS:4734-09-02 00:00:00
PVN72B :
Pimavanserin RC 12 (Base) ;

(4-Methoxy-3,5,6-trimethylpyridin-2-yl)methyl acetate ;
CAS:91219-90-8
OMP72 :
Omeprazole RC 12 ;

(4-Methylphenyl)sulfonamide ;
CAS:70-55-3
TBM01 :
Tolbutamide EP Impurity A ; Toluenesulfonamide ; Gliclazide EP Impurity A ;

(4-Phenylbutyl)phosphinyl acetic acid ;
CAS:83623-61-4
FSN27A :
Fosinopril USP RC G (Acid) ;

(4-Phenylbutyl)phosphinyl acetic acid disodium salt ;
FSN27N :
Fosinopril USP RC G (Disodium) ;

(4aR,6S,8aR)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol ;
CAS:60384-53-4
GTM06 :
Galantamine EP Impurity F ; Ent-Galantamine ;

(4aS,4bS,5aS,6aS,7R,8R,9aS,9bS,11S)-11-Fluoro-7-hydroxy-7-(2-hydroxyacetyl)-4a,6a,8-trimethyl-5a,6,6a,7,8,9,9a,9b,10,11-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2(4aH)-one ;
CAS:23961-95-7
FLT66 :
Fluticasone RC 6 ;

(4aS,6R,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol ;
CAS:357-70-0
GTM00B :
Galantamine (Base) ;

(4aS,6R,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol hydrobromide ;
CAS:1953-04-04 00:00:00
GTM00H :
Galantamine (HBr) ;

(4aS,6R,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol N-Oxide ;
CAS:134332-50-6
GTM50 :
Galantamine N-Oxide ;

(4aS,6R,8aS)-3-Methoxy-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol ;
CAS:41303-74-6
GTM05 :
Galantamine EP Impurity E ; N-Desmethyl Galantamine ;

(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepine-3,6-diol ;
CAS:60755-80-8
GTM51 :
Galantamine O-Desmethyl Impurity ;

(4aS,6S,8aR)-3-Methoxy-11-methyl-5,6,7,8,9,10,11,12-octahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol ;
CAS:21133-52-8
GTM03 :
Galantamine EP Impurity C ; Dihydro Galantamine ; Lycoramine ;

(4aS,6S,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol ;
CAS:1668-85-5
GTM02 :
Galantamine EP Impurity B ; Epi-Galantamine ;

(4aS,8aR)-4a,5,7,8,9,10,11,12-Octahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one ;
CAS:21041-10-1
GTM52 :
Galanthamine Dihydro Keto Impurity ; Dihydro Narwedine ; Dihydro Galanthaminone ;

(4aS,8aS)-3-Methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-one ;
CAS:510-77-0
GTM01 :
Galantamine EP Impurity A ; Narwedine ; Galanthaminone ;

(4aS,8aS)-3-Methoxy-11-methyl-9,10,11,12-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepine ;
CAS:664995-65-7
GTM04 :
Galantamine EP Impurity D ; Anhydro Galantamine ; Tetrahydro Galantamine ;

(4E)-6-(1,3-Dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid ;
CAS:31858-65-8
MCP31 :
Mycophenolic Acid O-Desmethyl Impurity ; O-Desmethyl Mycophenolic Acid ;

(4E)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoic acid ;
CAS:24280-93-1
MCP06A :
Mycophenolate Mofetil EP Impurity F ; Mycophenolic Acid ;

(4E)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoic acid methyl ester ;
CAS:31858-66-9
MCP05 :
Mycophenolate Mofetil EP Impurity E ; Mycophenolic Acid Methyl Ester ; Methyl Mycophenolate (USP) ;

(4E)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoic acid sodium salt ;
CAS:37415-62-6
MCP00N :
Mycophenolate Sodium ; Mycophenolic Acid Sodium Salt ;

(4E)-9-[[(2E)-4-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]oxiranyl]methyl]tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyl]oxy]non-4-enoic acid ;
CAS:85248-93-7
MPR03A :
Mupirocin EP Impurity C (Acid) ; Pseudomonic Acid D ;

(4E)-9-[[(2E)-4-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]oxiranyl]methyl]tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyl]oxy]non-4-enoic acid sodium salt ;
CAS:85178-60-5
MPR03N :
Mupirocin EP Impurity C (Sodium) ; Pseudomonic Acid D (Sodium) ;

(4E,6E)-7-[3-(4-Fuorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3-hydroxyhepta-4,6-dienoic acid ;
CAS:1207963-21-0
FLV06 :
Fluvastatin EP Impurity F ; Fluvastatin BP Impurity F ; Fluvastatin 3-Hydroxy-4,6-Diene ; Fluvastatin Hydroxydiene (USP) ;

(4E,6E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-(N-methyl(methylsulfonyl) amino]-5-pyrimidinyl]-3-hydroxyhepta-4,6-dienoic acid ;
CAS:1346606-44-7 (RS) 1422954-13-9 (S)
RSV46A :
Rosuvastatin 4,5-Anhydro Acid ; Rosuvastatin 4,6-Diene Impurity ; 4,5-Anhydro Rosuvastatin ;

(4E,6E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-(N-methyl(methylsulfonyl) amino]-5-pyrimidinyl]-3-hydroxyhepta-4,6-dienoic acid calcium salt ;
RSV46C :
Rosuvastatin 4,5-Anhydro Acid Calcium Salt ; Rosuvastatin Calcium 4,6-Diene Impurity ; 4,5-Anhydro Rosuvastatin Calcium ;

(4R) and (4S)-5-O-Demethyl-3,4,22,23-tetrahydroavermectin A1a ;
CAS:74567-01-4
IVM11 :
Ivermectin EP Impurity K ; Ivermectin 3,4-Dihydro Impurity (Mixture of Diastereomers) ;

(4R)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl methyl ester hydrochloride ;
CAS:187731-34-6
LCN40H :
Lercanidipine R-Isomer ;

(4R)-1-(4-O-+¦-D-Galactopyranosyl-+¦-D-glucopyranosyl)-4-(2-methylpropyl)-2-pyrrolidinone ;
CAS:501665-88-9
PRG52 :
Pregabalin Lactam R-Isomer Lactose Adduct ;

(4R)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3GÇÖ,4GÇÖ:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione ;
CAS:1797985-73-9
TTC50 :
Topotecan (R)-Isomer ;

(4R)-4-(3,4-Dichlorophenyl)-3,4-dihydronaphthalen-1(2H)-one ; (R)-4-(3,4-Dichlorophenyl)-1-tetralone ;
CAS:155748-61-1
STL06R :
Sertraline EP Impurity F ; Sertralone (USP) ; Sertraline Tetralone R-Isomer ; (R)-Sertraline Ketone (USP) ;

(4R)-4-Aminohex-5-enoic acid ;
CAS:77162-51-7
VGB51B :
Vigabatrin R-Isomer ;

(4R)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenyl butyl)phosphinyl]acetyl-L-proline propionate (ester) ;
CAS:1356446-78-0
FSN04A :
Fosinopril EP Impurity D (Acid) ; Fosinopril USP RC D ;

(4R)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenyl butyl)phosphinyl]acetyl-L-proline propionate (ester), sodium salt ;
CAS:1356353-41-7
FSN04N :
Fosinopril EP Impurity D (Sodium) ; Fosinopril USP RC D ;

(4R,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl- 1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide ;
CAS:14206-58-7
OTC01 :
Oxytetracycline EP Impurity A ; 4-epi-Oxytetracycline ;

(4R,4aS,12aS)-4-(Dimethylamino)-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide ;
CAS:7518-17-4
TCY04B :
Tetracycline EP Impurity D (Base) ; 4-epi-Anhydro Tetracycline ; Lymecycline EP Impurity D ; Chlortetracycline EP Impurity I ;

(4R,4aS,12aS)-4-(Dimethylamino)-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide ;
CAS:7518-17-4
LMC04B :
Lymecycline EP Impurity D (Base) ; Tetracycline Anhydro 4-Epimer (Base) ; Chlortetracycline EP Impurity I (Base) ;

(4R,4aS,12aS)-4-(Dimethylamino)-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide hydrochloride ;
CAS:4465-65-0
TCY04H :
Tetracycline EP Impurity D (HCl) ; 4-epi-Anhydro Tetracycline HCl ; Lymecycline EP Impurity D (HCl) ; Chlortetracycline EP Impurity I (HCl) ;

(4R,4aS,12aS)-4-(Dimethylamino)-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide hydrochloride ;
CAS:4465-65-0
LMC04H :
Lymecycline EP Impurity D (HCl) ; Chlortetracycline EP Impurity I (HCl) ; Tetracycline Anhydro 4-Epimer HCl ;

(4R,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide ;
CAS:43168-51-0
MNC01B :
Minocycline EP Impurity A (Base) ; Minocycline 4-Epimer ;

(4R,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide HCl ;
CAS:179471-96-6
MNC01H :
Minocycline EP Impurity A (HCl) ; Minocycline 4-Epimer (HCl) ;

(4R,4aS,5aR,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; 6-Demethyl-6-deoxyepitetra- cycline ;
CAS:906364-48-5
SCC54 :
Sancycline Epi-Isomer ;

(4R,4aS,5aR,12aS)-9-[2-(tert-Butylamino)acetamido]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide ;
CAS:1422262-97-2
TGC01B :
Tigecycline EP Impurity A (Base) ; Tigecycline 4-Epimer ;

(4R,4aS,5aS,6S,12aS)-4-(Dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide ;
CAS:79-85-6
TCY01B :
Tetracycline EP Impurity A (Base) ; 4-epi-Tetracycline ; Chlortetracycline EP Impurity D ; Lymecycline EP Impurity A ; Oxytetracycline EP Impurity G ;

(4R,4aS,5aS,6S,12aS)-4-(Dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide ;
CAS:79-85-6
LMC01B :
Lymecycline EP Impurity A (Base) ; Tetracycline 4-Epimer ; Chlortetracycline EP Impurity D (Base) ; Tetracycline EP Impurity A ;

(4R,4aS,5aS,6S,12aS)-4-(Dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide HCl ;
CAS:23313-80-6
LMC01H :
Lymecycline EP Impurity A (HCl) ; 4-Epi Tetracycline HCl ; Chlortetracycline EP Impurity D (HCl) ; Tetracycline EP Impurity A (HCl) ;

(4R,4aS,5aS,6S,12aS)-4-(Dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride ;
CAS:23313-80-6
TCY01H :
Tetracycline EP Impurity A (HCl) ; 4-epi-Tetracycline HCl ; Chlortetracycline EP Impurity D ; Lymecycline EP Impurity A ;

(4R,5S)-5-[(1S,2R)-1-Carboxy-2-hydroxypropyl]-3-[[(3S,5S)-5-[(dimethyl amino)carbonyl]pyrrolidin-3-yl]sulfanyl]-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid ;
CAS:1053703-36-8
MRP01A :
Meropenem EP Impurity A (Diacid) ; Meropenem Open-Ring Impurity (Diacid) ;

(4R,5S)-5-[(1S,2R)-1-Carboxy-2-hydroxypropyl]-3-[[(3S,5S)-5-[(dimethyl amino)carbonyl]pyrrolidin-3-yl]sulfanyl]-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid disodium salt ;
CAS:124190-28-9
MRP01N :
Meropenem EP Impurity A (Disodium Salt) ; Meropenem Open-Ring Impurity (Disodium Salt) ;

(4R,5S,6S)-3-[[(3S,5S)-1-[(2S,3R)-2-[(2S,3R)-5-Carboxy-4-[[(3S,5S)-5-[(dimethylamino)carbonyl]pyrrolidin-3-yl]sulfanyl]-3-methyl-2,3-dihydro-1H-pyrrol-2-yl]-3-hydroxybutanoyl]-5-[(dimethylamino)carbonyl]pyrrolidin-3-yl] sulfanyl]-6- [(1R)-
CAS:166901-45-7
MRP02 :
Meropenem EP Impurity B ; Meropenem Dimer ;

(4R,5S,6S)-3-[[(3S,5S)-5-[(Dimethylamino)carbonyl]pyrrolidin-3-yl]sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid ;
CAS:96036-03-2
MRP00A :
Meropenem (Anhydrous) ;

(4R,5S,6S)-3-[[(3S,5S)-5-[(Dimethylamino)carbonyl]pyrrolidin-3-yl]sulfinyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid ;
MRP61 :
Meropenem Sulfoxide ;

(4R,5S,6S)-3-[[(3S,5S)-5-[(Dimethylamino)carbonyl]pyrrolidin-3-yl]sulfonyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid ;
MRP62 :
Meropenem Sulfone ;

(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(Acetyloxy)-6-[[3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-4-O-propanoyl-a-L-ribo-hexopyranosyl)-3-(dimethylamino)-+ƒ-D-glucopyranosyl]oxy]-10-hydroxy-5-methoxy-9,16-dimethyl-7-(2-oxoethyl)oxacyclohexadeca-11,
CAS:18361-48-3
JSM11 :
Josamycin EP Impurity K ; Leucomycin A6 ;

(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(Acetyloxy)-6-[[3,6-dideoxy-4-O-(2,6-dideoxy-4-O-butanoyl-3-C-methyl-a-L-ribo-hexopyranosyl)-3-(dimethylamino)-+ƒ-D-glucopyranosyloxy]-10-hydroxy-5-methoxy-9,16-dimethyl-7-(2-oxoethyl)oxacyclohexadeca-11,13
JSM01 :
Josamycin EP Impurity A ;

(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(Acetyloxy)-6-[[3,6-dideoxy-4-O-(2,6-dideoxy-4-O-hexanoyl-3-C-methyl-a-L-ribo-hexopyranosyl)-3-(dimethylamino)-+ƒ-D-glucopyranosyl]oxy]-10-hydroxy-5-methoxy-9,16-dimethyl-7-(2-oxoethyl)oxacyclohexadeca-11,1
JSM10 :
Josamycin EP Impurity J ;

(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(Acetyloxy)-6-[[3,6-dideoxy-4-O-[2,6-dideoxy-3-C-methyl-4-O-(3-methylbutanoyl)-a-L-ribo-hexopyranosyl]-3-(dimethylamino)-+ƒ-D-glucopyranosyl]oxy]-10-hydroxy-5-methoxy-9,16-dimethyl-7-(2-oxoethyl)oxacyclohex
CAS:16846-24-5
JSM00 :
Josamycin ;

(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(Acetyloxy)-6-[[3,6-dideoxy-4-O-[2,6-dideoxy-3-C-methyl-4-O-(3-methylbutanoyl)-a-L-ribo-hexopyranosyl]-3-(dimethylamino)-+ƒ-D-glucopyranosyl]oxy]-10-hydroxy-7-(2-hydroxyethyl)-5-methoxy-9,16-dimethyloxacycl
CAS:40361-41-9
JSM02 :
Josamycin EP Impurity B ;

(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[[3,6-Dideoxy-3-(dimethylamino)-+¦-D-glucopyranosyl]oxy]-4-hydroxy-5-methoxy-9,16-dimethyl-7-(2-oxoethyl)-10-[[2,3,4,6-tetradeoxy-4-(dimethylamino)-+¦-D-erythro-hexopyranosyl]oxy]oxacyclohexadeca-11,13-dien-
CAS:70253-62-2
SPM01 :
Spiramycin EP Impurity A ; Neospiramycin I ;

(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[[3,6-Dideoxy-3-(dimethylamino)-+¦-D-glucopyranosyl]oxy]-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-10-[[2,3,4,6-tetradeoxy-4-(dimethylamino)-+¦-D-erythro-hexopyranosyl]oxy]oxacyclohexadeca-11,13-dien-4-yl
SPM07 :
Spiramycin EP Impurity G ; Neospiramycin II ;

(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[[3,6-Dideoxy-3-(dimethylamino)-+¦-D-glucopyranosyl]oxy]-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-10-[[2,3,4,6-tetradeoxy-4-(dimethylamino)-+¦-D-erythro-hexopyranosyl]oxy]oxacyclohexadeca-11,13-dien-4-yl
CAS:4617-99-6
SPM08 :
Spiramycin EP Impurity H ; Neospiramycin III ;

(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[[3,6-Dideoxy-4-O-(2,6-dideoxy-3-C-methyl-+¦-L-ribo-hexopyranosyl)-3-(dimethylamino)-+¦-D-glucopyranosyl]oxy]-10-[(2,6-dideoxy-3-C-methyl-+¦-L-ribo-hexopyranosyl)oxy]-4-hydroxy-5-methoxy-9,16-dimethyl-7-(2-ox
SPM04 :
Spiramycin EP Impurity D ; Spiramycin V ;

(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[[3,6-Dideoxy-4-O-(2,6-dideoxy-3-C-methyl-+¦-L-ribo-hexopyranosyl)-3-(dimethylamino)-+¦-D-glucopyranosyl]oxy]-4-hydroxy-5-methoxy-9,16-dimethyl-7-(2-oxoethyl)-10-[[2,3,4,6-tetradeoxy-4-(dimethylamino)-+¦-D-er
CAS:8025-81-8
SPM00 :
Spiramycin ; Spiramycin I ;

(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[[3,6-Dideoxy-4-O-(2,6-dideoxy-3-C-methyl-+¦-L-ribo-hexopyranosyl)-3-(dimethylamino)-+¦-D-glucopyranosyl]oxy]-4-hydroxy-7-(2-hydroxyethyl)-5-methoxy-9,16-dimethyl-10-[[2,3,4,6-tetradeoxy-4-(dimethylamino)-+¦-
CAS:249930-66-3
SPM02 :
Spiramycin EP Impurity B ; Spiramycin IV ;

(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[[3,6-Dideoxy-4-O-(2,6-dideoxy-3-C-methyl-4-O-propanoyl-a-L-ribo-hexopyranosyl)-3-(dimethylamino)-+ƒ-D-glucopyranosyl] oxy]-4,10-dihydroxy-5-methoxy-9,16-dimethyl-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-2
CAS:18361-47-2
JSM09 :
Josamycin EP Impurity I ; Leucomycin A7 ;

(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[[3,6-Dideoxy-4-O-(2,6-dideoxy-3-C-methyl-a-L-ribo-hexopyranosyl)-3-(dimethylamino)-+ƒ-D-glucopyranosyl]oxy]-4,10-dihydroxy-5-methoxy-9,16-dimethyl-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-2-one ;
CAS:22875-15-6
JSM06 :
Josamycin EP Impurity F ;

(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[[3,6-Dideoxy-4-O-[2,6-dideoxy-3-C-methyl-4-O-(3-methylbutanoyl)-a-L-ribo-hexopyranosyl]-3-(dimethylamino)-+ƒ-D-glucopyranosyl] oxy]-4,10-dihydroxy-5-methoxy-9,16-dimethyl-7-(2-oxoethyl)oxacyclohexadeca-11,
CAS:16846-34-7
JSM08 :
Josamycin EP Impurity H ; Leucomycin A1 ;

(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[[3,6-Dideoxy-4-O-[2,6-dideoxy-3-C-methyl-4-O-(3-methylbutanoyl)-a-L-ribo-hexopyranosyl]-3-(dimethylamino)-+ƒ-D-glucopyranosyl]oxy]-10-hydroxy-5-methoxy-9,16-dimethyl-7-(2-oxoethyl)-4-(propanoyloxy)oxacyclo
CAS:40615-47-2
JSM05 :
Josamycin EP Impurity E ;

(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[[4-O-(4-O-aAcetyl-2,6-dideoxy-3-C-methyl-a-L-ribo-hexopyranosyl)-3,6-dideoxy-3-(dimethylamino)-+ƒ-D-glucopyranosyl]oxy]-4,10-dihydroxy-5-methoxy-9,16-dimethyl-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-2-on
CAS:18361-49-4
JSM07 :
Josamycin EP Impurity G ; Leucomycin A9 ;

(4R,5S,6S,7R,9R,10Z,12E,14R,16R)-4-(Acetyloxy)-6-[[3,6-dideoxy-4-O-[2,6-dideoxy-3-C-methyl-4-O-(3-methylbutanoyl)-a-L-ribo-hexopyranosyl]-3-(dimethylamino)-+ƒ-D-glucopyranosyl]oxy]-14-hydroxy-5-methoxy-9,16-dimethyl-7-(2-oxoethyl)oxacyclohex
JSM04 :
Josamycin EP Impurity D ; Isojosamycin ;

(4R,5S,6S,7S,9R,10R,11E,13E,16R)-6-[[3,6-Dideoxy-4-O-(2,6-dideoxy-3-C-methyl-+¦-L-ribo-hexopyranosyl)-3-(dimethylamino)-+¦-D-glucopyranosyl]oxy]-7-(1-formylethenyl)-4-hydroxy-5-methoxy-9,16-dimethyl-10-[[2,3,4,6-tetradeoxy-4-(dimethylamino)-+¦
CAS:177584-13-3
SPM03 :
Spiramycin EP Impurity C ; 17-Methylenespiramycin I ;

(4R,5S,6S,7S,9R,10R,11E,13E,16R)-6-[[3,6-Dideoxy-4-O-(2,6-dideoxy-3-C-methyl-+¦-L-ribo-hexopyranosyl)-3-(dimethylamino)-+¦-D-glucopyranosyl]oxy]-7-ethyl-4-hydroxy-5-methoxy-9,16-dimethyl-10-[[2,3,4,6-tetradeoxy-4-(dimethylamino)-+¦-D-erythro-h
CAS:177584-14-4
SPM05 :
Spiramycin EP Impurity E ; 18-Deoxy 18-Dihydrospiramycin I ;

(4R,6R)-4-(tert-Butyldimethylsilyloxy)-6-(2-((1S,2S,6R,8S)-8-hydroxy-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)ethyl)-tetrahydropyran-2-one ;
CAS:79902-31-1
LVS64 :
Lovastatin Impurity 4 ;

(4R,6R)-4-Hydroxy-6-(2-((1S,2S,6R,8S)-8-hydroxy-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)ethyl)-tetrahydropyran-2-one ;
CAS:79952-42-4
SVS76
Simvastatin RC 16 ;

(4R,6R)-6-[2-[(1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-Hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl]ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one ;
CAS:79952-42-4
LVS31 :
Lovastatin Lactone Diol ; Simvastatin Lactone Diol ; Monacolin J ;

(4R,6R)-6-[2-[(1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-6,8-dihydroxy-2-methyl-1-naphthalenyl]ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one ;
CAS:159345-93-4
PVS31 :
Pravastatin Lactone Diol ;

(4R,6R)-6-[2-[(2S)-1,2-Dihydro-6-hydroxy-2-methyl-1-naphthalenyl]ethyl] tetrahydro-4-hydroxy-2H-pyran-2-one ;
PVS50 :
Pravastatin Dihydronaphthalene Lactone Impurity ;

(4R,6S)-6-[(1E)-2-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methyl sulfonyl)amino]-5-pyrimidinyl]ethenyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid ;
CAS:894787-93-0
RSV50A :
Rosuvastatin Acetonide (Acid) ;

(4R,6S)-6-[(1E)-2-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methyl sulfonyl)amino]-5-pyrimidinyl]ethenyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid t-butyl ester ;
CAS:289042-12-2
RSV06 :
Rosuvastatin EP Impurity F ; Rosuvastatin USP RC C ; Rosuvastatin Acetonide t-Butyl Ester ;

(4R,6S,E)-6-[2-[2-Cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl] vinyl] tetrahydro-4-hydroxypyran-2-one ;
CAS:141750-63-2
PTV04 :
Pitavastatin Lactone ;

(4RS)-10-Methoxy-4-(1-methylpiperidin-4-yl)-4H-benzo-[4,5]cyclohepta[1,2-b]thiophen-4-ol ;
CAS:59743-88-3
KTT02B :
Ketotifen EP Impurity B ; 4-Hydroxy-9,10-Dehydro-10-Methoxy Ketotifen ;

(4RS)-2-(1,1-Dimethylethyl)-1,2,3,4-tetrahydroisoquinoline-4,6,8-triol ;
CAS:94120-05-5
TBT02B :
Terbutaline EP Impurity B (Base) ;

(4RS)-2-(1,1-Dimethylethyl)-1,2,3,4-tetrahydroisoquinoline-4,6,8-triol hemisulfate ;
CAS:153657-83-1
TBT02S :
Terbutaline EP Impurity B (Hemisulfate) ;

(4RS)-2-(1-Methylethyl)-1,2,3,4-tetrahydroisoquinoline-4,6,8-triol ;
CAS:70988-89-5
OCP01 :
Orciprenaline EP Impurity A ; Metaproterenol EP Impurity A ;

(4RS)-4-[(7-Chloroquinolin-4-yl)amino]pentan-1-ol ;
CAS:10500-64-8
HCQ05B :
Hydroxychloroquine EP Impurity E (Base) ;

(4RS)-4-[(7-Chloroquinolin-4-yl)amino]pentan-1-ol HCl ;
CAS:5456-04-02 00:00:00
HCQ05H :
Hydroxychloroquine EP Impurity E (HCl) ;

(4RS)-4-Aminohex-5-enoic acid ;
CAS:68506-86-5 & 60643-86-9
VGB00B :
Vigabatrin (Base) ;

(4RS)-4-Aminohex-5-enoic acid HCl ;
CAS:1391054-02-6
VGB00H :
Vigabatrin (HCl) ; Vigabatrin Hydrochloride ;

(4RS)-4-Hydroxy-4-(1-methylpiperidin-4-yl)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one ;
CAS:126939-27-3
KTT03B :
Ketotifen EP Impurity C ; 4-Hydroxy Ketotifen ;

(4RS)-4-Phenyl-1-(2-sulfanylethyl)imidazolidin-2-one ;
CAS:32190-33-3
LVM03 :
Levamisole EP Impurity C ;

(4RS)-N4-(7-Chloroquinolin-4-yl)-N1-ethylpentane-1,4-diamine ;
CAS:1476-52-4
HCQ04B :
Hydroxychloroquine EP Impurity D (Base) ; N-Deshydroxyethyl Hydroxychloroquine ; Chloroquine USP RC D ; N-Desethyl Chloroquine ;

(4RS)-N4-(7-Chloroquinolin-4-yl)-N1-ethylpentane-1,4-diamine HCl ;
CAS:4298-11-07 00:00:00
HCQ04H :
Hydroxychloroquine EP Impurity D (HCl) ; N-Deshydroxyethyl Hydroxychloroquine HCl ; Chloroquine USP RC D (HCl) ; N-Desethyl Chloroquine HCl ;

(4S)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl methyl ester hydrochloride ;
CAS:184866-29-3
LCN41H :
Lercanidipine S-Isomer ;

(4S)-1-(4-Ethyl-4,9-dihydroxy-6-oxido-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4',6,7]indolizino[1,2-b]quinolin-10-yl)-N,N-dimethylmethanamine oxide ;
TTC52 :
Topotecan Bis-N-Oxide ;

(4S)-1-(4-O-+¦-D-Galactopyranosyl-+¦-D-glucopyranosyl)-4-(2-methylpropyl)-2-pyrrolidinone ;
CAS:466678-44-4
PRG53 :
Pregabalin Lactam S-Isomer Lactose Adduct ;

(4S)-1-[(2S)-3-Mercapto-2-methyl-1-oxopropyl]-4-(phenylthio)-L-proline ;
CAS:75176-37-3
ZFP50A :
Zofenopril Desbenzoyl Acid ; Zofenoprilat ;

(4S)-1-[(2S)-3-Mercapto-2-methyl-1-oxopropyl]-4-(phenylthio)-L-proline sodium salt ;
CAS:1329569-13-2
ZFP50N :
Zofenopril Desbenzoyl Sodium ; Zofenoprilat Sodium ;

(4S)-2-((R)-1-(2-Ethoxy-1-naphthamido)-2-methoxy-2-oxoethyl)-5,5-dimethylthiazolidine-4-carboxylic acid ;
NFC56 :
Nafcillin Penilloic Acid Methyl Ester ;

(4S)-2-((R)-Carboxy(2-ethoxy-1-naphthamido)methyl)-5,5-dimethylthiazolidine-4-carboxylic acid ;
CAS:940306-31-0
NFC55 :
Nafcillin Penilloic Acid ;

(4S)-2-[[[2-Carboxy-2-(thiophen-3-yl)acetyl]amino]methyl]-5,5-dimethyl- thiazolidine-4-carboxylic acid ;
TCC05 :
Ticarcillin EP Impurity E ; Penilloic Acids of Ticarcillin ;

(4S)-2-[Carboxy[(2-phenoxyacetyl)amino]methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid ;
PHP05A :
Phenoxymethylpenicillin EP Impurity E ; Penicilloic Acids of Phenoxymethylpenicillin ;

(4S)-2-[Carboxy[(2-phenoxyacetyl)amino]methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid ;
CAS:1049-84-9
PNV05A :
Penicillin V EP Impurity E ; Penicilloic Acids of Phenoxymethylpenicillin ;

(4S)-2-[carboxy[[(2R)-2-[[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino]-2- phenylacetyl]amino]methyl]-5,5-dimethylthiazolidine-4-carboxylic acid ;
CAS:64817-22-7
PPR02 :
Piperacillin EP Impurity B ; Piperacilloic Acid ; Penicilloic Acids of Piperacillin ;

(4S)-2-[Carboxy[[2-carboxy-2-(thiophen-3-yl)acetyl]amino]methyl]-5,5-dimethylthiazolidine-4-carboxylic acid ;
TCC04 :
Ticarcillin EP Impurity D ; Penicilloic Acids of Ticarcillin ;

(4S)-2-[Carboxy[[5-methyl-3-phenyllisoxazol-4-yl)carbonyl]amino]methyl]-5,5-dimethylthiazolidine-4-carboxylic acid ;
CAS:1642629-95-5
OXL02A :
Oxacillin EP Impurity B ; Penicilloic Acids of Oxacillin ;

(4S)-3-Acetyl-2-[carboxy[[(2R)-2-[[(4-ethyl-2,3-dioxopiperazin-1-yl) carbonyl] amino]-2-phenylacetyl]amino]methyl]-5,5-dimethylthiazolidine-4-carboxylic acid ;
PPR06 :
Piperacillin EP Impurity F ; Acetylated Penicilloic Acids of Piperacillin ;

(4S)-4,11-Diethyl-4,12-dihydroxy-9-[(4-piperidinopiperidino) carbonyloxy]-1H-pyrano[3GÇÖ,4GÇÖ:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione ;
CAS:185336-12-3
ITC13 :
Irinotecan EP Impurity M ; 12-Hydroxy Irinotecan (EP) ;

(4S)-4,11-Diethyl-4-hydroxy-9-[(2-hydroxy-4-piperidinopiperidino) carbonyl oxy]-1H-pyrano[3GÇÖ,4GÇÖ:6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione ; 2-Hydroxy Irinotecan ;
ITC35 :
Irinotecan 2-Hydroxy Impurity ;

(4S)-4-((3R,7S,8R,9S,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-3-hydroxypentanoic acid ;
CAS:108266-90-6
UDC65 :
Ursodeoxycholic Acid RC 15 ;

(4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-ol ;
CAS:374777-87-4
STL72 :
Sertraline RC 12 ;

(4S)-4-[(2-Methyl-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indol-6-yl)methyl]-1,3-oxazolidin-2-one ;
CAS:2518343-21-8
ZMT08B :
Zolmitriptan EP Impurity H (Base) ; Zolmitriptan Cyclic Impurity ;

(4S)-4-[[3-[2-(Dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinone ;
CAS:251451-30-6
ZMT25B :
Zolmitriptan USP RC E ; Zolmitriptan N-Oxide ; Zolmitriptan EP Impurity B ;

(4S)-4-[[4-[[(2,4-Diaminopteridin-6-yl)methyl]methylamino]benzoyl]amino]-5-methoxy-5-oxopentanoic acid ;
CAS:66147-29-3
MTX09 :
Methotrexate EP Impurity I ; Methotrexate USP RC I ; Methotrexate 1-Methyl Ester ; Methotrexate +¦-Methyl Ester ;

(4S)-4-Aminohex-5-enoic acid ;
CAS:74046-07-4
VGB52B :
Vigabatrin S-Isomer ;

(4S)-4-Cyclohexyl-[(4-phenylbutyl)phosphinyl]acetyl-L-proline ;
CAS:95399-71-6
FSN01A :
Fosinopril EP Impurity A (Acid) ; Fosinopril USP RC A ; Fosinopril Diacid ; Fosinoprilic Acid ;

(4S)-4-Cyclohexyl-[(4-phenylbutyl)phosphinyl]acetyl-L-proline disodium salt ;
FSN01N :
Fosinopril EP Impurity A (Sodium) ; Fosinopril USP RC A ; Fosinopril Diacid Disodium ; Fosinoprilic Acid Disodium Salt;

(4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenyl butyl) phosphinyl]acetyl-D-proline propionate (ester), hemibarium salt, sesquihydrate ;
FSN22B :
Fosinopril USP RC B ;

(4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl) phosphinyl]acetyl-L-proline propionate (ester), sodium salt ;
CAS:88889-14-9
FSN00N :
Fosinopril Sodium ;

(4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl) phosphinyl]acetyl-L-proline propionate ;
CAS:98048-97-6
FSN00A :
Fosinopril Acid ; (supplied as Fosinopril Sodium)

(4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxypropoxy](4-phenylbutyl) phosphinyl] acetyl-L-proline propionate (ester), sodium salt ;
FSN06N :
Fosinopril EP Impurity F (Sodium) ; Fosinopril USP RC F ;

(4S)-4-Cyclohexyl-1-[(RS)-1-hydroxy-2-methylpropoxy](4-phenylbutyl) phosphinyl]-acetyl-L-proline propionate (ester), sodium salt ;
CAS:1217600-34-4
FSN03N :
Fosinopril EP Impurity C (Sodium) ; Fosinopril USP RC C ;

(4S)-4-Ethyl-4-hydroxy-11-(1-hydroxypropyl)-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino-[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate ;
ITC11 :
Irinotecan EP Impurity K ; Irinotecan 11-Hydroxypropyl Analog ;

(4S)-4-Phenyl-1-[(R)-[(S)-1-hydroxy-2-methyl-propoxy](4-phenylbutyl) phospinyl]acetyl-L-proline propionate (ester), sodium salt ;
FSN05N :
Fosinopril EP Impurity E (Sodium) ; Fosinopril USP RC E ;

(4S)-Pivaloyloxymethyl 2-(3,6-dioxo-5-phenylpiperazin-2-yl)-5,5-dimethylthiazolidine-4-carboxylate ;
PVA02 :
Pivampicillin EP Impurity B ; Diketopiperazines of Pivampicillin ;

(4S,4aR,5R,12aS)-4-(Dimethylamino)-3,5,10,11,12a-pentahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide ;
CAS:4660-26-8
OTC06B :
Oxytetracycline EP Impurity F ; Anhydro Oxytetracycline ; Dehydrotetracycline ;

(4S,4aR,5R,12aS)-4-(Dimethylamino)-3,5,10,11,12a-pentahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide HCl ;
CAS:51596-09-9
OTC06H :
Oxytetracycline EP Impurity F (HCl) ; Anhydro Oxytetracycline HCl ; Dehydrotetracycline HCl ;

(4S,4aR,5S,5aR,6S,12aS) -4-(dimethylamino)-3,5,6,10,11,12a-hexahydroxy -6-methyl-1,12-dioxo-1,4,4a,5,5a,6,12,12a-octahydrotetracene -2-carboxamide ;
CAS:79-57-2
OTC00B :
Oxytetracycline (Anhydrous) ; Doxycycline EP Impurity E ;

(4S,4aR,5S,5aR,6S,12aS) -4-(dimethylamino)-3,5,6,10,11,12a-hexahydroxy -6-methyl-1,12-dioxo-1,4,4a,5,5a,6,12,12a-octahydrotetracene -2-carboxamide dihydrate ;
CAS:6153-64-6
OTC00D :
Oxytetracycline (Dihydrate) ; Doxycycline EP Impurity E ;

(4S,4aR,5S,5aR,6S,12aS) -4-(dimethylamino)-3,5,6,10,11,12a-hexahydroxy -6-methyl-1,12-dioxo-1,4,4a,5,5a,6,12,12a-octahydrotetracene -2-carboxamide HCl ;
CAS:2058-46-0
OTC00H :
Oxytetracycline (HCl) ; Doxycycline EP Impurity E (HCl) ;

(4S,4aR,5S,5aR,6S,12aS)-2-acetyl-4-(Dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-4a,5a,6,12a-tetrahydrotetracene-1,11(4H,5H)-dione ;
CAS:6542-44-5 7647-65-6
OTC03 :
Oxytetracycline EP Impurity C ; 2-Acetyl 2-Decarbamoyl Oxytetracycline ; Oxytetracycline 2-Acetyl Analog ;

(4S,4aS,12aS)-4-(Dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-2-naphthacenecarboxamide ;
CAS:1665-56-1
TCY03B :
Tetracycline EP Impurity C (Base) ; Anhydro Tetracycline ; Lymecycline EP Impurity C ; Chlortetracycline EP Impurity J ;

(4S,4aS,12aS)-4-(Dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-2-naphthacenecarboxamide hydrochloride ;
CAS:13803-65-1
TCY03H :
Tetracycline EP Impurity C (HCl) ; Anhydro Tetracycline HCl ; Lymecycline EP Impurity C (HCl) ; Chlortetracycline EP Impurity J (HCl) ;

(4S,4aS,12aS)-4-(Dimethylamino)-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide ;
CAS:1665-56-1
LMC03B :
Lymecycline EP Impurity C (Base) ; Anhydro Tetracycline ; Chlortetracycline EP Impurity J ;

(4S,4aS,12aS)-4-(Dimethylamino)-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide hydrochloride ;
CAS:13803-65-1
LMC03H :
Lymecycline EP Impurity C (HCl) ; Anhydro Tetracycline HCl ; Chlortetracycline EP Impurity J (HCl) ;

(4S,4aS,12aS)-7-Chloro-4-(dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-2-naphthacenecarboxamide ;
CAS:4497-08-09 00:00:00
TCY51B :
Tetracycline Anhydro Chloro (Base) ; Chlortetracycline EP Impurity L (Base) ;

(4S,4aS,12aS)-7-Chloro-4-(dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-2-naphthacenecarboxamide hydrochloride ;
CAS:65490-24-6
TCY51H :
Tetracycline Anhydro Chloro HCl ;

(4S,4aS,5aR,12aS)-4,7,9-Tris(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide ;
CAS:601455-95-2
MNC07B :
Minocycline EP Impurity G (Base) ; 9-Dimethylamino Minocycline ;

(4S,4aS,5aR,12aS)-4,7,9-Tris(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride ;
MNC07H :
Minocycline EP Impurity G (HCl) ; 9-Dimethylamino Minocycline HCl ;